
<html lang="en"     class="pb-page"  data-request-id="4447a0a6-064e-4b3b-b40f-da0ba5ad2420"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.6b01478;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2017.60.issue-6"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase Kinase" /></meta><meta name="dc.Creator" content="Paul A.  Brough" /></meta><meta name="dc.Creator" content="Lisa  Baker" /></meta><meta name="dc.Creator" content="Simon  Bedford" /></meta><meta name="dc.Creator" content="Kirsten  Brown" /></meta><meta name="dc.Creator" content="Seema  Chavda" /></meta><meta name="dc.Creator" content="Victoria  Chell" /></meta><meta name="dc.Creator" content="Jalanie  D’Alessandro" /></meta><meta name="dc.Creator" content="Nicholas G. M.  Davies" /></meta><meta name="dc.Creator" content="Ben  Davis" /></meta><meta name="dc.Creator" content="Loic  Le Strat" /></meta><meta name="dc.Creator" content="Alba T.  Macias" /></meta><meta name="dc.Creator" content="Daniel  Maddox" /></meta><meta name="dc.Creator" content="Patrick C.  Mahon" /></meta><meta name="dc.Creator" content="Andrew J.  Massey" /></meta><meta name="dc.Creator" content="Natalia  Matassova" /></meta><meta name="dc.Creator" content="Sean  McKenna" /></meta><meta name="dc.Creator" content="Johannes W. G.  Meissner" /></meta><meta name="dc.Creator" content="Jonathan D.  Moore" /></meta><meta name="dc.Creator" content="James B.  Murray" /></meta><meta name="dc.Creator" content="Christopher J.  Northfield" /></meta><meta name="dc.Creator" content="Charles  Parry" /></meta><meta name="dc.Creator" content="Rachel  Parsons" /></meta><meta name="dc.Creator" content="Stephen D.  Roughley" /></meta><meta name="dc.Creator" content="Terry  Shaw" /></meta><meta name="dc.Creator" content="Heather  Simmonite" /></meta><meta name="dc.Creator" content="Stephen  Stokes" /></meta><meta name="dc.Creator" content="Allan  Surgenor" /></meta><meta name="dc.Creator" content="Emma  Stefaniak" /></meta><meta name="dc.Creator" content="Alan  Robertson" /></meta><meta name="dc.Creator" content="Yikang  Wang" /></meta><meta name="dc.Creator" content="Paul  Webb" /></meta><meta name="dc.Creator" content="Neil  Whitehead" /></meta><meta name="dc.Creator" content="Mike  Wood" /></meta><meta name="dc.Description" content="Libraries of nonpurified resorcinol amide derivatives were screened by surface plasmon resonance (SPR) to determine the binding dissociation constant (off-rate, kd) for compounds binding to the pyr..." /></meta><meta name="Description" content="Libraries of nonpurified resorcinol amide derivatives were screened by surface plasmon resonance (SPR) to determine the binding dissociation constant (off-rate, kd) for compounds binding to the pyr..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 15, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01478" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01478" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01478" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01478" /></link>
        
    
    

<title>Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase Kinase | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01478" /></meta><meta property="og:title" content="Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase Kinase" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0017.jpeg" /></meta><meta property="og:description" content="Libraries of nonpurified resorcinol amide derivatives were screened by surface plasmon resonance (SPR) to determine the binding dissociation constant (off-rate, kd) for compounds binding to the pyruvate dehydrogenase kinase (PDHK) enzyme. Parallel off-rate measurements against HSP90 and application of structure-based drug design enabled rapid hit to lead progression in a program to identify pan-isoform ATP-competitive inhibitors of PDHK. Lead optimization identified selective sub-100-nM inhibitors of the enzyme which significantly reduced phosphorylation of the E1α subunit in the PC3 cancer cell line in vitro." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01478"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01478">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01478&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01478&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01478&amp;href=/doi/10.1021/acs.jmedchem.6b01478" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2271-2286</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01457" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01578" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase Kinase</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+A.++Brough">Paul A. Brough</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-7789-8101" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lisa++Baker">Lisa Baker</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simon++Bedford">Simon Bedford</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kirsten++Brown">Kirsten Brown</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Seema++Chavda">Seema Chavda</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Victoria++Chell">Victoria Chell</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jalanie++D%E2%80%99Alessandro">Jalanie D’Alessandro</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+G.+M.++Davies">Nicholas G. M. Davies</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ben++Davis">Ben Davis</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Loic++Le+Strat">Loic Le Strat</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alba+T.++Macias">Alba T. Macias</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Maddox">Daniel Maddox</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick+C.++Mahon">Patrick C. Mahon</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+J.++Massey">Andrew J. Massey</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Natalia++Matassova">Natalia Matassova</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sean++McKenna">Sean McKenna</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Johannes+W.+G.++Meissner">Johannes W. G. Meissner</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan+D.++Moore">Jonathan D. Moore</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+B.++Murray">James B. Murray</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Northfield">Christopher J. Northfield</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles++Parry">Charles Parry</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rachel++Parsons">Rachel Parsons</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+D.++Roughley">Stephen D. Roughley</a></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-0683-5693" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Terry++Shaw">Terry Shaw</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Heather++Simmonite">Heather Simmonite</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Stokes">Stephen Stokes</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allan++Surgenor">Allan Surgenor</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emma++Stefaniak">Emma Stefaniak</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan++Robertson">Alan Robertson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yikang++Wang">Yikang Wang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Webb">Paul Webb</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Neil++Whitehead">Neil Whitehead</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mike++Wood">Mike Wood</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div><div class="corresp-info"><strong>*</strong>(P. A. Brough) Tel. +44 (0)1223 895555; E-mail: <a href="/cdn-cgi/l/email-protection#17673975657862707f5761726579767b7e643974787a"><span class="__cf_email__" data-cfemail="d2a2fcb0a0bda7b5ba92a4b7a0bcb3bebba1fcb1bdbf">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01478&amp;href=/doi/10.1021%2Facs.jmedchem.6b01478" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2271–2286</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 15, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 October 2016</li><li><span class="item_label"><b>Published</b> online</span>15 February 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 March 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01478" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01478</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2271%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPaul%2BA.%2BBrough%252C%2BLisa%2BBaker%252C%2BSimon%2BBedford%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D6%26contentID%3Dacs.jmedchem.6b01478%26title%3DApplication%2Bof%2BOff-Rate%2BScreening%2Bin%2Bthe%2BIdentification%2Bof%2BNovel%2BPan-Isoform%2BInhibitors%2Bof%2BPyruvate%2BDehydrogenase%2BKinase%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2286%26publicationDate%3DMarch%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01478"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2866</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">17</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01478" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase Kinase&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;A. Brough&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;Baker&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;Bedford&quot;},{&quot;first_name&quot;:&quot;Kirsten&quot;,&quot;last_name&quot;:&quot;Brown&quot;},{&quot;first_name&quot;:&quot;Seema&quot;,&quot;last_name&quot;:&quot;Chavda&quot;},{&quot;first_name&quot;:&quot;Victoria&quot;,&quot;last_name&quot;:&quot;Chell&quot;},{&quot;first_name&quot;:&quot;Jalanie&quot;,&quot;last_name&quot;:&quot;D’Alessandro&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;G. M. Davies&quot;},{&quot;first_name&quot;:&quot;Ben&quot;,&quot;last_name&quot;:&quot;Davis&quot;},{&quot;first_name&quot;:&quot;Loic&quot;,&quot;last_name&quot;:&quot;Le Strat&quot;},{&quot;first_name&quot;:&quot;Alba&quot;,&quot;last_name&quot;:&quot;T. Macias&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Maddox&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;C. Mahon&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;J. Massey&quot;},{&quot;first_name&quot;:&quot;Natalia&quot;,&quot;last_name&quot;:&quot;Matassova&quot;},{&quot;first_name&quot;:&quot;Sean&quot;,&quot;last_name&quot;:&quot;McKenna&quot;},{&quot;first_name&quot;:&quot;Johannes&quot;,&quot;last_name&quot;:&quot;W. G. Meissner&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;D. Moore&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;B. Murray&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Northfield&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;Parry&quot;},{&quot;first_name&quot;:&quot;Rachel&quot;,&quot;last_name&quot;:&quot;Parsons&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;D. Roughley&quot;},{&quot;first_name&quot;:&quot;Terry&quot;,&quot;last_name&quot;:&quot;Shaw&quot;},{&quot;first_name&quot;:&quot;Heather&quot;,&quot;last_name&quot;:&quot;Simmonite&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Stokes&quot;},{&quot;first_name&quot;:&quot;Allan&quot;,&quot;last_name&quot;:&quot;Surgenor&quot;},{&quot;first_name&quot;:&quot;Emma&quot;,&quot;last_name&quot;:&quot;Stefaniak&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;Robertson&quot;},{&quot;first_name&quot;:&quot;Yikang&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Webb&quot;},{&quot;first_name&quot;:&quot;Neil&quot;,&quot;last_name&quot;:&quot;Whitehead&quot;},{&quot;first_name&quot;:&quot;Mike&quot;,&quot;last_name&quot;:&quot;Wood&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;2271-2286&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01478&quot;},&quot;abstract&quot;:&quot;Libraries of nonpurified resorcinol amide derivatives were screened by surface plasmon resonance (SPR) to determine the binding dissociation constant (off-rate, kd) for compounds binding to the pyruvate dehydrogenase kinase (PDHK) enzyme. Parallel off-rate measurements against HSP90 and application of structure-based drug design enabled rapid hit to lead progression in a program to identify pan-isoform ATP-competitive inhibitors of PDHK. Lead optimization identified selective sub-100-nM inhibitors of the enzyme which significantly reduced phosphorylation of the E1α subunit in the PC3 cancer cell line in vitro.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01478&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01478" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01478&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01478" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01478&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01478" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01478&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01478&amp;href=/doi/10.1021/acs.jmedchem.6b01478" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01478" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01478" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01478%26sid%3Dliteratum%253Aachs%26pmid%3D28199108%26genre%3Darticle%26aulast%3DBrough%26date%3D2017%26atitle%3DApplication%2Bof%2BOff-Rate%2BScreening%2Bin%2Bthe%2BIdentification%2Bof%2BNovel%2BPan-Isoform%2BInhibitors%2Bof%2BPyruvate%2BDehydrogenase%2BKinase%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D6%26spage%3D2271%26epage%3D2286%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292119" title="Surface plasmon resonance">Surface plasmon resonance</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/jmcmar.2017.60.issue-6/20170323/jmcmar.2017.60.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Libraries of nonpurified resorcinol amide derivatives were screened by surface plasmon resonance (SPR) to determine the binding dissociation constant (off-rate, <i>k</i><sub>d</sub>) for compounds binding to the pyruvate dehydrogenase kinase (PDHK) enzyme. Parallel off-rate measurements against HSP90 and application of structure-based drug design enabled rapid hit to lead progression in a program to identify pan-isoform ATP-competitive inhibitors of PDHK. Lead optimization identified selective sub-100-nM inhibitors of the enzyme which significantly reduced phosphorylation of the E1α subunit in the PC3 cancer cell line <i>in vitro</i>.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86260" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86260" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Pyruvate dehydrogenase kinase (PDHK, also abbreviated as PDK), is a member of the GHKL ATPase/kinase superfamily,<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> and a key regulator of the activity of the pyruvate dehydrogenase complex (PDC). Phosphorylation of specific serine residues in the E1α subunit of the PDC by the four mammalian isoforms of PDHK (PDHK-1, 2, 3, and 4) inhibits complex activity. Conversely, reactivation of the PDC is controlled by two opposing PDC phosphatase isozymes, PDP-1 and PDP-2.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The PDC performs a pivotal role in central carbon metabolism in that it links glycolysis with the TCA cycle by catalyzing the oxidative decarboxylation of pyruvate to acetyl-CoA in the mitochondrial matrix. Therefore, the net activity of the PDHK and PDP isoforms determines the degree to which glycolytically derived pyruvate is utilized for ATP generation by aerobic respiration.</div><div class="NLM_p">The known biological role of PDHK and studies linking increased expression of PDHK-4 to the suppression of glucose oxidation under conditions of insulin deficiency gave rise to the initial interest in this enzyme as a therapeutic target for the treatment of type 2 diabetes.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> These efforts led to identification of potent inhibitors of PDHK such as AZD7545<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and Nov3r<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> (compounds <b>3</b> and <b>2</b>; <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of compounds known to bind PDHK.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">More recently, PDHK has gained attention in the field of cancer metabolism in relation to its potential role in the phenomenon of “aerobic glycolysis”,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> wherein cancer cells exhibit increased utilization of glycolysis even in the presence of sufficient oxygen to oxidize glucose through aerobic respiration.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Several recent reports have demonstrated both cancer specific upregulation of PDHK expression as well as a role in maintaining the glycolytic phenotype of cancer cells.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14">(10-14)</a> The pyruvate analogue dichloroacetic acid (DCA, <b>1</b>; <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) is a weak inhibitor of PDHK which has been previously studied in the treatment of diabetes,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> lactic acidosis,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and myocardial ischemia,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and recently used to study the role of PDHK in cancer.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a> However, interpretation of these studies has been complicated by conflicting data and the lack of specificity of this agent for PDHK. Additionally, toxic effects such as neuropathy and cataract formation limit long-term treatment.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">In 2006 Knoechel et al.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> published PDHK-2 X-ray crystal structures demonstrating the binding sites of <b>1</b>, <b>2</b>, and <b>5</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Later, in 2007 Kato et al.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> published data which identified the binding sites for compounds <b>1</b>, <b>3</b>, and <b>4</b>. In PDHK-1 or PDHK-3, compound <b>3</b> (and compound <b>2</b> in PDHK-2) binds in a deep groove at the interface of the E2/L2 binding site of the N-terminal regulatory (R) domain. DCA (<b>1</b>) binds in a shallow pyruvate binding site located within the helix bundle of the R domain, and the allosteric inhibitor <b>5</b> binds in an extended site at the other end of the R domain to E2/L2. It is proposed that different inhibitor classes act by distinct mechanisms. Of particular interest was the disclosure of the binding of the natural product radicicol (<b>4</b>; <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) in the ATP binding site on PDHK-3. Radicicol (<b>4</b>) is also a weak inhibitor (<i>K</i><sub>i</sub> = 20 μM) of the molecular chaperone HSP90<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> and binds to the ATP site of that enzyme. HSP90 is a member of the same GHKL ATPase/Kinase super family as PDHK, and the ATP binding sites of these two enzymes share a high degree of similarity. Potent inhibitors of the ATP binding site of PDHK had not been disclosed in the literature at this time, and we therefore reasoned that mediation of PDHK activity via inhibition of ATP binding was a suitable strategy to investigate the therapeutic potential of inhibiting PDHK.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic overlay of the binding sites in PDHK-2 of <b>1</b>, (brown), <b>2</b> (yellow), ATP (magenta), and <b>5</b> (white).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We have significant previous experience in targeting the ATP site of the chaperone HSP90,<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26-28)</a> with a particular focus on using fragment-based drug design.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> From these studies we had generated many novel HSP90 inhibitors representing a number of distinct chemotypes. Cross screening of these assets against PDHK identified several HSP90 inhibitors from the resorcinol class of inhibitor which displayed <10 μM potency against PDHK-2. However, these compounds were not selective against HSP90, being typically 1–2 orders of magnitude more potent against HSP90. Close inspection of the PDHK and HSP90 binding sites (apo and ligand bound X-ray structures) led us to believe that selectivity between the PDHK and HSP90 ATP binding sites was achievable. Initial experiments demonstrated that building selectivity into existing HSP90 inhibitors using structural information was a feasible strategy. However, the considerable success of fragment-based approaches for HSP90<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> suggested that fragment-based screening could be amenable for identifying PDHK ATP site inhibitors.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78000" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78000" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A fragment screen against PDHK-2 using a proprietary library of 1063 fragments identified 78 class 1 hits (those that demonstrated binding in three distinct 1H NMR experiments and were competitive with ATP site binders (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01478/suppl_file/jm6b01478_si_001.pdf" class="ext-link">SI</a>). Of this hit set, 43 compounds generated ligand–protein X-ray structures following compound soaking into PDHK-3 crystals. Simple resorcinols were identified among this set of bound fragment hits. We evaluated the binding mode of the resorcinol analogue compound <b>6</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) determined by ligand–protein crystallography in PDHK-3 and discovered it was essentially identical to that seen for the same compound in HSP90 crystallographic studies (unpublished results), with respect to the interaction with key conserved residues and network water molecules. Synthetically tractable analogues of this hit include resorcinol tertiary amide derivatives, such as compound <b>7</b>, which has two promising elaboration vectors from the amide nitrogen. Resorcinol amides have previously been developed as potent HSP90 inhibitors,<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> with one example in the clinic,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and served as a reminder of the importance of considering selectivity in this program. One of the first resorcinol amides synthesized was the <i>N</i>-aryl, <i>N</i>-methyl compound <b>8</b>. This compound was tested for PDHK inhibition using a fluorescence polarization (FP) assay with a labeled resorcinol isoxazole inhibitor (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01478/suppl_file/jm6b01478_si_001.pdf" class="ext-link">SI</a>) and displayed low micromolar activity against the PDHK-2 isoform. This affinity measurement corresponded to a high ligand efficiency (LE) of 0.41 kcal/mol/heavy atom and thus represented a promising start point for further optimization. However, not surprisingly, this compound was essentially equipotent against HSP90 (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Ligand X-ray crystallography (in PDHK-2) showed the close overlap for the fragment hit <b>6</b> and resorcinol amide <b>8</b>. The <i>bis</i> amide <b>9</b> displayed submicromolar potency and some selectivity but still retained appreciable affinity for HSP90.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Fragment hit (<b>6</b>) and related resorcinol amide PDHK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Affinity of Compounds <b>8–11</b> as Measured by FP Assay against PDHK-2 and HSP90α</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0016.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">PDHK-2</th><th class="rowsep1 colsep0" colspan="3" align="center">HSP90α</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Cmpd</th><th class="colsep0 rowsep0" align="center">R1</th><th class="colsep0 rowsep0" align="center">R2</th><th class="colsep0 rowsep0" align="center" char=".">FP IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">cK<sub>i</sub><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">LE<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">FP IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">cK<sub>i</sub><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a> (μM)</th><th class="colsep0 rowsep0" align="center">LE<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">2.23</td><td class="colsep0 rowsep0" align="char" char=".">1.07</td><td class="colsep0 rowsep0" align="char" char=".">0.41</td><td class="colsep0 rowsep0" align="left">3.02</td><td class="colsep0 rowsep0" align="left">1.38</td><td class="colsep0 rowsep0" align="left">0.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">CONMe<sub>2</sub></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="char" char=".">0.41</td><td class="colsep0 rowsep0" align="left">2.97</td><td class="colsep0 rowsep0" align="left">1.23</td><td class="colsep0 rowsep0" align="left">0.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CONHEt</td><td class="colsep0 rowsep0" align="char" char=".">4.46</td><td class="colsep0 rowsep0" align="char" char=".">2.17</td><td class="colsep0 rowsep0" align="char" char=".">0.31</td><td class="colsep0 rowsep0" align="left">74% inh @200 μM</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>NEt<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">2.78</td><td class="colsep0 rowsep0" align="char" char=".">1.33</td><td class="colsep0 rowsep0" align="char" char=".">0.31</td><td class="colsep0 rowsep0" align="left">79% inh @200 μM</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Units for LE are kcal/mol/heavy atom.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">cK<sub>i</sub> for <b>8</b> against PDHK-1, PDHK-3, and PDHK-4 = 1.93, 0.55, and 1.27 μM, respectively. All results are the mean of at least two independent determinations.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">cK<sub>i</sub> is calculated inhibition constant, calculated from the FP IC<sub>50</sub>.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></p></div></div></div><div class="NLM_p">Though the structures of the PDHK-2 and HSP90 ATP binding sites are similar, they exhibit some important differences. Molecular modeling indicated that elaboration of the vector from the <i>N</i>-methyl of compound <b>7</b> would likely induce a steric clash with residues Ile96 and Lys98 in HSP90, as this was one region of the protein that differed in the two ATPases. Several simple derivatives of <b>8</b> were made (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), building from the <i>N</i>-methyl, and though many were equipotent to <b>8</b>, a number of compounds such as <b>10</b> and <b>11</b> exhibited selectivity over HSP90 (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). This selectivity, however, resulted in significantly reduced ligand efficiency (LE for <b>9</b> and <b>10</b> was 0.31 kcal/mol/HA). Compounds <b>8</b>–<b>10</b> were also tested for activity against PDHK-1, 3, and 4 and demonstrated equipotency against the four PDHK isoforms. This was in accordance with expectations based on the analysis of their respective ATP binding sites. Analysis of compound <b>10</b> bound to PDHK-2 and HSP90 demonstrated that <b>10</b> binds in a different (presumably less efficient) conformation in HSP90 as a consequence of unfavorable interactions with residues Lys58 and Ile96 in HSP90 (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Overlay of X-ray crystal structures (ATP binding region) of compound <b>10</b> in PDHK-2 (blue; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4K">5M4K</a>) and HSP90 (yellow; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4E">5M4E</a>), illustrating the different positions of the ligand in the two proteins due to the proximity of residues Ile96 and Lys58 in HSP90.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The initial results with respect to selectivity over HSP90 were encouraging and warranted further hit to lead studies. For these early compounds, no selectivity over the PDHK isoforms was observed. This pan isoform inhibition profile remained for the resorcinol amide inhibitors throughout the subsequent optimization, for both affinity and functional assays. We chose PDHK-1 as primary isoform for affinity assays, as literature suggested this may have a significant role in cell proliferation. PDHK-2 and PDHK-3 were suitable surrogates for X-ray crystallographic studies, based on detailed comparison of the PDHK ATP binding sites across the isoforms. We used PDHK-3 for fragment characterization and PDHK-2 for the majority of the subsequent SBDD. We recently reported on a method of screening which uses surface plasmon resonance (SPR) to measure the dissociation constant <i>k</i><sub>d</sub> (off-rate) of ligand-protein binding.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> This demonstrated that it was possible to accurately determine the <i>k</i><sub>d</sub> from unpurified reaction products. The theoretical basis for off-rate screening (ORS) has been discussed previously and relies on this aspect of binding being independent of ligand concentration. Optimizing the <i>k</i><sub>d</sub> has the greatest potential to enhance compound potency. Experimental validation of this approach<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> used several test cases, one of which was HSP90. We reasoned, based on the target and tractability of the synthetic route to resorcinol amides, that ORS could be used to screen libraries of resorcinol amides prepared from parallel chemistry as part of our PDHK hit to lead campaign.</div><div class="NLM_p">An amenable synthetic route was devised (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) which enabled the formation of acid chloride intermediates <b>13</b> and <b>13a</b>; subsequent coupling of these intermediates with excess amines and protecting group removal in a single well of a 1 mL 96 well plate led to formation of amides <b>7</b> and <b>7a</b>. Key to this route was the selection of acetate protecting groups for the resorcinol, which were removed under ambient conditions using methanolic ammonia.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0013.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Resorcinol Amide ORS Library<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span><i>Reagents and conditions</i>: (a) oxalyl chloride, cat. DMF, DCM; (b) R<sub>1</sub>R<sub>2</sub>NH, Et<sub>3</sub>N, DCM, 16 h; (c) NH<sub>3</sub>, MeOH.</p></p></figure><div class="NLM_p">The first library prepared was from a set of 56 secondary amines selected on the basis of diversity, availability, and consideration of early SAR from compounds such as those in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>. Following evaporation of solvents in the 96 well plate, DMSO (500 μL) was added to give a nominal compound concentration of 20 mM. Small aliquots of this solution were analyzed by LCMS to confirm the presence of the target resorcinol amide. However, as described previously, the purity, and thus concentration, of the target compound in the screening solution, was not expected to significantly affect the measurement of the <i>k</i><sub>d</sub>. The prepared library was screened concomitantly by SPR against PDHK-1 and HSP90 along with blank reference wells and control compounds. The compounds that generated the slowest off-rates for PDHK-1 in this assay are illustrated in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>. Under the library synthesis conditions, unreacted starting material <b>12</b> was converted to the primary amide <b>7</b> (R<sub>1</sub>, R<sub>2</sub> = H). Compound <b>7</b> had a fast PDHK-1 <i>k</i><sub>d</sub> of ≥1.0 s<sup>–1</sup> by SPR and, as described,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> should not affect the validity of the <i>k</i><sub>d</sub> measurement of the reaction product.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Structure of compounds with <i>k</i><sub>d</sub> ≤ 0.25 s<sup>–1</sup> against PDHK-1 as measured by SPR of the crude reaction products of a parallel library. LC purities (% at 254 nm) are shown for the ORS library sample. Purity of reprepared material is >95%. (B) Dissociation phase of crude samples of <b>15</b>, <b>16</b>, <b>17</b>, and <b>18</b> and the dual PDHK/HSP90 inhibitor control compound <b>19</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> by SPR. The compounds displayed bind to His-His-PDHK-1 immobilized on the NTA chip at 25 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Affinity Data for Initial ORS Library Screen Compounds against PDHK-1 and HSP90α as Measured by SPR and FP Assays<a class="ref internalNav" href="#t2fn2" aria-label="a">a</a>,<a class="ref internalNav" href="#t2fn3" aria-label="b">b</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">PDHK-1</th><th class="rowsep1 colsep0" colspan="4" align="center">HSP90α</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Cmpd</th><th class="colsep0 rowsep0" align="center">SPR <i>k</i><sub>d</sub> (crude) (s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center">SPR <i>k</i><sub>d</sub> (pure) (s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center">FP cK<sub>i</sub> (pure) (μM)</th><th class="colsep0 rowsep0" align="center">LE<a class="ref internalNav" href="#t2fn1" aria-label="*">*</a></th><th class="colsep0 rowsep0" align="center">SPR <i>k</i><sub>d</sub> (crude) (s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center">SPR <i>k</i><sub>d</sub> (pure) (s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center">FP cK<sub>i</sub> (pure) (μM)</th><th class="colsep0 rowsep0" align="center">LE<a class="ref internalNav" href="#t2fn1" aria-label="*">*</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b> (rac)</td><td class="colsep0 rowsep0" align="left">0.09</td><td class="colsep0 rowsep0" align="left">0.08</td><td class="colsep0 rowsep0" align="left">0.200</td><td class="colsep0 rowsep0" align="left">0.42</td><td class="colsep0 rowsep0" align="left">0.22</td><td class="colsep0 rowsep0" align="left">0.23</td><td class="colsep0 rowsep0" align="left">9.15</td><td class="colsep0 rowsep0" align="left">0.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(S)-15</b></td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.08</td><td class="colsep0 rowsep0" align="left">0.090</td><td class="colsep0 rowsep0" align="left">0.44</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.18</td><td class="colsep0 rowsep0" align="left">3.48</td><td class="colsep0 rowsep0" align="left">0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(R)-15</b></td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.27</td><td class="colsep0 rowsep0" align="left">1.17</td><td class="colsep0 rowsep0" align="left">0.37</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.60</td><td class="colsep0 rowsep0" align="left">62% @200</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.26</td><td class="colsep0 rowsep0" align="left">0.27</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.184</td><td class="colsep0 rowsep0" align="left">0.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">0.26</td><td class="colsep0 rowsep0" align="left">0.98</td><td class="colsep0 rowsep0" align="left">0.34</td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.014</td><td class="colsep0 rowsep0" align="left">0.136</td><td class="colsep0 rowsep0" align="left">0.31</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.001</td><td class="colsep0 rowsep0" align="left">0.032</td><td class="colsep0 rowsep0" align="left">0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">0.021</td><td class="colsep0 rowsep0" align="left">0.019</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">0.34</td><td class="colsep0 rowsep0" align="left">0.29</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">1.10</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">0.07</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NA</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>*</sup><p class="last">Units for LE are kcal/mol/heavy atom.</p></div><div class="footnote" id="t2fn2"><sup>a</sup><p class="last">Relevant synthetic procedures are in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01478/suppl_file/jm6b01478_si_001.pdf" class="ext-link">SI</a>.</p></div><div class="footnote" id="t2fn3"><sup>b</sup><p class="last">All results are the mean of at least two independent determinations. NT: not tested. NA: not applicable. cK<sub>i</sub> is calculated inhibition constant, calculated from FP IC<sub>50</sub>.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></p></div></div></div><div class="NLM_p">Several interesting features were apparent from this hit set. Compounds <b>15</b> and <b>18</b> have a low heavy atom count which correlated to high LE and looked to represent tractable starting points for further functionalization. Compounds <b>16</b> and <b>17</b> contain the second amide functionality seen in the potent (nonselective) compound <b>9</b>, suggesting a possible handle on affinity. The hit compounds <b>15</b>, <b>17</b>, and <b>18</b> were reprepared in pure form (see <a class="ref internalNav" href="#notes-1" aria-label="SI">SI</a>), and the individual enantiomers of racemic <b>15</b> were isolated by chiral preparative HPLC. <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> demonstrates affinity data for <b>15</b>–<b>19</b> against PDHK-1 and HSP90.</div><div class="NLM_p">In a subsequent library prepared under identical conditions, we identified two fused cyclic amides <b>20</b> and <b>21</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). Concomitant screening against PDHK-1 and HSP90 of the crude ORS library by SPR demonstrated that compound <b>20</b> was selective for PDHK, whereas, significantly, <b>21</b> was selective for HSP90 (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). This particular bicyclic amide scaffold represents a novel chemotype of HSP90 inhibitor. The impure ORS library sample (ca. 13% pure) was used to derive a measurement of the true HSP90 <i>K</i><sub>D</sub> of <b>21</b> by ITC (<i>K</i><sub>D</sub> = 185 nM; <a class="ref internalNav" href="#notes-1" aria-label="SI">SI</a>) and additionally used to solve the ligand–protein X-ray structure in HSP90α (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>).</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structure and SPR data associated with the crude ORS library compounds <b>20</b> and <b>21</b>. LC purities (% at 254 nm) are shown for the ORS library sample. Purity of reprepared material is >95% (see <a class="ref internalNav" href="#notes-1" aria-label="SI">SI</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. X-ray crystallography structure of compound <b>21</b> bound to HSP90 (orange; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4H">5M4H</a>). <b>21</b> forms hydrogen bonds with Asp93 and buried waters, and favorable vdW contacts with numerous residues including Ile96. Superimposed X-ray structure of PDHK-2 protein (blue) shows two key residues near the ligand which differ between the two (Ile96 and Met98 in HSP90; Gly285 and Val287 in PDHK-2). Weaker binding to PDHK-2 could be due to the lack of a residue that can mimic the vdW interactions made between the HSP90 Ile96 and <b>21</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The differences in affinity between the individual enantiomers of compound <b>15</b> could be rationalized by analysis of the protein–ligand structures. As with compound <b>10</b> in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, we hypothesized that (<i>R</i>)-<b>15</b> would need to shift in the HSP90 binding site in order to avoid a steric clash with Ile96. This shift would result in weaker hydrogen bonds made by the resorcinol hydroxyls. With a high LE and a 40-fold selectivity versus HSP90 by FP, compound (<i>S</i>)-<b>15</b> was selected as a start point for further elaboration. We initially targeted the vector from the 6-position to build toward the region of the protein where the phosphate moieties of ATP and ADP bind.</div><div class="NLM_p">We devised a synthetic route that enabled the 4-position amides to be further investigated along with incorporation of boronate ester functionality (compound <b>32</b>, <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) to enable 4-aryl and heteroaryl compounds to be synthesized via cross coupling reactions (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Using the key intermediates <b>28</b> and <b>32</b>, we rapidly generated a set of compounds which were screened against PDHK isoforms and HSP90 with the FP assay. In a parallel synthetic campaign, we also evaluated analogues of the <i>N</i>-benzyl resorcinol amide <b>18</b>. Key intermediates (<b>34</b> and <b>36</b>; <a class="ref internalNav" href="#sch3a" aria-label="Scheme 3">Scheme 3</a>a,b) were made to allow the optimization of position 6 in this second subseries. The synthetic transformations used to access these compounds were very similar to those described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> (full details in <a href="/doi/suppl/10.1021/acs.jmedchem.6b01478/suppl_file/jm6b01478_si_001.pdf" class="ext-link">SI</a>).</div><figure id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0014.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Tetrahydroquinoline Amide PDHK Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span><i>Reagents and Conditions</i>: (a) Ac<sub>2</sub>O, DCM, 16 h; (b) NBS, DMF, 16 h; (c) Zn(OAc)<sub>2</sub>, Zn, Pd<sub>2</sub>(dba)<sub>3</sub>, dppf, Zn(CN)<sub>2</sub>, DMF, 100 °C, 3.5 h; (d) <i>c.</i>HCl (aq), 100 °C, 16 h; (e) BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 16 h; (f) (<i>i</i>) oxalyl chloride, cat. DMF, DCM, rt, 35 min. (<i>ii</i>) <b>26</b>, Et<sub>3</sub>N, DCM, 0 °C to rt, 2 h; (g) Pd(C), H<sub>2</sub>, EtOAc, 2 h; (h) (<i>i</i>) oxalyl chloride, cat. DMF, DCM (<i>ii</i>) NHR<sub>1</sub>R<sub>2</sub>, Et<sub>3</sub>N, DCM, 0 °C to rt; (i) NH<sub>3</sub>, MeOH, 2.5–16 h; (j) <i>c.</i>HCl, H<sub>2</sub>O, 100 °C, 5 h; (k) (<i>i</i>) <b>12</b>, oxalyl chloride, cat. DMF, DCM, rt, 2 h; (<i>ii</i>) <b>30</b>, Et<sub>3</sub>N, DCM, 0 °C to rt; (l) tricyclohexylphosphine, Pd<sub>2</sub>(dba)<sub>3</sub>, <i>bis</i>-pinacolatodiboron, KOAc, 1,4-dioxane, 80 °C, 16 h; (m) ArCl, K<sub>2</sub>CO<sub>3</sub>, PdCl<sub>2</sub>(dppf)<sub>2</sub>, THF, H<sub>2</sub>O, Δ; (n) NH<sub>3</sub>, MeOH, rt 16 h.</p></p></figure><figure id="sch3a" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0015.jpeg" id="GRAPHIC-d132e1665-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <i>N</i>-Aryl Amide PDHK Inhibitors Substituted with (a) Amides or (b) Heterocycles at the 4 N-Aryl Position<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=sch3a"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span><i>Reagents and Conditions</i>: Part a: (a) (<i>i</i>) oxalyl chloride, DCM; (<i>ii</i>) NHR<sub>1</sub>R<sub>2</sub>, Et<sub>3</sub>N, DCM, 0 °C to rt; (b) NH<sub>3</sub>, MeOH, 16 h. Part b: (a) ArB(OH)<sub>2</sub>, Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, THF, H<sub>2</sub>O, K<sub>2</sub>CO<sub>3</sub>, Δ; (b) NH<sub>3</sub>, MeOH, 16 h.</p></p></figure><div class="NLM_p">Lead optimization of start points <b>15</b> and <b>18</b> generated approximately 360 compounds for each subclass (N-aryl and tetrahydroquinoline amides).<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> For this set, 97 compounds displayed cK<sub>i</sub> values of less than 100 nM against PDHK-1 in the FP binding assay. A variety of chemical moieties were evaluated to explore the SAR in the phosphate binding region of the PDHK ATP site. <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a> shows a selection of some of the highest affinity compounds synthesized in the first round of lead optimization. Though these compounds and others demonstrated enhanced affinity for PDHK, it proved difficult to fully rationalize the affinity with respect to ligand–protein interactions as the protein in this region (known as the ATP-lid) displayed high protein flexibility. This region was often disordered in the acquired X-ray crystal structures and was found to be dependent on the nearby ligand substituents (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>). However, it was evident from the SAR generated that 4-aryl amides (related to hit to lead compound <b>9</b>) and 4-linked heteroaryl compounds were consistently among the highest affinity compounds. In X-ray crystallographic studies of the compounds, such as those shown in <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>, it was observed that the oxygen of the 4-amide substituent moiety (labeled * for <b>29a</b>, <b>35a,b</b>; <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>) or the 2-nitrogen of heteroaryl pyrimidine compounds (e.g., <b>33b</b>, <b>33c</b>; <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>) occasionally made an interaction with Arg 250.</div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0008.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Selected compounds from hit to lead campaign. Oxygen atoms labeled * can interact with Arg 250 in ligand–protein X-ray structures. Pyrimidine and pyridine 2-nitrogen can also make this interaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0009.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures of ligands bound to PDHK-2, highlighting the ATP lid (orange), which is partially ordered but with different conformations when bound with <b>38</b> (cyan, disordered residues 305–314; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4M4N">4M4N</a>) and <b>35a</b> (green, disordered residues 305–313; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4M">5M4M</a>), while it is completely disordered when bound to <b>33a</b> (magenta, disordered residues 305–319; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4N">5M4N</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The compounds shown in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a> were further characterized by several orthogonal techniques. A functional DELFIA assay was developed that measured the inhibition of PDHK-mediated phosphorylation of the E1 subunit <i>in vitro</i>. In addition, when an ELISA-based assay was utilized to enable measurement of the ability of the test compounds to inhibit the phosphorylation of the E1 subunit in PC3 cells (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), the majority of compounds in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a> demonstrated <5 μM IC<sub>50</sub> values. Though the new compounds exhibited good to excellent selectivity over HSP90 in affinity-based assays, we were keen to study the effect of the new compounds on HSP90 in a cellular context. Thus, we developed an ELISA assay to measure HSP70 levels in cells. Up regulation of HSP70 is a well characterized signature of HSP90 inhibition and commonly measured to demonstrate efficacy of HSP90 inhibitors <i>in vitro</i> and as a pharmacodynamic biomarker for <i>in vivo</i> studies. The results are expressed as the concentration of compound needed to evoke a 4-fold increase of HSP70 compared to controls.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Data for Selected PDHK Inhibitors<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">PDHK-1</th><th class="colsep0 rowsep0" align="center">PDHK-1</th><th class="colsep0 rowsep0" align="center">PDHK-1</th><th class="colsep0 rowsep0" align="center">PDHK-1</th><th class="colsep0 rowsep0" align="center">ELISA</th><th class="colsep0 rowsep0" align="center">HSP90α</th><th class="colsep0 rowsep0" align="center">HSP70</th><th class="colsep0 rowsep0" align="center">GI<sub>50</sub></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">FP cK<sub>i</sub> (μM)</th><th class="colsep0 rowsep0" align="center">DELFIA (μM)</th><th class="colsep0 rowsep0" align="center">SPR <i>k</i><sub>D</sub> (μM)</th><th class="colsep0 rowsep0" align="center">ITC KD (μM)</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> PC3 (μM)</th><th class="colsep0 rowsep0" align="center">FP cK<sub>i</sub> (μM)</th><th class="colsep0 rowsep0" align="center">Induction PC3 (μM)</th><th class="colsep0 rowsep0" align="center">PC3 (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<b>29a</b>)</td><td class="colsep0 rowsep0" align="left">0.016</td><td class="colsep0 rowsep0" align="left">0.036</td><td class="colsep0 rowsep0" align="left">0.006</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">3.01</td><td class="colsep0 rowsep0" align="left">2.51</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<b>33a</b>)</td><td class="colsep0 rowsep0" align="left">0.124</td><td class="colsep0 rowsep0" align="left">0.139</td><td class="colsep0 rowsep0" align="left">0.115</td><td class="colsep0 rowsep0" align="left">0.153</td><td class="colsep0 rowsep0" align="left">2.68</td><td class="colsep0 rowsep0" align="left">10.6</td><td class="colsep0 rowsep0" align="left">27.4</td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<b>33b</b>)</td><td class="colsep0 rowsep0" align="left">0.640</td><td class="colsep0 rowsep0" align="left">0.135</td><td class="colsep0 rowsep0" align="left">0.009</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">1.82</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>80</td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<b>33c</b>)</td><td class="colsep0 rowsep0" align="left">0.037</td><td class="colsep0 rowsep0" align="left">0.063</td><td class="colsep0 rowsep0" align="left">0.019</td><td class="colsep0 rowsep0" align="left">0.032</td><td class="colsep0 rowsep0" align="left">2.74</td><td class="colsep0 rowsep0" align="left">1.98</td><td class="colsep0 rowsep0" align="left">>80</td><td class="colsep0 rowsep0" align="left">40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<b>33d</b>)</td><td class="colsep0 rowsep0" align="left">0.467</td><td class="colsep0 rowsep0" align="left">0.198</td><td class="colsep0 rowsep0" align="left">0.010</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">2.78</td><td class="colsep0 rowsep0" align="left">1.78</td><td class="colsep0 rowsep0" align="left">63.7</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<b>37a</b>)</td><td class="colsep0 rowsep0" align="left">0.067</td><td class="colsep0 rowsep0" align="left">0.072</td><td class="colsep0 rowsep0" align="left">0.016</td><td class="colsep0 rowsep0" align="left">0.060</td><td class="colsep0 rowsep0" align="left">1.72</td><td class="colsep0 rowsep0" align="left">6.55</td><td class="colsep0 rowsep0" align="left">57.7</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<b>35b</b>)</td><td class="colsep0 rowsep0" align="left">0.241</td><td class="colsep0 rowsep0" align="left">0.201</td><td class="colsep0 rowsep0" align="left">0.010</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">10.6</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>80</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<b>35a</b>)</td><td class="colsep0 rowsep0" align="left">0.026</td><td class="colsep0 rowsep0" align="left">0.0627</td><td class="colsep0 rowsep0" align="left">0.001</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">5.65</td><td class="colsep0 rowsep0" align="left">1.02</td><td class="colsep0 rowsep0" align="left">8.80</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(38</b>)</td><td class="colsep0 rowsep0" align="left">0.037</td><td class="colsep0 rowsep0" align="left">0.101</td><td class="colsep0 rowsep0" align="left">0.078</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">2.15</td><td class="colsep0 rowsep0" align="left">3.21</td><td class="colsep0 rowsep0" align="left">31.0</td><td class="colsep0 rowsep0" align="left">38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<b>38</b>)</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.015</td><td class="colsep0 rowsep0" align="left">0.010</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">5.77</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<b>40)</b></td><td class="colsep0 rowsep0" align="left">0.028</td><td class="colsep0 rowsep0" align="left">0.035</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left">0.573</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>80</td><td class="colsep0 rowsep0" align="left">26.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">All results are the mean of at least two independent determinations.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">p(Ser<sup>293</sup>)E1α. NT: not tested.</p></div></div></div><div class="NLM_p">The effect of the PDHK inhibitor radicicol on pE1α levels has not been measured; however, it is a very weak inhibitor of PDHK,<a onclick="showRef(event, 'ref23 ref38'); return false;" href="javascript:void(0);" class="ref ref23 ref38">(23, 38)</a> with IC<sub>50</sub> values reported of 0.23 and 1.2 mM. DCA is also a very weak inhibitor of the enzyme<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> (ca. 5 mM), and though, previous studies have shown a marginal effect on pE1α levels, this is only at very high compound concentrations (millimolar).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> We have, however, measured pE1α inhibition via the ELISA assay for compounds <b>2</b> and <b>3</b>. This study afforded values of 0.066 ± 0.03 μM (<i>n</i> = 13) for compound <b>2</b> and 0.041 ± 0.054 μM (<i>n</i> = 6) for <b>3</b>. It is important, however, to note that it was not possible to ablate pE1α levels for compounds that bind at the E2 subunit, such as <b>2</b> and <b>3</b>.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p">Further studies were focused on improving the potency and physiochemical properties of the compound series. To fully characterize the effects of PDHK inhibitors on cell growth, we wanted to have compounds that were potent (sub-100-nM in affinity assays was the original target) but also selective over Hsp90. To this end, SBDD played a big part in the optimization. We did find that many compounds potent in the cell-based ELISA assay had LogD values of >3.0. We also had to ensure that solubility and cell penetration were appropriate; the more cell active compounds had a balance of these properties. These considerations were particularly critical, as, to be effective; PDHK inhibitors must access the mitochondria. All of the mammalian PDHK isoforms are located in the matrix of the mitochondria; therefore, cell active compounds need to be capable of traversing not only the lipid bilayer of the cell membrane but also both the outer and inner membranes of the mitochondria. There are additional pH differences between these cell compartments (cytosol, mitochondrial intermembrane space, and mitochondrial matrix) which would require the appropriate pharmacological properties to enable membrane penetrance to be maintained under these differing conditions.</div><div class="NLM_p">Several compounds from this subsequent phase of lead optimization are shown in <a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>.</div><figure id="fig10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0010.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of optimized PDHK inhibitors. Synthesis is described in <a href="/doi/suppl/10.1021/acs.jmedchem.6b01478/suppl_file/jm6b01478_si_001.pdf" class="ext-link">SI</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The optimized compounds were tested in antiproliferation assays in a number of human cancer cell lines. Selected data is shown for the PC3 cell line in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>. Potency was poor in these assays, with GI<sub>50</sub> values typically >20 μM. These data were associated with moderate compound permeability and low micromolar activity in the ELISA assay, suggesting compound penetration to the mitochondria. Compound <b>40</b> (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>) was one of the most potent compounds identified in the affinity and functional assays. It inhibited E1α phosphorylation with submicromolar potency in multiple cell lines and demonstrated excellent selectivity over HSP90. The detailed characterization of <b>40</b> has been previously reported.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In accordance with other compounds in this series, <b>40</b> was weakly antiproliferative to cancer cells in standard culture media, but did display enhanced cellular potency under conditions which more closely mimic the tumor microenvironment, in both monolayer and 3D culture formats. As detailed previously, the suppression of cellular pE1α levels using high concentrations of <b>40</b> under normal culture conditions did result in activation of the PDC; however, this did not translate into a detectable change in lactate production (an indicator of glycolytic activity) or intracellular pyruvate levels unless the cells were incubated under austere conditions such as serum deprivation or dual <span class="smallcaps smallerCapital">d</span>-glucose/<span class="smallcaps smallerCapital">l</span>-glutamine depletion. This, in turn, correlated with a marked increase in antiproliferative activity. We further demonstrated that, under standard culture conditions, cancer cells alter flux through a compensatory pathway that allows pyruvate levels to be maintained when challenged with a PDK inhibitor. This mechanism was found to be compromised under austere conditions, resulting in a substantial reduction in steady state pyruvate levels and a subsequent reduction in glycolytic activity and proliferation rate. Several other compounds with similar structure and activity profile to compound <b>40</b> also had similar effects on cell proliferation (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01478/suppl_file/jm6b01478_si_001.pdf" class="ext-link">SI</a>).</div><div class="NLM_p">Based on these findings, we are of the opinion that the observed activity of some of the compounds (at high concentrations) on cancer cell growth under standard culture conditions is largely off-target mediated and the differences in activity between the compounds is due to differences in selectivity profiles.</div><div class="NLM_p">The compound optimization, however, afforded excellent improvements in HSP90 selectivity. The more potent compounds retained pan-PDHK isoform activity, and this was consistent with our original goal of generating pan-PDHK isoform inhibitors. Compound <b>40</b> demonstrated similar potency across all four PDHK isoforms in a DELFIA-based functional enzyme assay in the sub-100-nM range, with measured values of 35, 84, 40, and 91 nM against PDHK-1–4 respectively. No significant isoform selectivity was observed in functional or binding affinity assays for any compound tested, which can be rationalized by comparing the ATP binding site structures across the isoforms. The X-ray crystal structure of compound <b>40</b> (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>) bound to PDHK-2 (2.6 Å; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V25">4V25</a>) reveals that the resorcinol moiety forms a series of direct and water-mediated hydrogen bonds to various residues within the PDHK-2 ATP binding site, including Asp282 and Thr346. The chloromethylpyrimidine also forms additional contacts to the side chains of residues Asn247 and Arg250 with the difluoro moiety pointing toward the open solvent region.</div><figure id="fig11" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0011.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Interactions between compound <b>40</b> and PDHK-2. Hydrogen atoms were added and optimized to <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V25">4V25</a> to show the hydrogen bond network.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81642" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81642" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Fragment screening has become an established Hit ID platform and, as disclosed here, was successful in identifying suitable high LE start points for PDHK inhibitors targeting the ATP site. Though the resorcinol fragment hits could have been anticipated based on the ATP site similarity of PDHK to HSP90, the application of a kinetic element via off-rate screening proved valuable in rapidly selecting which vectors to explore and in identifying distinct scaffolds for elaboration. This can often be a challenge when faced with a high hit rate from a fragment screen. Given the importance of kinetics (and off-rate in particular) to optimizing potency, identifying kinetically efficient compounds early is clearly an advantage.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> We were able to demonstrate that the off-rates for HSP90 binding were faster for many library compounds by cross screening the prepared libraries by off-rate in an HSP90 SPR assay. While it can be argued that selectivity is not so important for fragment hits, it is clearly advantageous to be kinetically less efficient against off targets at an early stage, especially when they share a high degree of structural similarity. As previously demonstrated,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> off-rates can be reliably measured on nonpurified chemical libraries, and this led to a significant time saving, as compound purification is a well-known bottleneck in drug discovery programs.</div><div class="NLM_p">Recently Meng et al.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> have reported on a series of resorcinol amide PDHK inhibitors which used the HSP90 inhibitor AUY922 (<b>41</b>)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> as a start point to design inhibitors with increased PDHK affinity (<b>42</b>, <a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>). While these novel inhibitors had activities consistent with PDHK inhibition, they are in fact dual inhibitors being equipotent against HSP90. This makes it difficult to attribute the reported antiproliferative effects to PDHK inhibition alone. Indeed, our results suggest that a significant component of the antiproliferative activity may be due to HSP90 inhibition, as potent PDHK inhibitors with poor HSP90 activity from our series demonstrated weak antiproliferative effects. Another important consideration is the differing ATP affinities of PDHK and HSP90. The <i>K</i><sub>m</sub> of PDHK for ATP is 5 μM,<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> whereas it is approximately 150 μM for HSP90,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and this has an impact on target druggability. Within this recent report,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> it was intriguing to note that an elaborated resorcinol amide HSP90 inhibitor was not chosen for elaboration; presumably this decision was based on the disclosure that this chemotype had no PDHK activity in the original screen against PDHK. We demonstrate here that a fragment-based approach can be complementary to the screening of larger compounds by enabling rapid progression to selective compounds with high affinity. Of interest is a similar approach by Tso et al.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> which identified pan-isoform PDHK inhibitors which bind at the ATP binding site. Compound <b>43</b> (PS10, <a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>) has an IC<sub>50</sub> of 2.1, 0.80, 21.3, and 0.84 μM against PDHK-1–4, respectively, with an HSP90 IC<sub>50</sub> of 47 μM. These compounds were studied in a glucose tolerance model and have not yet been evaluated in an anticancer context. Several groups have reported DCA-amide derivatives such as compounds <b>44</b><a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> and <b>45</b><a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>) as inhibitors of PDHK, with <b>45</b> reportedly binding at the ATP binding site of PDHK and not at the presumed pyruvate binding pocket previously identified for DCA. The ITC derived <i>K</i><sub>D</sub> for <b>45</b> is reported as 40.8 μM.</div><figure id="fig12" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0012.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structures of HSP90 inhibitor AUY922 (<b>41)</b>, dual HSP90/PDHK inhibitor (<b>42)</b>, resorcinol sulphonamide inhibitor (<b>43)</b>, and DCA<b>-</b>amides (<b>44</b> and <b>45</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71355" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71355" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We used off-rate screening against a library of nonpurified resorcinol amides as part of a hit to lead campaign against PDHK hits identified by an NMR-based fragment screen. Utilizing structure-based design from numerous ligand protein X-ray structures, two resorcinol-based subseries were identified (tetrahydroquinoline and <i>N</i>-aryl amides), and examples of each subseries exhibited nanomolar binding affinities to PDHK as measured by several techniques and inhibition of the PDHK mediated phosphorylation of the E1 subunit of the PDC in cells. This inhibition did not lead to appreciable antiproliferative effects against human cancer cell lines <i>in vitro</i> under normal cell growth media conditions. The identification of the disclosed compounds demonstrates the utility of off-rate screening for the rapid progression of the hit to lead phase of a drug discovery program and provided tool compounds to characterize biological effects of pan-isoform PDHK inhibitors.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03005" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03005" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Determination of PDHK Binding Affinity by Fluorescence Polarization</h3><div class="NLM_p">This assay was developed using a fluorescein-labeled probe, VER-160364 (5-[({4-[5-(5-chloro-2,4- dihydroxyphenyl)-3-(ethylcarbamoyl)-1,2-oxazol-4-yl] phenyl}methyl) carbamoyl]-2-(6-hydroxy-3-oxo-3H-xanthen-9- yl)benzoic acid; see <a class="ref internalNav" href="#notes-1" aria-label="SI">SI</a> for synthesis) which binds to the ATP site of PHDK resulting in an increase in anisotropy. PDHK-1 protein was used at its K<sub>d</sub> concentration of 30 nM, which was determined by titration with a probe concentration of 10 nM.</div><div class="NLM_p last">Compounds were tested in a 384-well format incorporating 10-point tripling titration curves in assay buffer (50 mM MOPS pH 7.5; 50 mM K<sub>2</sub>PO<sub>4</sub>; 150 mM NaCl; 1 mM DTT; 5% Glycerol; 0.1% Octyl-D-β-glucopyranoside). Following a 90 min incubation period, the plates were read using a Biotek Synergy plate reader (Ex 485/20 nm; Em 528/20 nm) and Delta mP was calculated by subtracting free probe values from the values obtained at the varying compound concentrations. The data was fitted by nonlinear regression using XLFIT4 within a custom ABASE (IDBS) protocol in order to determine IC<sub>50</sub> values.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> PDHK-1–4 Enzyme Functional Assay</h3><div class="NLM_p last">DELFIA assay reagents (assay buffer, wash buffer, enhancement solution and antirabbit IgG–Eu-N1 secondary antibody) and plates were obtained from PerkinElmer (MD, USA). Test compounds were subjected to a 10 point tripling dilution in DMSO, diluted in MOPS buffer (60 mM MOPS pH7.2, 15 mM Magnesium acetate, 60 mM KCl) and added to the enzyme mix (10 nM PDHK-1, 2 or 3, or 20 nM PDHK-4, 300 nM E1, 0.1 mg/mL BSA, 1 mM DTT) in 96-well V-bottom plates (Greiner). The reaction was initiated by the addition of ATP to a final concentration of 5 μM followed by a 1 h incubation at 30 °C. The reaction was then stopped by the addition of STOP solution (50 mM Carbonate-Bicarbonate Buffer, pH 9.6), and then transferred to 96 well DEFLIA yellow plates. The plates were then sealed and incubated overnight at 4 °C. Detection and quantification of p(Ser<sup>293</sup>) E1α levels was then achieved through incubation with anti-p(Ser<sup>293</sup>) E1α primary antibody (Genscript) followed by antirabbit secondary IgG–Eu-N1 antibody and addition of enhancement solution as per the manufacturer’s instructions. The time-resolved fluorescent signal was then measured using a Victor2 plate reader (PerkinElmer). The data was fitted by nonlinear regression using XLFIT4 within a custom ABASE (IDBS) protocol in order to determine IC<sub>50</sub> values.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> HSP70 in-Cell ELISA Assay</h3><div class="NLM_p last">DELFIA assay reagents (assay buffer, enhancement solution and europium-labeled secondary antibody) were obtained from PerkinElmer (MD, USA). PC-3 cells were seeded (1 × 10<sup>4</sup> per well) into 96 well black-walled cell culture plates. The following day, the cells were treated with a 10 point tripling dilution series of test compound for 24 h followed by fixation with TBS containing 4% formaldehyde for 15 min at RT. The cells were then permeabilized by the addition of permeabilization buffer (TBS containing 1% triton-X-100) and a further 15 min incubation at RT. The cells were then washed 3-times with TBS, followed by the addition of quenching solution (TBS containing 1% H<sub>2</sub>O<sub>2</sub>), a 20 min incubation at RT and a further 3 washes with TBS. The permeabilized cells were then incubated for 30 min with blocking buffer (TBS containing 5% (w/v) dried milk) followed by a 90 min incubation with HSP70 primary antibody (ENZO; 1:1000 dilution in TBS containing 200 μg/mL BSA). The wells were then washed 3 times with wash buffer (TBS containing 0.1% Tween-20), followed by the addition of europium-labeled antimouse secondary antibody (1:1000 in DELFIA assay buffer) and a 1 h incubation at RT. The wells were then washed 3 times with wash buffer followed by the addition of enhancement solution. The time-resolved fluorescence signal was measured using a Victor2 plate reader (PerkinElmer).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Phospho (Ser<sup>293</sup>)E1α MSD ELISA Assay</h3><div class="NLM_p">All reagents were purchased from Meso Scale Discovery (Maryland, USA) unless otherwise stated. Following compound treatment, cells were treated with lysis buffer (TBS pH 7.4, 1% Tween-20, 1 mM EGTA, 1 mM EDTA, 1 mM NaF, protease and phosphatase inhibitor cocktails (Roche)) on ice and the lysates added to standard bind 96 well MSD plates which were preloaded with custom phospho (Ser<sup>293</sup>) E1α “capture” antibody (2 μg/mL in TBST containing 3% (w/v) blocker A, Genescript) and blocked with 3% (w/v) blocker A, followed by a 1 h incubation at RT. The wells were then washed 3 times with TBST (0.05% tween 20) followed by the addition of 2 μg/mL E1α “detection” antibody (2 μg/mL) (Abcam) and a further 1 h incubation at RT. The wells were again washed 3 times with TBST followed by the addition of 1 μg/mL goat antimouse sulfotag antibody and incubated at RT for 1h., After a further TBST wash, 2 times read buffer T was added and the chemiluminescent signal was measured on a MSD sector imager 2400.</div><div class="NLM_p last">Cellular phospho (Ser<sup>232</sup>) E1α and phospho (Ser<sup>300</sup>) E1α levels were measured using commercially available assay kits as per the manufacturer’s instructions (Abcam, UK).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry</h3><div class="NLM_p">Compounds were characterized by <sup>1</sup>H NMR, <sup>13</sup>C NMR, LCMS, HRMS and HPLC. All compounds tested in biological assays were >95% purity by HPLC with exception of those compounds from Off-rate screening libraries and compound <b>38</b> (92%). Hits from off-rate screening were resynthesized and measured to be >95% pure. A compound characterization table is included within the <a class="ref internalNav" href="#notes-1" aria-label="SI">SI</a>.</div><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 2,4-Bis(acetyloxy)benzoic Acid (<b>12</b>)</h4><div class="NLM_p last">To a stirred suspension of 2,4-dihydrobenzoic acid (40 g, 259.5 mmol) in acetic anhydride (85 mL) was added conc. H<sub>2</sub>SO<sub>4</sub> (20 drops) and then the mixture was warmed to 65 °C for 30 min. Analysis by LCMS and TLC indicated formation of the desired product. The reaction mixture was cooled to ambient temperature and then poured onto a mixture of ice and water (ca.1:1) (1700 mL) with rapid stirring. Stirring was continued for 30 min, then the solid was collected via filtration, washed well with water then <i>iso</i>-hexane, before drying <i>in vacuo</i> at 40 °C overnight to afford the desired product (49.4 g, 80%) as a colorless solid: LCMS (<i>method C</i>): <i>t</i><sub>R</sub> = 0.93 min; <i>m</i>/<i>z</i> = 256 [M+NH<sub>4</sub>]<sup>+</sup>;.<sup>1</sup>H NMR (DMSO<i>-d</i><sub>6</sub>): δ 2.24 (s, 3H), 2.29 (s, 3H), 7.09 (d, 1H, <i>J</i> = 2.3 Hz), 7.18 (dd, 1H, <i>J</i> = 8.6, 2.3 Hz), 7.98 (d, 1H, <i>J</i> = 8.6 Hz), 13.17 (brs, 1H).</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 3-(Acetyloxy)-4-(carbonochloridoyl)phenyl Acetate (<b>13</b>)</h4><div class="NLM_p last">To a stirred solution of 2,4-bis(acetyloxy)benzoic acid (<b>12</b>) (64 mg, 270 μmol) in DCM (5 mL) was added DMF (2 drops) followed by oxalyl chloride (57 μL. 86 mg, 675 μmol, 2.5 equiv) at ambient temperature. After 2 h the solvents were evaporated to dryness and the crude acid chloride (<b>13</b>) was used immediately in the following step without further purification.</div></div><div id="sec5_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Off-Rate Screening Library Preparation: General Procedure A. (<b>7</b>)</h4><div class="NLM_p last">A 1.0 mL polypropylene Matrix storage tube was charged with <b>13</b> (0.05 M in DCM; 200 μL, 10 μmol). Triethylamine (7.0 μL, 5.0 mg, 50 μmol, 5.0 equiv) was added followed by the appropriate amine (1.0 M in DMF; 12.0 μL, 12.0 μmol, 1.2 equiv). The tube was capped, agitated briefly to ensure mixing, and allowed to stand at ambient temperature for 26 h. Ammonia (7.0 N in MeOH; 450 μL, 3.0 mmol, 300 equiv) was added and the tube recapped, agitated briefly to ensure mixing. After 48 h, the solvents were removed <i>in vacuo</i> (Genevac EZ-2; low bp mixture program; <i>T</i><sub>max</sub> 45 °C). The crude product was dissolved in DMSO-<i>d</i><sub>6</sub> (500 μL) to give a nominal 20 mM solution of <b>7.</b></div></div><div id="sec5_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 3-(Acetyloxy)-4-{[4-(carbonochloridoyl)phenyl](methyl)carbamoyl}phenyl Acetate (<b>13a</b>)</h4><div class="NLM_p last">Prepared from 4-[<i>N</i>-methyl-2,4-bis(acetyloxy)benzamido]benzoic acid (<b>12a</b>) following same method and scale as that described for compound <b>13</b>.</div></div><div id="sec5_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Off-Rate Screening Library Preparation: General Procedure B. (<b>7a</b>)</h4><div class="NLM_p last"><i>N</i>-methyl aniline library members were prepared from <b>13a</b> following same method and scale as that described for compound <b>7</b>.</div></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 4-[(6-Fluoro-2-methyl-3,4-dihydro-2H-quinolin-1-yl)carbonyl]benzene-1,3-diol (<i>rac</i>-<b>15</b>)</h3><div class="NLM_p">Title compound was prepared following General Procedure A, utilizing 6-fluoro-2-methyl-1,2,3,4-tetrahydroquinoline: LCMS (<i>method C</i>) <i>t</i><sub>R</sub> = 1.10 min; <i>m</i>/<i>z</i> = 302 [M + H]<sup>+</sup>; LC purity (254 nm) = 54%; synthesis of purified material is described in <a class="ref internalNav" href="#notes-1" aria-label="SI">SI</a>.</div><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Benzyl 4-[4-(<i>N</i>-methyl-2,4-dihydroxybenzamido)benzoyl]piperazine-1-carboxylate (<b>16</b>)</h4><div class="NLM_p last">Title compound was prepared following General Procedure B, utilizing benzyl piperazine-1-carboxylate: LCMS (<i>method C</i>) <i>t</i><sub>R</sub> = 1.04 min; <i>m</i>/<i>z</i> = 490 [M + H]<sup>+</sup>; LC purity (254 nm) = 54%.</div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 4-[4-(<i>N</i>-Methyl-2,4-dihydroxybenzamido)benzoyl]-3,4-dihydro-2H-1,4-benzoxazine-2-arboxylic Acid (<b>17</b>)</h4><div class="NLM_p last">Title compound was prepared following General Procedure B, utilizing ethyl 3,4-dihydro-2<i>H</i>-1,4-benzoxazine-2-carboxylate: LCMS (<i>method C</i>) <i>t</i><sub>R</sub> = 0.86 min; <i>m</i>/<i>z</i> = 446 [M-H]<sup>−</sup>; LC purity (254 nm) = 28%; synthesis of purified material is described in <a class="ref internalNav" href="#notes-1" aria-label="SI">SI</a>.</div></div><div id="sec5_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i>-Benzyl-2,4-dihydroxy-<i>N</i>-phenylbenzamide (<b>18</b>)</h4><div class="NLM_p last">Title compound was prepared following General Procedure A, utilizing N-benzylaniline: LCMS (<i>method C</i>) <i>t</i><sub>R</sub> = 1.16 min; <i>m</i>/<i>z</i> = 320 [M + H]<sup>+</sup>; LC purity (254 nm) = 53%; synthesis of purified material is described in <a class="ref internalNav" href="#notes-1" aria-label="SI">SI</a>.</div></div><div id="sec5_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4-[6,7-Dimethoxy-1-(pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline-2-carbonyl]benzene-1,3-diol (<b>19</b>)</h4><div class="NLM_p last">Title compound was prepared following General Procedure A, utilizing 6,7-dimethoxy-1-(pyridin-3-yl)-1,2,3,4-tetrahydroisoquinoline: LCMS (<i>method C</i>) <i>t</i><sub>R</sub> = 0.80 min; <i>m</i>/<i>z</i> = 407 [M + H]<sup>+</sup>; LC purity (254 nm) = 25%; synthesis of purified material is described in <a class="ref internalNav" href="#notes-1" aria-label="SI">SI</a>.</div></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 4-[7-(Trifluoromethyl)-4H,5H,6H,7H-pyrazolo[1,5-<i>a</i>]pyrimidine-4-carbonyl]benzene-1,3-diol</h3><div class="NLM_p">Title compound was prepared following General Procedure A, utilizing 7-(trifluoromethyl)-4H,5H,6H,7H-pyrazolo[1,5-<i>a</i>]pyrimidine: LCMS (<i>method C</i>) <i>t</i><sub>R</sub> = 0.831 min; <i>m</i>/<i>z</i> = 327 [M + H]<sup>+</sup>; LC purity (254 nm) = 13%; synthesis of purified material is described in <a class="ref internalNav" href="#notes-1" aria-label="SI">SI</a>.</div><div id="sec5_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2-(<i>S</i>)-Methyl-1,2,3,4-tetramethylisoquinoline (<b>22</b>)</h4><div class="NLM_p last">The title compound was prepared by chiral preparative supercritical fluid chromatography using CO<sub>2</sub>. <i>Chromatography conditions</i>: Column: Chiralcel OJ-H, 30 × 250 mm. Eluant: 10% methanol (0.5% isopropylamine). Flow rate: 70 mL/min. Detection: UV 225 nm. Sample 2-methyl-1,2,3,4-tetramethylisoquinoline (TCI America) 12g (81.6 mmol) was dissolved in 486 mL MeOH (0.15% isopropylamine) followed by 540 × 22 mg injections, stacked injection interval 174 s. Peak eluting at 7.85–8.80 min was collected and evaporated to afford title compound (5.5 g, 45.9%) as an amber-colored liquid: LCMS (<i>method C</i>) <i>t</i><sub>R</sub> = 0.74 min; <i>m</i>/<i>z</i> = 148 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.13 (d, <i>J</i> = 6.3 Hz, 3H), 1.33–1.50 (m, 1H), 1.75–1.91 (m, 1H), 2.44–2.78 (m, 2H), 3.23–3.34 (m, 1H), 5.53 (s, 1H), 6.33–6.47 (m, 2H), 6.78–6.87 (m, 2H); optical rotation [α]<sub>D</sub> = −79 Deg (c = 0.2 MeOH). Lit. (S) [α]<sub>D</sub> = −85 Deg (c = 1.5 benzene); ee =99.6%. The R enantiomer eluted at 9.05–10.28 min, optical rotation [α]<sub>D</sub> = +78 Deg (c = 0.2 MeOH).</div></div><div id="sec5_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 1-(6-Bromo-2-(<i>S</i>)-methyl-1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-one (<b>23</b>)</h4><div class="NLM_p last">To a solution of 2-(S)-methyl-1,2,3,4-tetrahydroquinoline (<b>22</b>) (5g, 36.96 mmol) in dichloromethane (34 mL) was added acetic anhydride (4.26 mL, 50 mmol) and the reaction stirred at ambient temperature for 4 h under nitrogen atmosphere. A further 1 mL of acetic anhydride was added and the reaction mixture stirred overnight. The solvents were removed <i>in vacuo</i> to afford a liquid which was dissolved in EtOAc (60 mL) and the organic phase was then washed sequentially with water (50 mL), 1N NaOH (aq) (50 mL), water (50 mL) and sat NaCl (aq) (50 mL), then dried over magnesium sulfate, filtered and the filtrate evaporated <i>in vacuo</i> to afford a yellow oil. The product was dissolved in DMF (26 mL) and <i>N</i>-bromosuccinimide (6.20 g, 34.86 mmol) was added in portions and mixture then stirred overnight. The reaction mixture was partitioned between EtOAc (200 mL) and water (100 mL). The organic phase was separated then washed with saturated aqueous ammonium chloride solution (100 mL) then sat. NaCl (aq) (2 × 50 mL). The reaction mixture was dried over magnesium sulfate, filtered and filtrate evaporated <i>in vacuo</i> to afford product (9.3 g, quant.) as a yellow oil: LCMS (<i>method C</i>): <i>t</i><sub>R</sub> = 1.28 min; <i>m</i>/<i>z</i> = 268 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.14 (d, <i>J</i> = 6.5 Hz, 3H), 1.32–1.46 (m, 1H), 2.16 (s, 3H), 2.29–2.43 (m, 1H), 2.46–2.70 (m, 2H), 4.82 (brs, 1H), 7.09 (brs, 1H), 7.32–7.39 (m, 2H).</div></div><div id="sec5_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 1-Acetyl-2-(<i>S</i>)-methyl-1,2,3,4-tetrahydroquinoline-6-carbonitrile (<b>24</b>)</h4><div class="NLM_p last">Zinc acetate (0.24 g, 1.32 mmol), zinc dust (0.092 g, 1.41 mmol), 1.1′-bis(diphenylphosphino)ferrocene (46 mg, 0.83 mmol), and tris(dibenzylideneacetone)dipalladium(0) (31 mg, 0.034 mmol) were added to a solution of 1-(6-bromo-2-(S)-methyl-1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-one (<b>23</b>) (8.21 g, 30.62 mmol) in DMF (17 mL). The mixture was allowed to stir under nitrogen atmosphere for a few minutes before then adding zinc cyanide (2.19, 18.65 mmol). The mixture was then heated at 100 °C for I3.5 h under nitrogen atmosphere. The reaction mixture was allowed to cool to ambient temperature and then water (25 mL) was added. The resulting solid was filtered off then washed with water (200 mL). The solid was dissolved in EtOAc (400 mL) and washed with water (2 × 400 mL) and brine (400 mL). Phases were separated and the organic phase was dried over MgSO<sub>4</sub> filtered and the filtrate evaporated <i>in vacuo</i> to afford a pale-yellow solid, which was triturated with hexane to give title compound (5.53 g, 84%) as a pale-yellow solid: LCMS (<i>method C</i>): <i>t</i><sub>R</sub> = 1.06 min; <i>m</i>/<i>z</i> = 215 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.18 (d, <i>J</i> = 6.5 Hz, 3H), 1.43–1.58 (m, 1H), 2.22 (s, 3H), 2.36 (dq, <i>J</i> = 6.5, 13.2 Hz, 1H), 2.63 (ddd, <i>J</i> = 5.3, 9.3, 15.2 Hz, 1H), 2.74 (dt, <i>J</i> = 5.8, 15.4 Hz, 1H), 4.77 (q, <i>J</i> = 6.5 Hz, 1H), 7.37 (d, <i>J</i> = 6.8 Hz, 1H), 7.48–7.55 (m, 2H).</div></div><div id="sec5_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-(<i>S</i>)-Methyl-1,2,3,4-tetrahydroquinoline-6-carboxylic Acid (<b>25</b>)</h4><div class="NLM_p last">Concentrated HCl (12 M, 40 mL, 478 mmol) was added to a suspension of 1-acetyl-2-(S)-methyl-1,2,3,4-tetrahydroquinoline-6-carbonitrile (<b>24</b>) (6.03 g, 28.1 mmol) in water (20 mL) and the reaction mixture was heated at reflux overnight. The mixture was allowed to cool to ambient temperature then further cooled with an ice–water bath. The pH was adjusted to pH = 3 by addition of solid NaOH pellets to the stirred mixture. The precipitate was filtered, washed with water (50 mL) then <i>iso</i>-hexane (50 mL) and dried <i>in vacuo</i> at 60 °C to afford title compound (4.87 g, 90%) as a tan-colored solid: LCMS (<i>method C</i>): <i>t</i><sub>R</sub> = 1.03 min; <i>m</i>/<i>z</i> = 192 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.15 (d, <i>J</i> = 6.3 Hz, 3H), 1.39 (m, 1H), 1.79–1.90 (m, 1H), 2.69 (m, 2H), 3.31–3.45 (m, 1H), 6.43 (d, <i>J</i> = 8.9 Hz, 1H), 6.46 (s, 1H), 7.44 (m, 2H), 11.86 (s, 1H).</div></div><div id="sec5_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Benzyl 2-(<i>S</i>)-methyl-1,2,3,4-tetrahydroquinoline-6-carboxylate (<b>26</b>)</h4><div class="NLM_p last">To a solution of 2-(S)-methyl-1,2,3,4-tetrahydroquinoline-6-carboxylic acid (<b>25</b>) (4.87 g, 25.47 mmol) in DMF (130 mL) under a nitrogen atmosphere was added potassium carbonate (17.6 g, 127.4 mmol) then benzyl bromide (3.33 mL, 30 mmol) was added dropwise. The reaction mixture was stirred overnight at ambient temperature and then partitioned between EtOAc (400 mL) and water (400 mL). The phases were separated and the organic phase was washed with sat NaCl (aq) solution (2 × 200 mL), dried over magnesium sulfate, filtered and the filtrate evaporated in vacuo to afford title compound (7.3 g, quant.) as a brown oil: LCMS (<i>method C</i>): <i>t</i><sub>R</sub> = 1.45 min; <i>m</i>/<i>z</i> = 282 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.26 (d, <i>J</i> = 6.3 Hz, 3H), 1.52–1.67 (m, 1H), 1.93–2.02 (m, 1H), 2.73–2.89 (m, 2H), 3.51 (m, 1H), 4.22 (brs, 1H), 5.33 (s, 2H), 6.36–6.47 (m, 1H), 7.31–7.50 (m, 5H), 7.70–7.75 (m, 2H).</div></div><div id="sec5_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Benzyl 1-[2,4-Bis(acetyloxy)benzoyl]-2-(<i>S</i>)-methyl-1,2,3,4-tetrahydroquinoline-6-carboxylate (<b>27</b>)</h4><div class="NLM_p last">To a solution of 2,4-bis(acetyloxy)benzoic acid (<b>12</b>; 3.09 g, 12.91 mmol) in DCM (80 mL) was added oxalyl chloride (2.0 M solution in DCM, 8.7 mL, 17.4 mmol) followed by two drops of DMF. After 35 min the solvents were removed <i>in vacuo</i> and the residue was redissolved in DCM (60 mL), cooled in an ice–water bath, and triethylamine (5.2 g, 52 mmol) was added followed by a solution of benzyl 2-(S)-methyl-1,2,3,4-tetrahydroquinoline-6-carboxylate (<b>26</b>) (3.29 g, 11.71 mmol) in DCM (40 mL). The reaction mixture was allowed to warm to ambient temperature and stir under nitrogen atmosphere for 2 h. The reaction mix was washed with sat. NaHCO<sub>3</sub> solution (100 mL) and the phases were separated. The aqueous phase was re-extracted with DCM (100 mL). The combined organic phases were dried over magnesium sulfate, filtered and the filtrate evaporated <i>in vacuo</i> to afford product as a brown oil (8 g). The crude product was purified by flash chromatography on silica gel (100 g) eluting with a gradient of <i>iso-</i>hexane-40% EtOAc/<i>iso</i>-hexane to afford the title compound (3.51 g, 60%) as a pale yellow gum: LCMS (<i>method C</i>): <i>t</i><sub>R</sub> = 1.45 min; <i>m</i>/<i>z</i> = 502 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.22 (d, <i>J</i> = 6.5 Hz, 3H), 1.61 (s, 1H), 2.27 (s, 3H), 2.30 (s, 3H), 2.31–2.45 (m, 2H), 2.73–2.91 (m, 2H), 4.81 (brs, 1H), 5.35 (d, <i>J</i> = 3.2 Hz, 2H), 6.88 (s, 1H), 6.99 (d, <i>J</i> = 1.9 Hz, 1H), 7.05–7.20 (m, 1H), 7.33–7.49 (m, 5H), 7.68 (d, <i>J</i> = 8.3 Hz, 1H), 7.89 (d, <i>J</i> = 1.8 Hz, 1H).</div></div><div id="sec5_7_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1-[2,4-Bis(acetyloxy)benzoyl]-2-(<i>S</i>)-methyl-1,2,3,4-tetrahydroquinoline-6-carboxylic Acid (<b>28</b>)</h4><div class="NLM_p last">A solution of benzyl 1-[2,4-bis(acetyloxy)benzoyl]-2-(S)-methyl-1,2,3,4-tetrahydroquinoline-6-carboxylate (<b>27</b>) (3.51 g, 7.00 mmol) in ethyl acetate (75 mL) was degassed by evaporation then nitrogen purging (3 cycles) followed by bubbling nitrogen gas through the solution for 5 min. A catalytic amount of 10% Palladium on charcoal (microspatula) was added and the reaction flask was flushed with Hydrogen gas and shaken under a positive pressure of hydrogen gas for 2 h. The reaction mixture was filtered through a pad of Celite to remove catalyst. The filtrate solvents were then removed to afford title compound (2.83 g, 98%).as a white foam: LCMS (<i>method A</i>): <i>t</i><sub>R</sub> = 2.16 min; <i>m</i>/<i>z</i> = 412 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.74–0.90 (m, 1H), 1.14 (d, <i>J</i> = 6.5 Hz, 3H), 1.53 (dq, <i>J</i> = 6.1, 13.3 Hz, 1H), 2.31 (dq, <i>J</i> = 6.7, 13.1 Hz, 1H), 2.44(s,3H), 2.54 (s, 3H), 2.76 (m, 2H), 4.58 (q, <i>J</i> = 6.4 Hz, 1H), 6.04–6.22 (m, 2H), 6.97 (dd, <i>J</i> = 4.0, 8.3 Hz, 1H), 7.21 (dd, <i>J</i> = 2.0, 8.3 Hz, 1H), 7.45 (d, <i>J</i> = 1.9 Hz, 1H), 8.43–8.53 (m, 1H).</div></div><div id="sec5_7_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (2<i>S</i>)-1-(2,4-Dihydroxybenzoyl)-<i>N</i>,2-dimethyl-<i>N</i>-(quinoxalin-6-ylmethyl)-1,2,3,4-tetrahydroquinoline-6-carboxamide (<b>29a</b>)</h4><div class="NLM_p last">Oxalyl chloride (2.0 M in DCM, 0.24 mL, 0.28 mmol) was added to a stirred solution of <b>28</b> (100 mg, 0.24 mmol) in DCM (4 mL) followed by DMF (few drops). The reaction mixture was stirred at rt for ca. 45 min then the solvent removed in vacuo. The resultant residue was dissolved in DCM (5 mL) then Et<sub>3</sub>N (88 μL, 1.2 mmol) was added followed by <i>N</i>-methyl-1-quinoxalin-6-ylmethanamine (60 mg, 0.36 mmol). The reaction was stirred at rt for ca. 3.5 h then 7N NH<sub>3</sub> in MeOH (1.0 mL) was added and stirring continued at rt overnight The reaction mixture was diluted with DCM (20 mL) then washed with H<sub>2</sub>O (20 mL) followed by brine (20 mL). The phases were separated and organic extract was dried (MgSO<sub>4</sub>), filtered and the filtrate solvents removed in vacuo. The crude product was purified by flash column chromatography on silica using 0–3% MeOH in DCM (gradient) as the eluent to afford the title compound (68 mg, 58%) as an off-white solid: LCMS (<i>method C</i>): <i>t</i><sub>R</sub> = 1.08 min; <i>m</i>/<i>z</i> = 483 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6;</sub> 353 K) δ 1.13 (d, <i>J</i> = 6.5 Hz, 3H), 1.54 (dq, <i>J</i> = 6.2, 13.1 Hz, 1H), 2.30 (dq, <i>J</i> = 6.6, 13.4 Hz, 1H), 2.74 (m, 2H), 2.97 (s, 3H), 4.61 (q, <i>J</i> = 6.5 Hz, 1H), 4.86 (s, 2H), 6.15 (dd, <i>J</i> = 2.3, 8.3 Hz, 1H), 6.18 (d, <i>J</i> = 2.2 Hz, 1H), 6.89 (d, <i>J</i> = 8.3 Hz, 1H), 6.95 (d, <i>J</i> = 8.3 Hz, 1H), 7.06 (dd, <i>J</i> = 1.9, 8.3 Hz, 1H), 7.29 (s, 1H), 7.76 (d, <i>J</i> = 8.5 Hz, 1H), 7.96 (s, 1H), 8.11 (d, <i>J</i> = 8.6 Hz, 1H), 8.89–8.95 (m, 2H), 9.35 (s, 1H), 9.59 (s, 1H); <sup>13</sup>C NMR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>, 353 K) δ 18.7 (CH3), 23.8 (CH2), 30.1 (CH2), 35.4 (CH3, broad), 48.4 (CH), 51.2 (CH2, broad), 102.3 (CH), 106.3 (CH), 114.0 (C), 123.6 (CH), 124.3 (CH), 126.0 (CH), 126.6 (CH), 129.1 (CH), 129.3 (CH), 129.7 (CH), 131.2 (C), 131.8 (C), 138.7 (C), 139.5 (C), 141.3 (C), 141.9 (C), 145.0 (CH), 145.3 (CH), 156.5 (C), 159.7 (C), 168.6 (C), 170.2 (C) ; HRMS, calcd for C<sub>28</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub> [M]+ found 482.1951 requires 482.1954; HPLC 100% (t<sub><i>R</i></sub> = 0.86 min).</div></div><div id="sec5_7_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 6-Bromo-2-(<i>S</i>)-methyl-1,2,3,4-tetrahydroquinoline (<b>30</b>)</h4><div class="NLM_p last">To a suspension of 1-(6-bromo-2-(S)-methyl-1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-one (<b>23</b>) (5.16 g, 19.24 mmol) in water (15 mL) was added conc HCl (12N, 25 mL) and the mixture was heated to reflux for 5 h then allowed to cool to ambient temperature. Further water was added and the pH of the mixture adjusted to pH = 4 by cautious addition of solid NaOH pellets. The precipitate was filtered off and washed with water then <i>iso</i>-hexane and dried <i>in vacuo</i> to afford title compound (2.07 g, 48%) as an off-white solid: LCMS (method C): <i>t</i><sub>R</sub> = 1.41 min; <i>m</i>/<i>z</i> = 226 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.12 (d, <i>J</i> = 6.3 Hz, 3H), 1.26–1.47 (m, 1H), 1.75–1.88 (m, 1H), 2.56–2.77 (m, 2H), 3.22–3.32 (m, 1H), 5.82 (s, 1H), 6.40 (d, <i>J</i> = 8.3 Hz, 1H), 6.94–6.99 (m, 2H).</div></div><div id="sec5_7_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 3-(Acetyloxy)-4-(6-bromo-2-(<i>S</i>)-methyl-1,2,3,4-tetrahydroquinoline-1-carbonyl)phenyl Acetate (<b>31</b>)</h4><div class="NLM_p last">Oxalyl chloride solution (2.0 M in DCM, 6.9 mL) was added to a solution of 2,4-bis(acetyloxy)benzoic acid (<b>12</b>) (2.18 g, 9.17 mmol) in DCM (60 mL) and 2 drops of DMF was added. After 2 h the solvent was removed in vacuo and the residue redissolved in DCM (30 mL) and cooled with an ice–water bath. A solution of 6-bromo-2-(S)-methyl-1,2,3,4-tetrahydroquinoline (<b>30</b>) (2.07 g, 9.17 mmol) and triethylamine (36.7 mmol) was added and the reaction mixture allowed to warm to ambient temperature and stir for 1.5 h. A further 30 mL of DCM was added and the organic solution washed with water (90 mL), then sat. NaCl (aq) solution (100 mL), dried over magnesium sulfate, filtered and the filtrate concentrated <i>in vacuo</i> to afford a brown oil. The crude product was purified by flash chromatography on silica gel (100 g) eluting with a gradient of 0 to 30% <i>iso</i>-hexane in ethyl acetate to afford the title compound (2.56 g, 63%) as a white foam: LCMS (<i>method A</i>): <i>t</i><sub>R</sub> = 2.46 min; <i>m</i>/<i>z</i> = 446 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.21 (d, <i>J</i> = 6.5 Hz, 3H), 1.51–1.60 (m, 3H), 2.27 (s, 3H), 2.30 (s, 3H), 2.33–2.43 (m, 1H), 2.63–2.81 (m, 2H), 4.78 (s, 1H), 6.89 (s, 1H), 6.99 (d, <i>J</i> = 1.9 Hz, 1H), 7.08 (s, 1H), 7.32 (d, <i>J</i> = 2.1 Hz, 1H);</div></div><div id="sec5_7_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 3-(Acetyloxy)-4-[2-(<i>S</i>)-methyl-6-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydroquinoline-1-carbonyl]phenyl Acetate (<b>32</b>)</h4><div class="NLM_p last">A mixture of tricyclohexyl phosphine (31 mg, 0.11 mmol) and dipalladium(0) tris(dibenzylideneacetone) (102 mg, 0.11 mmol) in 1,4-dioxane (15 mL) under a nitrogen atmosphere was stirred for 20 min. This mixture was then added to a mixture of <b>31</b> (1.00 g, 2.24 mmol), <i>bis</i>-pinacolatodiboron (625 mg, 2.46 mmol) and potassium acetate (329 mg, 3.36 mmol) under nitrogen atmosphere in 1,4 dioxane (20 mL). The reaction mixture was heated overnight at 80 °C then allowed to cool to ambient temperature. The reaction mixture was filtered through Celite and the filter pad washed with EtOAc (70 mL). The combined filtrate was washed with water (80 mL) then sat. NaCl (aq) (80 mL) and dried over magnesium sulfate. The mixture was filtered and filtrate solvents removed <i>in vacuo</i> to leave a yellow oil. The crude product was purified by flash chromatography on silica gel (70 g) eluting with a gradient of 0 to 30% ethyl acetate in <i>iso</i>-hexane to afford the title compound (1.01 g, 91%) as a colorless solid: LCMS (<i>method A</i>): <i>t</i><sub>R</sub> = 2.71 min; <i>m</i>/<i>z</i> = 494 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.21 (d, <i>J</i> = 6.5 Hz, 3H), 1.35 (s, 12H), 1.50–1.64 (m, 1H), 1.76 (s, 1H), 2.26 (s, 3H), 2.30 (s, 3H), 2.31–2.45 (m, 1H), 2.68–2.85 (m, 2H), 6.76–6.95 (m, 2H), 6.98 (d, <i>J</i> = 2.1 Hz, 1H), 7.29 (s, 1H), 7.38 (d, <i>J</i> = 7.6 Hz, 1H), 7.61 (s, 1H).</div></div><div id="sec5_7_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 4–[(2<i>S</i>)-2-Methyl-6-(3-methylquinolin-2-yl)-1,2,3,4-tetrahydroquinoline-1-carbonyl]benzene-1,3-diol (<b>33a</b>)</h4><div class="NLM_p last">Compound <b>32</b> (250 mg, 0.51 mmol), 2-chloro-3-methylquinoline (90 mg, 0.51 mmol), potassium carbonate (212 mg, 1.53 mmol) and Pd(dppf)<sub>2</sub>Cl<sub>2</sub>.DCM (37 mg, 0.05 mmol) were combined and dissolved in a solution of THF (11 mL) and H<sub>2</sub>O (1 mL). The solution was sparged with N<sub>2</sub> for 5 min before being heated in a microwave synthesizer for 40 min at 120 °C. NH<sub>3</sub> in MeOH solution (7N, 2 mL, 14 mmol) was added to the reaction mixture, which was left to stir at rt under N<sub>2</sub> atmosphere for 2.5 h. The reaction mixture was diluted with EtOAc and washed twice with H<sub>2</sub>O, followed by a further wash with saturated brine solution. The organic phase was separated and dried over MgSO<sub>4</sub> and filtered. The filtrate solvents were evaporated to a brown solid, which was purified by automated flash chromatography using a solvent system of 0 to 80% EtOAc in hexane to yield 197 mg of impure product as a pale-brown gum. This was further purified by automated flash chromatography on silica gel using a solvent system of 0 to 2.5% MeOH in DCM to yield title compound (76 mg, 35%) as a colorless glass: LCMS (<i>method A</i>): <i>t</i><sub>R</sub> = 2.53 min; <i>m</i>/<i>z</i> = 425 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.18 (d, <i>J</i> = 6.5 Hz, 3H), 1.55 (dq, <i>J</i> = 6.0, 13.4 Hz, 1H), 2.35 (dq, <i>J</i> = 6.6, 12.9 Hz, 1H), 2.44 (s, 3H), 2.69–2.87 (m, 2H), 4.62 (q, <i>J</i> = 6.4 Hz, 1H), 6.11–6.26 (m, 2H), 6.92–7.08 (m, 2H), 7.22 (dd, <i>J</i> = 2.0, 8.3 Hz, 1H), 7.46 (d, <i>J</i> = 1.9 Hz, 1H), 7.57 (ddd, <i>J</i> = 1.2, 6.9, 8.1 Hz, 1H), 7.70 (ddd, <i>J</i> = 1.4, 6.9, 8.4 Hz, 1H), 7.91 (d, 1H), 7.99 (d, <i>J</i> = 8.5 Hz, 1H), 8.23 (s, 1H), 9.62 (s, 1H), 9.75 (s, 1H); <sup>13</sup>C NMR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>) δ 19.4 (CH3), 20.3 (CH3), 24.5 (CH2), 30.9 (CH2), 48.8 (CH), 102.3 (CH), 106.5 (CH), 115.1 (C), 124.4 (CH), 126.1 (CH), 126.4 (CH), 127.0 (CH), 127.0 (C), 128.3 (CH), 128.6 (CH), 128.8 (CH), 129.1 (C), 130.2 (CH), 132.1 (C), 135.9 (C), 136.7 (CH), 137.7 (C), 146.0 (C), 156.2 (C), 159.2 (C), 159.7 (C), 168.6 (C); HRMS, calcd for C<sub>27</sub>H<sub>24</sub>N<sub>2</sub>O<sub>3</sub> [M]+ found 424.1728 requires 424.1787; HPLC 100% (t<sub><i>R</i></sub> = 1.06 min).</div></div><div id="sec5_7_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 4-[(2<i>S</i>)-6-{2-Chloro-7H-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}-2-methyl-1,2,3,4-tetrahydroquinoline-1-carbonyl]benzene-1,3-diol (<b>33b</b>)</h4><div class="NLM_p last">This compound was synthesized by the same procedure outlined for <b>33a</b>. Thus, <b>32</b> and 2,4-dichloro-7H-pyrrolo[2,3-<i>d</i>]pyrimidine were reacted as described to afford crude product that was purified by PREP HPLC at pH4 (methods in <a class="ref internalNav" href="#notes-1" aria-label="SI">SI</a>) to afford title compound (12 mg, 16%) as a beige-colored solid: LCMS (<i>method C</i>): <i>t</i><sub>R</sub> = 1.23 min; <i>m</i>/<i>z</i> = 435 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (399 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.16 (d, <i>J</i> = 6.5 Hz, 3H), 1.58 (dq, <i>J</i> = 5.9, 13.2 Hz, 1H), 2.24–2.43 (m, 1H), 2.74–3.01 (m, 2H), 4.62 (q, <i>J</i> = 6.3 Hz, 1H), 6.15 (d, <i>J</i> = 2.2 Hz, 1H), 6.21 (dd, <i>J</i> = 2.2, 8.4 Hz, 1H), 6.95 (d, <i>J</i> = 3.7 Hz, 1H), 7.02 (d, <i>J</i> = 8.4 Hz, 1H), 7.07 (d, <i>J</i> = 8.5 Hz, 1H), 7.68 (d, <i>J</i> = 3.6 Hz, 1H), 7.75 (dd, <i>J</i> = 2.0, 8.5 Hz, 1H), 7.99 (d, <i>J</i> = 1.9 Hz, 1H); <sup>13</sup>C NMR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>) δ 19.2 (CH3), 24.4 (CH2), 30.5 (CH2), 48.9 (CH), 100.8 (CH), 102.3 (CH), 106.7 (CH), 113.2 (C), 115.1 (C), 125.1 (CH), 125.8 (CH), 127.9 (CH), 128.5 (CH), 130.3 (CH), 131.8 (C), 132.7 (C), 140.4 (C), 152.1 (C), 154.0 (C), 155.9 (C), 157.1 (C), 159.8 (C), 168.6 (C); HRMS, calcd for C<sub>23</sub>H<sub>19</sub>N<sub>4</sub>O<sub>3</sub>Cl [M]+ found 434.1145 requires 434.1146; HPLC 99.5% (t<sub><i>R</i></sub> = 0.96 min).</div></div><div id="sec5_7_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 4-[(2<i>S</i>)-6-(2-Chloro-5-methylpyrimidin-4-yl)-2-methyl-1,2,3,4-tetrahydroquinoline-1-carbonyl]benzene-1,3-diol (<b>33c</b>)</h4><div class="NLM_p last">This compound was synthesized by the same procedure outlined for <b>33a</b>. Thus, <b>32</b> and 2,4-dichloro-5-methylpyrimidined were reacted as described to afford crude product that was purified by flash chromatography on silica gel eluting with a gradient of 0 to 45% ethyl acetate in hexane to afford the title compound (47 mg, 43%) as a pale yellow solid: LCMS (<i>method C</i>): <i>t</i><sub>R</sub> = 1.28 min; <i>m</i>/<i>z</i> = 410 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.15 (d, <i>J</i> = 6.5 Hz, 3H), 1.49–1.62 (m, 1H), 2.26–2.33 (m, 1H), 2.33–2.37 (m, 3H), 2.71–2.88 (m, 2H), 4.60 (q, <i>J</i> = 6.4 Hz, 1H), 6.14 (d, <i>J</i> = 2.2 Hz, 1H), 6.20 (dd, <i>J</i> = 2.2, 8.4 Hz, 1H), 7.00 (dd, <i>J</i> = 2.1, 8.4 Hz, 2H), 7.29 (dd, <i>J</i> = 2.1, 8.4 Hz, 1H), 7.54 (d, <i>J</i> = 2.0 Hz, 1H), 9.62 (s, 1H), 9.68 (s, 1H);. <sup>13</sup>C NMR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>) δ 16.2 (CH3), 19.3 (CH3), 24.3 (CH2), 30.5 (CH2), 48.9 (CH), 102.3 (CH), 106.6 (CH), 115.0 (C), 124.4 (CH), 126.2 (CH), 127.3 (C), 128.5 (CH), 130.3 (CH), 131.4 (C), 132.3 (C), 139.6 (C), 155.9 (C), 157.6 (C), 159.8 (C), 161.9 (CH), 166.5 (C), 168.6 (C);; HRMS, calcd for C<sub>22</sub>H<sub>20</sub>N<sub>3</sub>O<sub>3</sub>Cl [M]+ found 409.1193 requires 409.1193; HPLC 100% (t<sub><i>R</i></sub> = 1.08 min).</div></div><div id="sec5_7_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 4-[(2<i>S</i>)-6-{2-chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl}-2-methyl-1,2,3,4-tetrahydroquinoline-1-carbonyl]benzene-1,3-diol (<b>33d</b>)</h4><div class="NLM_p last">This compound was synthesized by the same procedure outlined for <b>33a</b>. Thus, <b>32</b> and 2,4-dichlorothieno[3,2-<i>d</i>]pyrimidine were reacted as described to afford crude product that was purified by flash chromatography on silica gel eluting with a gradient of 0 to 80% ethyl acetate in hexane then o to 2.5% MeOH in DCM to afford the title compound (12 mg, 13%) as a yellow solid: LCMS (<i>method A</i>): <i>t</i><sub>R</sub> = 2.56 min; <i>m</i>/<i>z</i> = 452 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.17 (d, <i>J</i> = 6.5 Hz, 3H), 1.61 (dq, <i>J</i> = 5.9, 13.0 Hz, 1H), 2.32 (dq, <i>J</i> = 6.2, 13.6 Hz, 1H), 2.76–3.02 (m, 2H), 4.63 (q, <i>J</i> = 6.3 Hz, 1H), 6.14 (d, <i>J</i> = 2.2 Hz, 1H), 6.23 (dd, <i>J</i> = 2.2, 8.4 Hz, 1H), 7.06 (d, <i>J</i> = 8.4 Hz, 1H), 7.14 (d, <i>J</i> = 8.5 Hz, 1H), 7.70 (d, <i>J</i> = 5.5 Hz, 1H), 7.75 (dd, <i>J</i> = 2.2, 8.5 Hz, 1H), 8.00 (d, <i>J</i> = 2.2 Hz, 1H), 8.67 (d, <i>J</i> = 5.5 Hz, 1H), 9.55–9.80 (m, 2H); <sup>13</sup>C NMR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>) δ 19.4 (CH3), 20.3 (CH3), 24.5 (CH2), 30.9 (CH2), 48.8 (CH), 102.3 (CH), 106.5 (CH), 115.1 (C), 124.4 (CH), 126.1 (CH), 126.4 (CH), 127.0 (CH), 127.0 (C), 128.3 (CH), 128.6 (CH), 128.8 (CH), 129.1 (C), 130.2 (CH), 132.1 (C), 135.9 (C), 136.7 (CH), 137.7 (C), 146.0 (C), 156.2 (C), 159.2 (C), 159.7 (C), 168.6 (C); HRMS, calcd for C<sub>23</sub>H<sub>18</sub>N<sub>3</sub>O<sub>3</sub>SCl [M]+ found 451.0755 requires 451.0757; HPLC 100% (t<sub><i>R</i></sub> = 1.17 min).</div></div><div id="sec5_7_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-Benzyl-2,4-dihydroxy-<i>N</i>-{4-[methyl(quinoxalin-6-ylmethyl)carbamoyl]phenyl}benzamide (<b>35a</b>)</h4><div class="NLM_p last">This compound was synthesized by same procedure outlined for <b>29a</b>. Thus, <b>34</b> (see <a class="ref internalNav" href="#notes-1" aria-label="SI">SI</a>) and <i>N</i>-methyl-1-quinoxalin-6-ylmethanamine were reacted as described to afford crude product that was purified by flash chromatography on silica gel eluting with a gradient of 0 to 70% ethyl acetate in hexane to afford the title compound (64 mg, 55%) as a colorless solid: LCMS (<i>method C</i>): <i>t</i><sub>R</sub> = 1.16 min; <i>m</i>/<i>z</i> = 519 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.91 (s, 3H), 4.81 (s, 2H), 5.09 (s, 2H), 6.05 (dd, <i>J</i> = 2.3, 8.5 Hz, 1H), 6.17 (d, <i>J</i> = 2.3 Hz, 1H), 6.84 (d, <i>J</i> = 8.5 Hz, 1H), 7.14 (d, <i>J</i> = 8.4 Hz, 2H), 7.18–7.38 (m, 7H), 7.72 (d, <i>J</i> = 7.4 Hz, 1H), 7.95 (s, 1H), 8.10 (d, <i>J</i> = 8.6 Hz, 1H), 8.86–8.98 (m, 2H), 9.35 (s, 1H), 9.90 (s, 1H); <sup>13</sup>C NMR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>, 353 K) δ 52.2 (CH2), 102.3 (CH), 106.0 (CH), 112.9 (C), 126.5 (CH), 126.6 (C, broad), 126.7 (CH), 127.3 (CH), 127.8 (CH), 129.1 (CH), 129.2 (C, broad), 129.9 (CH), 133.3 (C), 137.2 (C), 139.3 (C), 141.3 (C), 141.9 (C), 143.9 (C), 145.0 (CH), 145.3 (CH), 157.0 (C), 159.6 (C), 169.2 (C), 169.8 (C); HRMS, calcd for C<sub>31</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub> [M]+ found 518.1957 requires 518.1954; HPLC 100% (t<sub><i>R</i></sub> = 0.91 min).</div></div><div id="sec5_7_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-Benzyl-2,4-dihydroxy-<i>N</i>-(4-{[(4-methoxyphenyl)methyl](methyl)carbamoyl}phenyl)benzamide (<b>35b</b>)</h4><div class="NLM_p last">This compound was synthesized by the same procedure outlined for <b>29a</b>. Thus, <b>34</b> (see <a class="ref internalNav" href="#notes-1" aria-label="SI">SI</a>) and [(4-methoxyphenyl)methyl](methyl)amine were reacted as described to afford crude product that was purified by flash chromatography on silica gel eluting with a gradient of 0 to 40% ethyl acetate in hexane to afford the title compound (51 mg, 46%) as a colorless solid: LCMS (<i>method C</i>): <i>t</i><sub>R</sub> = 1.29 min; <i>m</i>/<i>z</i> = 497 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) rotamers δ 2.67 and 2.83 (s, 3H), 3.74 (s, 3H), 4.25 (s, 1H), 4.54 (s, 1H), 5.07 (s, 2H), 6.06 (d, <i>J</i> = 7.4 Hz, 1H), 6.10 (d, <i>J</i> = 2.2 Hz, 1H), 6.78–6.99 (m, 4H), 7.10 (d, <i>J</i> = 7.8 Hz, 2H), 7.14–7.37 (m, 8H), 9.57 (s, 1H), 9.90 (s, 1H); <sup>13</sup>C NMR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>, 353 K) δ 52.2 (CH2), 54.8 (CH3), 102.3 (CH), 106.0 (CH), 112.9 (C), 113.8 (CH), 126.4 (CH), 126.5 (CH), 126.6 (CH), 127.3 (CH), 127.8 (CH), 128.3 (CH), 128.7 (C), 129.9 (CH), 133.7 (C), 137.2 (C), 143.7 (C), 157.0 (C), 158.3 (C), 159.6 (C), 169.2 (C), 169.9 (C); HRMS, calcd for C<sub>30</sub>H<sub>28</sub>N<sub>2</sub>O<sub>5</sub> [M]+ found 496.2002 requires 496.1998; HPLC 98.5% (t<sub><i>R</i></sub> = 1.02 min).</div></div><div id="sec5_7_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-Benzyl-<i>N</i>-[4-(2-chloro-5-methylpyrimidin-4-yl)phenyl]-2,4-dihydroxybenzamid (<b>37a</b>)</h4><div class="NLM_p last">This compound was synthesized by the same procedure outlined for <b>29a</b>. Thus, <b>36</b> (see <a class="ref internalNav" href="#notes-1" aria-label="SI">SI</a>) and 2,4-dichloro-5-methylpyrimidine were reacted as described to afford crude product that was purified by flash chromatography on silica gel eluting with a gradient of 0 to 40% ethyl acetate in hexane to afford the title compound (37 mg, 44%) as a colorless solid: LCMS (<i>method A</i>): <i>t</i><sub>R</sub> = 2.51 min; <i>m</i>/<i>z</i> = 446 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (399 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.26 (s, 3H), 5.13 (s, 2H), 6.09–6.14 (m, 2H), 6.96 (d, <i>J</i> = 8.2 Hz, 1H), 7.16–7.28 (m, 3H), 7.30–7.43 (m, 4H), 7.46–7.59 (m, 2H), 8.66 (d, <i>J</i> = 0.6 Hz, 1H), 9.60 (s, 1H), 9.91 (s, 1H); <sup>13</sup>C NMR (100.6 MHz, DMSO-<i>d</i><sub>6</sub>) δ 16.0 (CH3), 52.2 (CH2), 102.3 (CH), 106.4 (CH), 114.2 (C), 126.5 (CH), 127.0 (CH), 127.4 (CH), 127.5 (C), 128.3 (CH), 129.2 (CH), 130.4 (CH), 133.3 (C), 137.7 (C), 144.7 (C), 156.2 (C), 157.5 (C), 159.8 (C), 162.0 (CH), 166.2 (C), 169.3 (C); HRMS, calcd for C<sub>25</sub>H<sub>20</sub>N<sub>3</sub>O<sub>3</sub>Cl [M]+ found 445.1201 requires 445.1193; HPLC 100% (t<sub><i>R</i></sub> = 1.07 min).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01478">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71702" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71702" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01478" class="ext-link">10.1021/acs.jmedchem.6b01478</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Data relating to screening protocols, X-ray crystallographic studies, protein production, additional compound synthesis, analysis, and characterization (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01478/suppl_file/jm6b01478_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01478/suppl_file/jm6b01478_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01478/suppl_file/jm6b01478_si_001.pdf">jm6b01478_si_001.pdf (692.07 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01478/suppl_file/jm6b01478_si_002.csv">jm6b01478_si_002.csv (2.43 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and structural factors have been deposited with the Protein database. The PDB codes are as follows. Compound <b>10:</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4K">5M4K</a> (PDHK-2), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4E">5M4E</a> (HSP90); <b>21:</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4H">5M4H</a> (HSP90); <b>33a:</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4N">5M4N</a> (PDHK-2); <b>35a:</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4M">5M4M</a> (PDHK-2); <b>38:</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4P">5M4P</a> (PDHK-2).</p><div class="testing" data-doi="10.1021/acs.jmedchem.6b01478" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55886" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55886" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul A. Brough</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7789-8101" title="Orcid link">http://orcid.org/0000-0001-7789-8101</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7d0d531f0f12081a153d0b180f131c11140e531e1210"><span class="__cf_email__" data-cfemail="42326c20302d37252a023427302c232e2b316c212d2f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa Baker</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon Bedford</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kirsten Brown</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seema Chavda</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Victoria Chell</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jalanie D’Alessandro</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas G. M. Davies</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ben Davis</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Loic Le Strat</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alba T. Macias</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Maddox</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick C. Mahon</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew J. Massey</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Natalia Matassova</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sean McKenna</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Johannes W. G. Meissner</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan D. Moore</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James B. Murray</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Northfield</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles Parry</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rachel Parsons</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen D. Roughley</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0683-5693" title="Orcid link">http://orcid.org/0000-0003-0683-5693</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Terry Shaw</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heather Simmonite</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Stokes</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allan Surgenor</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emma Stefaniak</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan Robertson</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yikang Wang</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Webb</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Neil Whitehead</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mike Wood</span> - <span class="hlFld-Affiliation affiliation">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, U.K.</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d132e4238-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02077" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02077" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Karl Erhard (GSK, Collegeville, PA, USA) for chiral PREP HPLC purification.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40213" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40213" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="first last">This paper was published ASAP on February 15, 2017, without one of the contributing author names in the affiliations. The corrected version was reposted on March 10, 2017.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i51" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i51"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i52" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i52"> Abbreviations Used</h2><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">PDHK</td><td class="NLM_def"><p class="first last">pyruvate dehydrogenase kinase</p></td></tr><tr><td class="NLM_term">DCA</td><td class="NLM_def"><p class="first last">dichloroacetate</p></td></tr><tr><td class="NLM_term">PC3</td><td class="NLM_def"><p class="first last">prostate cancer 3</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">ITC</td><td class="NLM_def"><p class="first last">isothermal calorimetry</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">GI<sub>50</sub></td><td class="NLM_def"><p class="first last">half maximal growth inhibition</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatography mass spectrometry</p></td></tr><tr><td class="NLM_term">FP</td><td class="NLM_def"><p class="first last">fluorescence polarization</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high resolution mass spectrometry</p></td></tr><tr><td class="NLM_term">HA</td><td class="NLM_def"><p class="first last">heavy atom</p></td></tr><tr><td class="NLM_term">cK<sub>i</sub></td><td class="NLM_def"><p class="first last">calculated inhibition constant</p></td></tr><tr><td class="NLM_term">ORS</td><td class="NLM_def"><p class="first last">off-rate screening</p></td></tr><tr><td class="NLM_term">SBDD</td><td class="NLM_def"><p class="first last">structure-based drug design</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07550" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07550" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 50 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Bowker-Kinley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, K. M.</span><span> </span><span class="NLM_article-title">Evidence that pyruvate dehydrogenase kinase belongs to the ATPase/kinase superfamily</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span><span class="refDoi"> DOI: 10.1042/bj3440047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1042%2Fbj3440047" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=1999&pages=47-53&author=M.+Bowker-Kinleyauthor=K.+M.+Popov&title=Evidence+that+pyruvate+dehydrogenase+kinase+belongs+to+the+ATPase%2Fkinase+superfamily&doi=10.1042%2Fbj3440047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1042%2Fbj3440047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3440047%26sid%3Dliteratum%253Aachs%26aulast%3DBowker-Kinley%26aufirst%3DM.%26aulast%3DPopov%26aufirst%3DK.%2BM.%26atitle%3DEvidence%2520that%2520pyruvate%2520dehydrogenase%2520kinase%2520belongs%2520to%2520the%2520ATPase%252Fkinase%2520superfamily%26jtitle%3DBiochem.%2520J.%26date%3D1999%26volume%3D344%26spage%3D47%26epage%3D53%26doi%3D10.1042%2Fbj3440047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Steussy, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowker-Kinley, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, R. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, J. A.</span><span> </span><span class="NLM_article-title">Structure of pyruvate dehydrogenase kinase. Novel folding pattern for a serine protein kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">37443</span><span class="NLM_x">–</span> <span class="NLM_lpage">37450</span><span class="refDoi"> DOI: 10.1074/jbc.M104285200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1074%2Fjbc.M104285200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=37443-37450&author=C.+N.+Steussyauthor=K.+M.+Popovauthor=M.+M.+Bowker-Kinleyauthor=R.+B.+Sloanauthor=R.+A.+Harrisauthor=J.+A.+Hamilton&title=Structure+of+pyruvate+dehydrogenase+kinase.+Novel+folding+pattern+for+a+serine+protein+kinase&doi=10.1074%2Fjbc.M104285200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M104285200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M104285200%26sid%3Dliteratum%253Aachs%26aulast%3DSteussy%26aufirst%3DC.%2BN.%26aulast%3DPopov%26aufirst%3DK.%2BM.%26aulast%3DBowker-Kinley%26aufirst%3DM.%2BM.%26aulast%3DSloan%26aufirst%3DR.%2BB.%26aulast%3DHarris%26aufirst%3DR.%2BA.%26aulast%3DHamilton%26aufirst%3DJ.%2BA.%26atitle%3DStructure%2520of%2520pyruvate%2520dehydrogenase%2520kinase.%2520Novel%2520folding%2520pattern%2520for%2520a%2520serine%2520protein%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D37443%26epage%3D37450%26doi%3D10.1074%2Fjbc.M104285200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Patel, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korotchkina, L. G.</span><span> </span><span class="NLM_article-title">Regulation of the pyruvate dehydrogenase complex</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span><span class="refDoi"> DOI: 10.1042/BST0340217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1042%2FBST0340217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=16545080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1ersro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=217-222&author=M.+S.+Patelauthor=L.+G.+Korotchkina&title=Regulation+of+the+pyruvate+dehydrogenase+complex&doi=10.1042%2FBST0340217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of the pyruvate dehydrogenase complex</span></div><div class="casAuthors">Patel, M. S.; Korotchkina, L. G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">217-222</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The pyruvate dehydrogenase complex (PDC) plays a central role in the maintenance of glucose homoeostasis in mammals.  C flux through PDC is meticulously controlled by elaborate mechanisms involving post-translational (short-term) phosphorylation/dephosphorylation and transcriptional (long-term) controls.  The former regulatory mechanism involving multiple phosphorylation sites and tissue-specific distribution of the dedicated kinases and phosphatases is not only dependent on the interactions among the catalytic and regulatory components of the complex but also sensitive to the intramitochondrial redox state and metabolite levels as indicators of the energy status.  Furthermore, differential transcriptional controls of the regulatory components of PDC further add to the complexity needed for long-term tuning of PDC activity for the maintenance of glucose homoeostasis during normal and disease states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxgyCnDeW--LVg90H21EOLACvtfcHk0lg6RIdirUpc5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1ersro%253D&md5=41176d0204bbd5687736b93993cf78b5</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1042%2FBST0340217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0340217%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DM.%2BS.%26aulast%3DKorotchkina%26aufirst%3DL.%2BG.%26atitle%3DRegulation%2520of%2520the%2520pyruvate%2520dehydrogenase%2520complex%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2006%26volume%3D34%26spage%3D217%26epage%3D222%26doi%3D10.1042%2FBST0340217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inskeep, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowker-Kinley, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. A.</span><span> </span><span class="NLM_article-title">Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1593</span><span class="NLM_x">–</span> <span class="NLM_lpage">1599</span><span class="refDoi"> DOI: 10.2337/diabetes.48.8.1593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.2337%2Fdiabetes.48.8.1593" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1999&pages=1593-1599&author=P.+Wuauthor=K.+Inskeepauthor=M.+M.+Bowker-Kinleyauthor=K.+M.+Popovauthor=R.+A.+Harris&title=Mechanism+responsible+for+inactivation+of+skeletal+muscle+pyruvate+dehydrogenase+complex+in+starvation+and+diabetes&doi=10.2337%2Fdiabetes.48.8.1593"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.48.8.1593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.48.8.1593%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DInskeep%26aufirst%3DK.%26aulast%3DBowker-Kinley%26aufirst%3DM.%2BM.%26aulast%3DPopov%26aufirst%3DK.%2BM.%26aulast%3DHarris%26aufirst%3DR.%2BA.%26atitle%3DMechanism%2520responsible%2520for%2520inactivation%2520of%2520skeletal%2520muscle%2520pyruvate%2520dehydrogenase%2520complex%2520in%2520starvation%2520and%2520diabetes%26jtitle%3DDiabetes%26date%3D1999%26volume%3D48%26spage%3D1593%26epage%3D1599%26doi%3D10.2337%2Fdiabetes.48.8.1593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Morrell, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orme, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butlin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayers, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilgour, E.</span><span> </span><span class="NLM_article-title">AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1168</span><span class="NLM_x">–</span> <span class="NLM_lpage">1170</span><span class="refDoi"> DOI: 10.1042/bst0311168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1042%2Fbst0311168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=14641019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps12jsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=1168-1170&author=J.+A.+Morrellauthor=J.+Ormeauthor=R.+J.+Butlinauthor=T.+E.+Rocheauthor=R.+M.+Mayersauthor=E.+Kilgour&title=AZD7545+is+a+selective+inhibitor+of+pyruvate+dehydrogenase+kinase+2&doi=10.1042%2Fbst0311168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2</span></div><div class="casAuthors">Morrell, J. A.; Orme, J.; Butlin, R. J.; Roche, T. E.; Mayers, R. M.; Kilgour, E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1168-1170</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The PDH (pyruvate dehydrogenase) multi-enzyme complex catalyzes a key regulatory step in oxidative glycolysis.  Phosphorylation of the E1 subunit of the complex on serine residues results in the inactivation of enzyme activity.  A family of four dedicated PDH kinase isoenzymes exists, each of which displays a distinct tissue-specific expression profile.  AZD7545 is one of a series of PDH kinase inhibitors developed for the treatment of type 2 diabetes.  The isoenzyme-selectivity profile of AZD7545 and related compds. is described and the consequences for their in vivo mode of action are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRKIXN95mX-bVg90H21EOLACvtfcHk0li9oBiAv9Tzsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps12jsr8%253D&md5=86c9fe03c05f86792c14953c381d3beb</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1042%2Fbst0311168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0311168%26sid%3Dliteratum%253Aachs%26aulast%3DMorrell%26aufirst%3DJ.%2BA.%26aulast%3DOrme%26aufirst%3DJ.%26aulast%3DButlin%26aufirst%3DR.%2BJ.%26aulast%3DRoche%26aufirst%3DT.%2BE.%26aulast%3DMayers%26aufirst%3DR.%2BM.%26aulast%3DKilgour%26aufirst%3DE.%26atitle%3DAZD7545%2520is%2520a%2520selective%2520inhibitor%2520of%2520pyruvate%2520dehydrogenase%2520kinase%25202%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2003%26volume%3D31%26spage%3D1168%26epage%3D1170%26doi%3D10.1042%2Fbst0311168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Aicher, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebernitz, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewell, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knorr, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperbeck, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brand, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strohschein, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinluan, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shetty, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelGrande, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozito, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maniara, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, W. R.</span><span> </span><span class="NLM_article-title">R)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionamides are orally active inhibitors of pyruvate dehydrogenase kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2741</span><span class="NLM_x">–</span> <span class="NLM_lpage">2746</span><span class="refDoi"> DOI: 10.1021/jm9902584</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9902584" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=2741-2746&author=T.+D.+Aicherauthor=R.+C.+Andersonauthor=G.+R.+Bebernitzauthor=G.+M.+Coppolaauthor=C.+F.+Jewellauthor=D.+C.+Knorrauthor=C.+Liuauthor=D.+M.+Sperbeckauthor=L.+J.+Brandauthor=R.+J.+Strohscheinauthor=J.+Gaoauthor=C.+C.+Vinluanauthor=S.+S.+Shettyauthor=C.+Draglandauthor=E.+L.+Kaplanauthor=D.+DelGrandeauthor=A.+Islamauthor=X.+Liuauthor=R.+J.+Lozitoauthor=W.+M.+Maniaraauthor=R.+E.+Walterauthor=W.+R.+Mann&title=R%29-3%2C3%2C3-Trifluoro-2-hydroxy-2-methylpropionamides+are+orally+active+inhibitors+of+pyruvate+dehydrogenase+kinase&doi=10.1021%2Fjm9902584"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm9902584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9902584%26sid%3Dliteratum%253Aachs%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DAnderson%26aufirst%3DR.%2BC.%26aulast%3DBebernitz%26aufirst%3DG.%2BR.%26aulast%3DCoppola%26aufirst%3DG.%2BM.%26aulast%3DJewell%26aufirst%3DC.%2BF.%26aulast%3DKnorr%26aufirst%3DD.%2BC.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DSperbeck%26aufirst%3DD.%2BM.%26aulast%3DBrand%26aufirst%3DL.%2BJ.%26aulast%3DStrohschein%26aufirst%3DR.%2BJ.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DVinluan%26aufirst%3DC.%2BC.%26aulast%3DShetty%26aufirst%3DS.%2BS.%26aulast%3DDragland%26aufirst%3DC.%26aulast%3DKaplan%26aufirst%3DE.%2BL.%26aulast%3DDelGrande%26aufirst%3DD.%26aulast%3DIslam%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLozito%26aufirst%3DR.%2BJ.%26aulast%3DManiara%26aufirst%3DW.%2BM.%26aulast%3DWalter%26aufirst%3DR.%2BE.%26aulast%3DMann%26aufirst%3DW.%2BR.%26atitle%3DR%2529-3%252C3%252C3-Trifluoro-2-hydroxy-2-methylpropionamides%2520are%2520orally%2520active%2520inhibitors%2520of%2520pyruvate%2520dehydrogenase%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D2741%26epage%3D2746%26doi%3D10.1021%2Fjm9902584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Aicher, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shetty, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knorr, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperbeck, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brand, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinluan, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragland, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaselli, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozito, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maniara, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillers, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelGrande, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, W. R.</span><span> </span><span class="NLM_article-title">Secondary amides of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">236</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span><span class="refDoi"> DOI: 10.1021/jm990358+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990358%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=236-249&author=T.+D.+Aicherauthor=R.+C.+Andersonauthor=J.+Gaoauthor=S.+S.+Shettyauthor=G.+M.+Coppolaauthor=J.+L.+Stantonauthor=D.+C.+Knorrauthor=D.+M.+Sperbeckauthor=L.+J.+Brandauthor=C.+C.+Vinluanauthor=E.+L.+Kaplanauthor=C.+J.+Draglandauthor=H.+C.+Tomaselliauthor=A.+Islamauthor=R.+J.+Lozitoauthor=X.+Liuauthor=W.+M.+Maniaraauthor=W.+S.+Fillersauthor=D.+DelGrandeauthor=R.+E.+Walterauthor=W.+R.+Mann&title=Secondary+amides+of+%28R%29-3%2C3%2C3-trifluoro-2-hydroxy-2-methylpropionic+acid+as+inhibitors+of+pyruvate+dehydrogenase+kinase&doi=10.1021%2Fjm990358%2B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm990358%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990358%252B%26sid%3Dliteratum%253Aachs%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DAnderson%26aufirst%3DR.%2BC.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DShetty%26aufirst%3DS.%2BS.%26aulast%3DCoppola%26aufirst%3DG.%2BM.%26aulast%3DStanton%26aufirst%3DJ.%2BL.%26aulast%3DKnorr%26aufirst%3DD.%2BC.%26aulast%3DSperbeck%26aufirst%3DD.%2BM.%26aulast%3DBrand%26aufirst%3DL.%2BJ.%26aulast%3DVinluan%26aufirst%3DC.%2BC.%26aulast%3DKaplan%26aufirst%3DE.%2BL.%26aulast%3DDragland%26aufirst%3DC.%2BJ.%26aulast%3DTomaselli%26aufirst%3DH.%2BC.%26aulast%3DIslam%26aufirst%3DA.%26aulast%3DLozito%26aufirst%3DR.%2BJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DManiara%26aufirst%3DW.%2BM.%26aulast%3DFillers%26aufirst%3DW.%2BS.%26aulast%3DDelGrande%26aufirst%3DD.%26aulast%3DWalter%26aufirst%3DR.%2BE.%26aulast%3DMann%26aufirst%3DW.%2BR.%26atitle%3DSecondary%2520amides%2520of%2520%2528R%2529-3%252C3%252C3-trifluoro-2-hydroxy-2-methylpropionic%2520acid%2520as%2520inhibitors%2520of%2520pyruvate%2520dehydrogenase%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D236%26epage%3D249%26doi%3D10.1021%2Fjm990358%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kim, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, C. V.</span><span> </span><span class="NLM_article-title">Cancer’s molecular sweet tooth and the Warburg effect</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">8927</span><span class="NLM_x">–</span> <span class="NLM_lpage">8930</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-06-1501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1158%2F0008-5472.CAN-06-1501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=16982728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1aitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=8927-8930&author=J.+W.+Kimauthor=C.+V.+Dang&title=Cancer%E2%80%99s+molecular+sweet+tooth+and+the+Warburg+effect&doi=10.1158%2F0008-5472.CAN-06-1501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer's Molecular Sweet Tooth and the Warburg Effect</span></div><div class="casAuthors">Kim, Jung-Whan; Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8927-8930</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  More than 80 years ago, the renowned biochemist Otto Warburg described how cancer cells avidly consume glucose and produce lactic acid under aerobic conditions.  Recent studies arguing that cancer cells benefit from this phenomenon, termed the Warburg effect, have renewed discussions about its exact role as cause, correlate, or facilitator of cancer.  Mol. advances in this area may reveal tactics to exploit the cancer cell's "sweet tooth" for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqohObedUNtO7Vg90H21EOLACvtfcHk0ligyQtCxlRlEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1aitL4%253D&md5=96e33e46621768b0119cdfe08c3bd46a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-1501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-1501%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DCancer%25E2%2580%2599s%2520molecular%2520sweet%2520tooth%2520and%2520the%2520Warburg%2520effect%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D8927%26epage%3D8930%26doi%3D10.1158%2F0008-5472.CAN-06-1501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Warburg, O.</span><span> </span><span class="NLM_article-title">Uber den Stoffwechsel der Carcinomzelle</span> <span class="citation_source-journal">Klin. Wochenschr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1925</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span><span class="refDoi"> DOI: 10.1007/BF01726151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1007%2FBF01726151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADyaB2MXhvValsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1925&pages=534-536&author=O.+Warburg&title=Uber+den+Stoffwechsel+der+Carcinomzelle&doi=10.1007%2FBF01726151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The metabolism of carcinoma cells</span></div><div class="casAuthors">Warburg, Otto</div><div class="citationInfo"><span class="NLM_cas:title">Klinische Wochenschrift</span>
        (<span class="NLM_cas:date">1925</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">534-6</span>CODEN:
                <span class="NLM_cas:coden">KLWOAZ</span>;
        ISSN:<span class="NLM_cas:issn">0023-2173</span>.
    </div><div class="casAbstract">Carcinoma cells not only oxidize glucose but they convert (glucolysis) a large part of it into lactic acid (10-12% of their own wt. per hr.).  This differentiates them sharply from embryonic tissue and from resting and active epithelium.  The metabolism of carcinoma cells is predominantly glucolytic, subordinately oxidative.  The reverse is true of normal body cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvePgMrHSg6bVg90H21EOLACvtfcHk0ligyQtCxlRlEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaB2MXhvValsg%253D%253D&md5=7bcae1fd77934207a87a16bcd9abb50a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2FBF01726151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01726151%26sid%3Dliteratum%253Aachs%26aulast%3DWarburg%26aufirst%3DO.%26atitle%3DUber%2520den%2520Stoffwechsel%2520der%2520Carcinomzelle%26jtitle%3DKlin.%2520Wochenschr.%26date%3D1925%26volume%3D4%26spage%3D534%26epage%3D536%26doi%3D10.1007%2FBF01726151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Kim, J. w.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchernyshyov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenza, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, C. V.</span><span> </span><span class="NLM_article-title">HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1016/j.cmet.2006.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1016%2Fj.cmet.2006.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=16517405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislyhtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=177-185&author=J.+w.+Kimauthor=I.+Tchernyshyovauthor=G.+L.+Semenzaauthor=C.+V.+Dang&title=HIF-1-mediated+expression+of+pyruvate+dehydrogenase+kinase%3A+a+metabolic+switch+required+for+cellular+adaptation+to+hypoxia&doi=10.1016%2Fj.cmet.2006.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia</span></div><div class="casAuthors">Kim, Jung-whan; Tchernyshyov, Irina; Semenza, Gregg L.; Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">177-185</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Activation of glycolytic genes by HIF-1 is considered crit. for metabolic adaptation to hypoxia through increased conversion of glucose to pyruvate and subsequently to lactate.  We found that HIF-1 also actively suppresses metab. through the tricarboxylic acid cycle (TCA) by directly trans-activating the gene encoding pyruvate dehydrogenase kinase 1 (PDK1).  PDK1 inactivates the TCA cycle enzyme, pyruvate dehydrogenase (PDH), which converts pyruvate to acetyl-CoA.  Forced PDK1 expression in hypoxic HIF-1α null cells increases ATP levels, attenuates hypoxic ROS generation, and rescues these cells from hypoxia-induced apoptosis.  These studies reveal a hypoxia-induced metabolic switch that shunts glucose metabolites from the mitochondria to glycolysis to maintain ATP prodn. and to prevent toxic ROS prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkmBOJaCXUx7Vg90H21EOLACvtfcHk0ligyQtCxlRlEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislyhtrw%253D&md5=783b85071f8a48f5262ba9522d1715b0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2006.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2006.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2Bw.%26aulast%3DTchernyshyov%26aufirst%3DI.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DHIF-1-mediated%2520expression%2520of%2520pyruvate%2520dehydrogenase%2520kinase%253A%2520a%2520metabolic%2520switch%2520required%2520for%2520cellular%2520adaptation%2520to%2520hypoxia%26jtitle%3DCell%2520Metab.%26date%3D2006%26volume%3D3%26spage%3D177%26epage%3D185%26doi%3D10.1016%2Fj.cmet.2006.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, S.</span><span> </span><span class="NLM_article-title">Overexpression of pyruvate dehydrogenase kinase 3 increases drug resistance and early recurrence in colon cancer</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">1405</span><span class="NLM_x">–</span> <span class="NLM_lpage">1414</span><span class="refDoi"> DOI: 10.1016/j.ajpath.2011.05.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1016%2Fj.ajpath.2011.05.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=21763680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2jsb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2011&pages=1405-1414&author=C.+Luauthor=S.+Linauthor=C.+Chienauthor=S.+Linauthor=C.+Leeauthor=B.+Linauthor=J.+Leeauthor=S.+Tsai&title=Overexpression+of+pyruvate+dehydrogenase+kinase+3+increases+drug+resistance+and+early+recurrence+in+colon+cancer&doi=10.1016%2Fj.ajpath.2011.05.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of pyruvate dehydrpgenase kinase 3 increases drug resistance and early recurrence in colon cancer</span></div><div class="casAuthors">Lu, Chun-Wun; Lin, Shau-Chieh; Chien, Chun-Wei; Lin, Shih-Chieh; Lee, Chung-Ta; Lin, Bo-Wen; Lee, Jenq-Chang; Tsai, Shaw-Jenq</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1405-1414</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The switch of cellular metab. from mitochondrial respiration to glycolysis is the hallmark of cancer cells and is assocd. with tumor malignancy.  Pyruvate dehydrogenase kinase-1 (PDK1) and PDK3 participate in the metabolic switch of cancer cells; however, the medical significance of PDK1 and PDK3 in cancer progression is not known.  Here, we assessed the expression profiles of PDK1 and PDK3 in colorectal cancer.  Western blot anal. (n = 74) demonstrated that PDK3 was markedly increased in colon cancer compared to that in adjacent normal tissues, whereas PDK1 was decreased in cancer cells.  In addn., PDK3 expression was pos. correlated with that of hypoxia inducible factor-1α (HIF-1α) in cancer cells.  Further anal. using immunohistochem. staining revealed that PDK3 levels were pos. assocd. with severity of cancer and neg. assocd. with disease-free survival.  In vitro studies using several colon cancer cell lines showed that PDK3 expression was controlled by HIF-1α and contributed to hypoxia-induced increased drug resistance, perhaps explaining why patients with PDK3 overexpression have a greater incidence of treatment failure.  Taken together, our findings suggest that PDK3 plays an important role in the metabolic switch and drug resistance of colon cancer and is potentially a novel target for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQmjhmaIUuIrVg90H21EOLACvtfcHk0ligyQtCxlRlEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2jsb%252FI&md5=44cb57fc1b370446524ecaa0a5a0fa05</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2011.05.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2011.05.050%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DTsai%26aufirst%3DS.%26atitle%3DOverexpression%2520of%2520pyruvate%2520dehydrogenase%2520kinase%25203%2520increases%2520drug%2520resistance%2520and%2520early%2520recurrence%2520in%2520colon%2520cancer%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2011%26volume%3D179%26spage%3D1405%26epage%3D1414%26doi%3D10.1016%2Fj.ajpath.2011.05.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">McFate, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohyeldin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriques, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halim, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teahan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Califano, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeoung, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, A.</span><span> </span><span class="NLM_article-title">Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">22700</span><span class="NLM_x">–</span> <span class="NLM_lpage">22708</span><span class="refDoi"> DOI: 10.1074/jbc.M801765200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1074%2Fjbc.M801765200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=22700-22708&author=T.+McFateauthor=A.+Mohyeldinauthor=H.+Luauthor=J.+Thakarauthor=J.+Henriquesauthor=N.+D.+Halimauthor=H.+Wuauthor=M.+J.+Schellauthor=T.+M.+Tsangauthor=O.+Teahanauthor=S.+Zhouauthor=J.+A.+Califanoauthor=N.+H.+Jeoungauthor=R.+A.+Harrisauthor=A.+Verma&title=Pyruvate+dehydrogenase+complex+activity+controls+metabolic+and+malignant+phenotype+in+cancer+cells&doi=10.1074%2Fjbc.M801765200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M801765200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M801765200%26sid%3Dliteratum%253Aachs%26aulast%3DMcFate%26aufirst%3DT.%26aulast%3DMohyeldin%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DThakar%26aufirst%3DJ.%26aulast%3DHenriques%26aufirst%3DJ.%26aulast%3DHalim%26aufirst%3DN.%2BD.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DSchell%26aufirst%3DM.%2BJ.%26aulast%3DTsang%26aufirst%3DT.%2BM.%26aulast%3DTeahan%26aufirst%3DO.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DCalifano%26aufirst%3DJ.%2BA.%26aulast%3DJeoung%26aufirst%3DN.%2BH.%26aulast%3DHarris%26aufirst%3DR.%2BA.%26aulast%3DVerma%26aufirst%3DA.%26atitle%3DPyruvate%2520dehydrogenase%2520complex%2520activity%2520controls%2520metabolic%2520and%2520malignant%2520phenotype%2520in%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D22700%26epage%3D22708%26doi%3D10.1074%2Fjbc.M801765200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Papandreou, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontana, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denko, N. C.</span><span> </span><span class="NLM_article-title">HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span><span class="refDoi"> DOI: 10.1016/j.cmet.2006.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1016%2Fj.cmet.2006.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=16517406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislyhtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=187-197&author=I.+Papandreouauthor=R.+A.+Cairnsauthor=L.+Fontanaauthor=A.+L.+Limauthor=N.+C.+Denko&title=HIF-1+mediates+adaptation+to+hypoxia+by+actively+downregulating+mitochondrial+oxygen+consumption&doi=10.1016%2Fj.cmet.2006.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption</span></div><div class="casAuthors">Papandreou, Ioanna; Cairns, Rob A.; Fontana, Lucrezia; Lim, Ai Lin; Denko, Nicholas C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-197</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The HIF-1 transcription factor drives hypoxic gene expression changes that are thought to be adaptive for cells exposed to a reduced-oxygen environment.  For example, HIF-1 induces the expression of glycolytic genes.  It is presumed that increased glycolysis is necessary to produce energy when low oxygen will not support oxidative phosphorylation at the mitochondria.  However, we find that while HIF-1 stimulates glycolysis, it also actively represses mitochondrial function and oxygen consumption by inducing pyruvate dehydrogenase kinase 1 (PDK1).  PDK1 phosphorylates and inhibits pyruvate dehydrogenase from using pyruvate to fuel the mitochondrial TCA cycle.  This causes a drop in mitochondrial oxygen consumption and results in a relative increase in intracellular oxygen tension.  We show by genetic means that HIF-1-dependent block to oxygen utilization results in increased oxygen availability, decreased cell death when total oxygen is limiting, and reduced cell death in response to the hypoxic cytotoxin tirapazamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohIkKC5qqbwLVg90H21EOLACvtfcHk0lhUGWMMF_Nn7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislyhtr0%253D&md5=1e6d9a6dcf39366211043e1f37cd9716</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2006.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2006.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DPapandreou%26aufirst%3DI.%26aulast%3DCairns%26aufirst%3DR.%2BA.%26aulast%3DFontana%26aufirst%3DL.%26aulast%3DLim%26aufirst%3DA.%2BL.%26aulast%3DDenko%26aufirst%3DN.%2BC.%26atitle%3DHIF-1%2520mediates%2520adaptation%2520to%2520hypoxia%2520by%2520actively%2520downregulating%2520mitochondrial%2520oxygen%2520consumption%26jtitle%3DCell%2520Metab.%26date%3D2006%26volume%3D3%26spage%3D187%26epage%3D197%26doi%3D10.1016%2Fj.cmet.2006.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Wigfield, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giatromanolaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koukourakis, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. L.</span><span> </span><span class="NLM_article-title">PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">1975</span><span class="NLM_x">–</span> <span class="NLM_lpage">1984</span><span class="refDoi"> DOI: 10.1038/sj.bjc.6604356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1038%2Fsj.bjc.6604356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=18542064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvV2ht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2008&pages=1975-1984&author=S.+M.+Wigfieldauthor=S.+C.+Winterauthor=A.+Giatromanolakiauthor=J.+Taylorauthor=M.+L.+Koukourakisauthor=A.+L.+Harris&title=PDK-1+regulates+lactate+production+in+hypoxia+and+is+associated+with+poor+prognosis+in+head+and+neck+squamous+cancer&doi=10.1038%2Fsj.bjc.6604356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer</span></div><div class="casAuthors">Wigfield, S. M.; Winter, S. C.; Giatromanolaki, A.; Taylor, J.; Koukourakis, M. L.; Harris, A. L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1975-1984</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Here we describe the expression and function of a HIF-1-regulated protein pyruvate dehydrogenase kinase-1 (PDK-1) in head and neck squamous cancer (HNSCC).  Using RNAi to downregulate hypoxia-inducible PDK-1, we found that lactate and pyruvate excretion after 16-48 h of hypoxia was suppressed to normoxic levels.  This indicates that PDK-1 plays an important role in maintaining glycolysis.  Knockdown had no effect on proliferation or survival under hypoxia.  The immunohistochem. expression of PDK-1 was assessed in 140 cases of HNSCC.  PDK-1 expression was not expressed in normal tissues but was upregulated in HNSCC and found to be predominantly cytoplasmic with occasional strong focal nuclear expression.  It was strongly related to poor outcome (P=0.005 split by median).  These results indicate that HIF regulation of PDK-1 has a key role in maintaining lactate prodn. in human cancer and that the investigation of PDK-1 inhibitors should be investigated for antitumor effects.  British Journal of Cancer (2008) 98, 1975-1984. doi:10.1038/sj.bjc.6604356 www.bjcancer.com Published online 10 June 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMry8iR1mdVbVg90H21EOLACvtfcHk0lhUGWMMF_Nn7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvV2ht7s%253D&md5=fb7ee783af4d76335fc6e307140a67fe</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604356%26sid%3Dliteratum%253Aachs%26aulast%3DWigfield%26aufirst%3DS.%2BM.%26aulast%3DWinter%26aufirst%3DS.%2BC.%26aulast%3DGiatromanolaki%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DKoukourakis%26aufirst%3DM.%2BL.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DPDK-1%2520regulates%2520lactate%2520production%2520in%2520hypoxia%2520and%2520is%2520associated%2520with%2520poor%2520prognosis%2520in%2520head%2520and%2520neck%2520squamous%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2008%26volume%3D98%26spage%3D1975%26epage%3D1984%26doi%3D10.1038%2Fsj.bjc.6604356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Stacpoole, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornhauser, D. M.</span><span> </span><span class="NLM_article-title">Metabolic effects of dichloroacetate in patients with diabetes mellitus and hyperlipoproteinemia</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">526</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span><span class="refDoi"> DOI: 10.1056/NEJM197803092981002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1056%2FNEJM197803092981002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=625308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADyaE1cXhvVeisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=1978&pages=526-530&author=P.+W.+Stacpooleauthor=G.+W.+Mooreauthor=D.+M.+Kornhauser&title=Metabolic+effects+of+dichloroacetate+in+patients+with+diabetes+mellitus+and+hyperlipoproteinemia&doi=10.1056%2FNEJM197803092981002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic effects of dichloroacetate in patients with diabetes mellitus and hyperlipoproteinemia</span></div><div class="casAuthors">Stacpoole, Peter W.; Moore, George W.; Kornhauser, David M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">526-30</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">Oral administration of 3-4 g Na dichloroacetate (I) [2156-56-1]/day for 3 days decreased fasting hyperglycemia and plasma lactate [50-21-5] and alanine [56-41-7] levels in subjects with diabetes and (or) hyperlipoproteinemia.  I also decreased plasma cholesterol [57-88-5] and triglycerides and slightly increased plasma ketone bodies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcjrs4BUDDr7Vg90H21EOLACvtfcHk0lhUGWMMF_Nn7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhvVeisLc%253D&md5=d7b98e86a8026f8f995eb7a77aa61b04</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1056%2FNEJM197803092981002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM197803092981002%26sid%3Dliteratum%253Aachs%26aulast%3DStacpoole%26aufirst%3DP.%2BW.%26aulast%3DMoore%26aufirst%3DG.%2BW.%26aulast%3DKornhauser%26aufirst%3DD.%2BM.%26atitle%3DMetabolic%2520effects%2520of%2520dichloroacetate%2520in%2520patients%2520with%2520diabetes%2520mellitus%2520and%2520hyperlipoproteinemia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1978%26volume%3D298%26spage%3D526%26epage%3D530%26doi%3D10.1056%2FNEJM197803092981002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Abdelmalak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramezani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shroads, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coats, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langaee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankar, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neiberger, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramony, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stacpoole, P. W.</span><span> </span><span class="NLM_article-title">Long-term safety of dichloroacetate in congenital lactic acidosis</span> <span class="citation_source-journal">Mol. Genet. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span><span class="refDoi"> DOI: 10.1016/j.ymgme.2013.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1016%2Fj.ymgme.2013.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=23611579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt12ju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2013&pages=139-143&author=M.+Abdelmalakauthor=A.+Lewauthor=R.+Ramezaniauthor=A.+L.+Shroadsauthor=B.+S.+Coatsauthor=T.+Langaeeauthor=M.+N.+Shankarauthor=R.+E.+Neibergerauthor=S.+H.+Subramonyauthor=P.+W.+Stacpoole&title=Long-term+safety+of+dichloroacetate+in+congenital+lactic+acidosis&doi=10.1016%2Fj.ymgme.2013.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term safety of dichloroacetate in congenital lactic acidosis</span></div><div class="casAuthors">Abdelmalak, Monica; Lew, Alicia; Ramezani, Ryan; Shroads, Albert L.; Coats, Bonnie S.; Langaee, Taimour; Shankar, Meena N.; Neiberger, Richard E.; Subramony, S. H.; Stacpoole, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Genetics and Metabolism</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-143</span>CODEN:
                <span class="NLM_cas:coden">MGMEFF</span>;
        ISSN:<span class="NLM_cas:issn">1096-7192</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We followed 8 patients (4 males) with biochem. and/or mol. genetically proven deficiencies of the E1α subunit of the pyruvate dehydrogenase complex (PDC; 3 patients) or respiratory chain complexes I (1 patient), IV (3 patients) or I + IV (1 patient) who received oral dichloroacetate (DCA; 12.5 mg/kg/12 h) for 9.7 to 16.5 years.  All subjects originally participated in randomized controlled trials of DCA and were continued on an open-label chronic safety study.  Patients (1 adult) ranged in age from 3.5 to 40.2 years at the start of DCA administration and are currently aged 16.9 to 49.9 years (mean ± SD: 23.5 ± 10.9 years).  Subjects were either normal or below normal body wt. for age and gender.  The 3 PDC deficient patients did not consume high fat (ketogenic) diets.  DCA maintained normal blood lactate concns., even in PDC deficient children on essentially unrestricted diets.  Hematol., electrolyte, renal and hepatic status remained stable.  Nerve conduction either did not change or decreased modestly and led to redn. or temporary discontinuation of DCA in 3 patients, although symptomatic worsening of peripheral neuropathy did not occur.  We conclude that chronic DCA administration is generally well-tolerated in patients with congenital causes of lactic acidosis and is effective in maintaining normal blood lactate levels, even in PDC-deficient children not consuming strict ketogenic diets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp26R7P5zGnwLVg90H21EOLACvtfcHk0ljBRIm_LXw2jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt12ju7o%253D&md5=ab1d2158d9c3fb5cba8ec7a444de419f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ymgme.2013.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymgme.2013.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DAbdelmalak%26aufirst%3DM.%26aulast%3DLew%26aufirst%3DA.%26aulast%3DRamezani%26aufirst%3DR.%26aulast%3DShroads%26aufirst%3DA.%2BL.%26aulast%3DCoats%26aufirst%3DB.%2BS.%26aulast%3DLangaee%26aufirst%3DT.%26aulast%3DShankar%26aufirst%3DM.%2BN.%26aulast%3DNeiberger%26aufirst%3DR.%2BE.%26aulast%3DSubramony%26aufirst%3DS.%2BH.%26aulast%3DStacpoole%26aufirst%3DP.%2BW.%26atitle%3DLong-term%2520safety%2520of%2520dichloroacetate%2520in%2520congenital%2520lactic%2520acidosis%26jtitle%3DMol.%2520Genet.%2520Metab.%26date%3D2013%26volume%3D109%26spage%3D139%26epage%3D143%26doi%3D10.1016%2Fj.ymgme.2013.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Bersin, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stacpoole, P. W.</span><span> </span><span class="NLM_article-title">Dichloroacetate as metabolic therapy for myocardial ischemia and failure</span> <span class="citation_source-journal">Am. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span><span class="refDoi"> DOI: 10.1016/S0002-8703(97)80007-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1016%2FS0002-8703%2897%2980007-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=1997&pages=841-855&author=R.+M.+Bersinauthor=P.+W.+Stacpoole&title=Dichloroacetate+as+metabolic+therapy+for+myocardial+ischemia+and+failure&doi=10.1016%2FS0002-8703%2897%2980007-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0002-8703%2897%2980007-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-8703%252897%252980007-5%26sid%3Dliteratum%253Aachs%26aulast%3DBersin%26aufirst%3DR.%2BM.%26aulast%3DStacpoole%26aufirst%3DP.%2BW.%26atitle%3DDichloroacetate%2520as%2520metabolic%2520therapy%2520for%2520myocardial%2520ischemia%2520and%2520failure%26jtitle%3DAm.%2520Heart%2520J.%26date%3D1997%26volume%3D134%26spage%3D841%26epage%3D855%26doi%3D10.1016%2FS0002-8703%2897%2980007-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Sutendra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelakis, E. D.</span><span> </span><span class="NLM_article-title">Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology</span> <span class="citation_source-journal">Front. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="refDoi"> DOI: 10.3389/fonc.2013.00038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.3389%2Ffonc.2013.00038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=23471124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A280%3ADC%252BC3svksVWnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=38&author=G.+Sutendraauthor=E.+D.+Michelakis&title=Pyruvate+dehydrogenase+kinase+as+a+novel+therapeutic+target+in+oncology&doi=10.3389%2Ffonc.2013.00038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology</span></div><div class="casAuthors">Sutendra Gopinath; Michelakis Evangelos D</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">38</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Current drug development in oncology is non-selective as it typically focuses on pathways essential for the survival of all dividing cells.  The unique metabolic profile of cancer, which is characterized by increased glycolysis and suppressed mitochondrial glucose oxidation (GO) provides cancer cells with a proliferative advantage, conducive with apoptosis resistance and even increased angiogenesis.  Recent evidence suggests that targeting the cancer-specific metabolic and mitochondrial remodeling may offer selectivity in cancer treatment.  Pyruvate dehydrogenase kinase (PDK) is a mitochondrial enzyme that is activated in a variety of cancers and results in the selective inhibition of pyruvate dehydrogenase, a complex of enzymes that converts cytosolic pyruvate to mitochondrial acetyl-CoA, the substrate for the Krebs' cycle.  Inhibition of PDK with either small interfering RNAs or the orphan drug dichloroacetate (DCA) shifts the metabolism of cancer cells from glycolysis to GO and reverses the suppression of mitochondria-dependent apoptosis.  In addition, this therapeutic strategy increases the production of diffusible Krebs' cycle intermediates and mitochondria-derived reactive oxygen species, activating p53 or inhibiting pro-proliferative and pro-angiogenic transcription factors like nuclear factor of activated T cells and hypoxia-inducible factor 1α.  These effects result in decreased tumor growth and angiogenesis in a variety of cancers with high selectivity.  In a small but mechanistic clinical trial in patients with glioblastoma, a highly aggressive and vascular form of brain cancer, DCA decreased tumor angiogenesis and tumor growth, suggesting that metabolic-targeting therapies can be translated directly to patients.  More recently, the M2 isoform of pyruvate kinase (PKM2), which is highly expressed in cancer, is associated with suppressed mitochondrial function.  Similar to DCA, activation of PKM2 in many cancers results in increased mitochondrial function and decreased tumor growth.  Therefore, reversing the mitochondrial suppression with metabolic-modulating drugs, like PDK inhibitors or PKM2 activators holds promise in the rapidly expanding field of metabolic oncology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAv468BxBUDmBAiYWy6n3SfW6udTcc2ebhi7YR1DuCRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svksVWnsg%253D%253D&md5=8a28a9f69bd677139d94ab1ae15721fb</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2013.00038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2013.00038%26sid%3Dliteratum%253Aachs%26aulast%3DSutendra%26aufirst%3DG.%26aulast%3DMichelakis%26aufirst%3DE.%2BD.%26atitle%3DPyruvate%2520dehydrogenase%2520kinase%2520as%2520a%2520novel%2520therapeutic%2520target%2520in%2520oncology%26jtitle%3DFront.%2520Oncol.%26date%3D2013%26volume%3D3%26spage%3D38%26doi%3D10.3389%2Ffonc.2013.00038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Michelakis, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, J. R.</span><span> </span><span class="NLM_article-title">Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">989</span><span class="NLM_x">–</span> <span class="NLM_lpage">994</span><span class="refDoi"> DOI: 10.1038/sj.bjc.6604554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1038%2Fsj.bjc.6604554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=18766181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFyqt7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=989-994&author=E.+D.+Michelakisauthor=L.+Websterauthor=J.+R.+Mackey&title=Dichloroacetate+%28DCA%29+as+a+potential+metabolic-targeting+therapy+for+cancer&doi=10.1038%2Fsj.bjc.6604554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer</span></div><div class="casAuthors">Michelakis, E. D.; Webster, L.; Mackey, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">989-994</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The unique metab. of most solid tumors (aerobic glycolysis, i.e., Warburg effect) is not only the basis of diagnosing cancer with metabolic imaging but might also be assocd. with the resistance to apoptosis that characterizes cancer.  The glycolytic phenotype in cancer appears to be the common denominator of diverse mol. abnormalities in cancer and may be assocd. with a (potentially reversible) suppression of mitochondrial function.  The generic drug dichloroacetate is an orally available small mol. that, by inhibiting the pyruvate dehydrogenase kinase, increases the flux of pyruvate into the mitochondria, promoting glucose oxidn. over glycolysis.  This reverses the suppressed mitochondrial apoptosis in cancer and results in suppression of tumor growth in vitro and in vivo.  Here, we review the scientific and clin. rationale supporting the rapid translation of this promising metabolic modulator in early-phase cancer clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYBltOSIrw3bVg90H21EOLACvtfcHk0ljBRIm_LXw2jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFyqt7vN&md5=2b08b0b34ca23ba50fb22cf49e8c0544</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604554%26sid%3Dliteratum%253Aachs%26aulast%3DMichelakis%26aufirst%3DE.%2BD.%26aulast%3DWebster%26aufirst%3DL.%26aulast%3DMackey%26aufirst%3DJ.%2BR.%26atitle%3DDichloroacetate%2520%2528DCA%2529%2520as%2520a%2520potential%2520metabolic-targeting%2520therapy%2520for%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2008%26volume%3D99%26spage%3D989%26epage%3D994%26doi%3D10.1038%2Fsj.bjc.6604554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Michelakis, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutendra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dromparis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haromy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niven, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gammer, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdulkarim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMurtry, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petruk, K. C.</span><span> </span><span class="NLM_article-title">Metabolic modulation of glioblastoma with dichloroacetate</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3000677</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1126%2Fscitranslmed.3000677" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=31-34&author=E.+D.+Michelakisauthor=G.+Sutendraauthor=P.+Dromparisauthor=L.+Websterauthor=A.+Haromyauthor=E.+Nivenauthor=C.+Maguireauthor=T.+L.+Gammerauthor=J.+R.+Mackeyauthor=D.+Fultonauthor=B.+Abdulkarimauthor=M.+S.+McMurtryauthor=K.+C.+Petruk&title=Metabolic+modulation+of+glioblastoma+with+dichloroacetate&doi=10.1126%2Fscitranslmed.3000677"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3000677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3000677%26sid%3Dliteratum%253Aachs%26aulast%3DMichelakis%26aufirst%3DE.%2BD.%26aulast%3DSutendra%26aufirst%3DG.%26aulast%3DDromparis%26aufirst%3DP.%26aulast%3DWebster%26aufirst%3DL.%26aulast%3DHaromy%26aufirst%3DA.%26aulast%3DNiven%26aufirst%3DE.%26aulast%3DMaguire%26aufirst%3DC.%26aulast%3DGammer%26aufirst%3DT.%2BL.%26aulast%3DMackey%26aufirst%3DJ.%2BR.%26aulast%3DFulton%26aufirst%3DD.%26aulast%3DAbdulkarim%26aufirst%3DB.%26aulast%3DMcMurtry%26aufirst%3DM.%2BS.%26aulast%3DPetruk%26aufirst%3DK.%2BC.%26atitle%3DMetabolic%2520modulation%2520of%2520glioblastoma%2520with%2520dichloroacetate%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2010%26volume%3D2%26spage%3D31%26epage%3D34%26doi%3D10.1126%2Fscitranslmed.3000677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Stacpoole, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornhauser, D. M.</span><span> </span><span class="NLM_article-title">Toxicity of chronic dichloroacetate</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">300</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="refDoi"> DOI: 10.1056/NEJM197902153000726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1056%2FNEJM197902153000726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=215910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A280%3ADyaE1M%252Fptl2jsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=1979&pages=372&author=P.+W.+Stacpooleauthor=G.+W.+Mooreauthor=D.+M.+Kornhauser&title=Toxicity+of+chronic+dichloroacetate&doi=10.1056%2FNEJM197902153000726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity of chronic dichloroacetate</span></div><div class="casAuthors">Stacpoole P W; Moore G W; Kornhauser D M</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">300</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">372</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTsOA6VwfoPtO98rul4nhSdfW6udTcc2eaTojwux6QAvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE1M%252Fptl2jsA%253D%253D&md5=36db9003ceea21ee311c58915ff32ca4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1056%2FNEJM197902153000726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM197902153000726%26sid%3Dliteratum%253Aachs%26aulast%3DStacpoole%26aufirst%3DP.%2BW.%26aulast%3DMoore%26aufirst%3DG.%2BW.%26aulast%3DKornhauser%26aufirst%3DD.%2BM.%26atitle%3DToxicity%2520of%2520chronic%2520dichloroacetate%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1979%26volume%3D300%26spage%3D372%26doi%3D10.1056%2FNEJM197902153000726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Knoechel, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bungay, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasten, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. G.</span><span> </span><span class="NLM_article-title">Regulatory roles of the N-terminal domain based on crystal structures of human Pyruvate Dehydrogenase Kinase 2 containing physiological and synthetic ligands</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span><span class="refDoi"> DOI: 10.1021/bi051402s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi051402s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlajtr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=402-415&author=T.+R.+Knoechelauthor=A.+D.+Tuckerauthor=C.+M.+Robinsonauthor=C.+Phillipsauthor=W.+Taylorauthor=P.+J.+Bungayauthor=S.+A.+Kastenauthor=T.+E.+Rocheauthor=D.+G.+Brown&title=Regulatory+roles+of+the+N-terminal+domain+based+on+crystal+structures+of+human+Pyruvate+Dehydrogenase+Kinase+2+containing+physiological+and+synthetic+ligands&doi=10.1021%2Fbi051402s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Regulatory Roles of the N-Terminal Domain Based on Crystal Structures of Human Pyruvate Dehydrogenase Kinase 2 Containing Physiological and Synthetic Ligands</span></div><div class="casAuthors">Knoechel, Thorsten R.; Tucker, Alec D.; Robinson, Colin M.; Phillips, Chris; Taylor, Wendy; Bungay, Peter J.; Kasten, Shane A.; Roche, Thomas E.; Brown, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">402-415</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinase (PDHK) regulates the activity of the pyruvate dehydrogenase multienzyme complex.  PDHK inhibition provides a route for therapeutic intervention in diabetes and cardiovascular disorders.  We report crystal structures of human PDHK isoenzyme 2 (PDHK2) complexed with physiol. and synthetic ligands.  Several of the PDHK2 structures disclosed have C-terminal cross arms that span a large trough region between the N-terminal regulatory (R) domains of the PDHK2 dimers.  The structures contg. bound ATP and ADP demonstrate variation in the conformation of the active site lid, residues 316-321, which enclose the nucleotide β and γ phosphates at the active site in the C-terminal catalytic domain.  We have identified three novel ligand binding sites located in the R domain of PDHK2.  Dichloroacetate (DCA) binds at the pyruvate binding site in the center of the R domain, which together with ADP, induces significant changes at the active site.  Nov3r and AZ12 inhibitors bind at the lipoamide binding site that is located at one end of the R domain.  Pfz3 (an allosteric inhibitor) binds in an extended site at the other end of the R domain.  We conclude that the N-terminal domain of PDHK has a key regulatory function and propose that the different inhibitor classes act by discrete mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI0BAYhcMgn7Vg90H21EOLACvtfcHk0lix5EgOkoS3hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlajtr7L&md5=62e6162ff1191e7b5ae88014dcb71830</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fbi051402s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi051402s%26sid%3Dliteratum%253Aachs%26aulast%3DKnoechel%26aufirst%3DT.%2BR.%26aulast%3DTucker%26aufirst%3DA.%2BD.%26aulast%3DRobinson%26aufirst%3DC.%2BM.%26aulast%3DPhillips%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DW.%26aulast%3DBungay%26aufirst%3DP.%2BJ.%26aulast%3DKasten%26aufirst%3DS.%2BA.%26aulast%3DRoche%26aufirst%3DT.%2BE.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26atitle%3DRegulatory%2520roles%2520of%2520the%2520N-terminal%2520domain%2520based%2520on%2520crystal%2520structures%2520of%2520human%2520Pyruvate%2520Dehydrogenase%2520Kinase%25202%2520containing%2520physiological%2520and%2520synthetic%2520ligands%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D402%26epage%3D415%26doi%3D10.1021%2Fbi051402s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Kato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, D. T.</span><span> </span><span class="NLM_article-title">Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">992</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span><span class="refDoi"> DOI: 10.1016/j.str.2007.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1016%2Fj.str.2007.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=17683942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFyjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=992-1004&author=M.+Katoauthor=J.+Liauthor=J.+L.+Chuangauthor=D.+T.+Chuang&title=Distinct+structural+mechanisms+for+inhibition+of+pyruvate+dehydrogenase+kinase+isoforms+by+AZD7545%2C+dichloroacetate%2C+and+radicicol&doi=10.1016%2Fj.str.2007.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct Structural Mechanisms for Inhibition of Pyruvate Dehydrogenase Kinase Isoforms by AZD7545, Dichloroacetate, and Radicicol</span></div><div class="casAuthors">Kato, Masato; Li, Jun; Chuang, Jacinta L.; Chuang, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">992-1004</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinase (PDK) isoforms are mol. switches that downregulate the pyruvate dehydrogenase complex (PDC) by reversible phosphorylation in mitochondria.  We have detd. structures of human PDK1 or PDK3 bound to the inhibitors AZD7545, dichloroacetate (DCA), and radicicol.  We show that the trifluoromethylpropanamide end of AZD7545 projects into the lipoyl-binding pocket of PDK1.  This interaction results in inhibition of PDK1 and PDK3 activities by aborting kinase binding to the PDC scaffold.  Paradoxically, AZD7545 at satg. concns. robustly increases scaffold-free PDK3 activity, similar to the inner lipoyl domain.  Good DCA d. is present in the helix bundle in the N-terminal domain of PDK1.  Bound DCA promotes local conformational changes that are communicated to both nucleotide-binding and lipoyl-binding pockets of PDK1, leading to the inactivation of kinase activity. Finally, radicicol inhibits kinase activity by binding directly to the ATP-binding pocket of PDK3, similar to Hsp90 and Topo VI from the same ATPase/kinase superfamily.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCpzfnlsNVarVg90H21EOLACvtfcHk0lix5EgOkoS3hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFyjsbo%253D&md5=3efc7e8b434566932ef28ca3486c401a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2007.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2007.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChuang%26aufirst%3DJ.%2BL.%26aulast%3DChuang%26aufirst%3DD.%2BT.%26atitle%3DDistinct%2520structural%2520mechanisms%2520for%2520inhibition%2520of%2520pyruvate%2520dehydrogenase%2520kinase%2520isoforms%2520by%2520AZD7545%252C%2520dichloroacetate%252C%2520and%2520radicicol%26jtitle%3DStructure%26date%3D2007%26volume%3D15%26spage%3D992%26epage%3D1004%26doi%3D10.1016%2Fj.str.2007.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Delmotte, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delmotte-Plaque, J.</span><span> </span><span class="NLM_article-title">A new antifungal substance of fungal origin</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1953</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span><span class="refDoi"> DOI: 10.1038/171344a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1038%2F171344a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=1953&pages=344&author=P.+Delmotteauthor=J.+Delmotte-Plaque&title=A+new+antifungal+substance+of+fungal+origin&doi=10.1038%2F171344a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2F171344a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F171344a0%26sid%3Dliteratum%253Aachs%26aulast%3DDelmotte%26aufirst%3DP.%26aulast%3DDelmotte-Plaque%26aufirst%3DJ.%26atitle%3DA%2520new%2520antifungal%2520substance%2520of%2520fungal%2520origin%26jtitle%3DNature%26date%3D1953%26volume%3D171%26spage%3D344%26doi%3D10.1038%2F171344a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Soga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiotsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. V.</span><span> </span><span class="NLM_article-title">Development of radicicol analogues</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span><span class="refDoi"> DOI: 10.2174/1568009033481859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.2174%2F1568009033481859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=14529387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2is74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=359-369&author=S.+Sogaauthor=Y.+Shiotsuauthor=S.+Akinagaauthor=S.+V.+Sharma&title=Development+of+radicicol+analogues&doi=10.2174%2F1568009033481859"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Development of radicicol analogues</span></div><div class="casAuthors">Soga, Shiro; Shiotsu, Yukimasa; Akinaga, Shiro; Sharma, Sreenath V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">359-369</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Radicicol, a macrocyclic antibiotic produced by fungi, was originally isolated many years ago, and was described as tyrosine kinase inhibitor.  We also rediscovered radicicol as an inhibitor of signal transduction of oncogene products, such as K-ras and v-Src, using yeast and mammalian cell-based assays.  In a study of mechanisms of action, it was revealed that radicicol depletes the Hsp90 client signaling mols. in cells, and thus inhibit the signal transduction pathway.  In addn., direct binding of radicicol to the N-terminal ATP/ADP binding site of Hsp90 was shown, and thus radicicol has been recognized as a structurally unique antibiotic that binds and inhibits the mol. chaperone Hsp90.  Although radicicol itself has little or no activity in animals because of instability in animals, its oxime derivs. showed potent antitumor activities against human tumor xenograft models.  Hsp90 client proteins were depleted and apoptosis was induced in the tumor specimen treated with radicicol oxime derivs.  Taken together, these results suggest that the antitumor activity of radicicol oxime derivs. is mediated by binding to Hsp90 and destabilization of Hsp90 client proteins in the tumor.  Among Hsp90 clients, we focused on ErbB2 and Bcr-Abl as examples of important targets of Hsp90 inhibitors.  Radicicol oxime showed potent antitumor activity against ER neg./ErbB2 overexpressing breast cancer and Bcr-Abl expressing CML.  Putative mechanisms of action and future directions of radicicol oxime against these kinds of tumor are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-uapkd0TYQrVg90H21EOLACvtfcHk0ljDDf2_BysaVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2is74%253D&md5=59ef4ec5535cec06665a164be0b12305</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F1568009033481859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009033481859%26sid%3Dliteratum%253Aachs%26aulast%3DSoga%26aufirst%3DS.%26aulast%3DShiotsu%26aufirst%3DY.%26aulast%3DAkinaga%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DS.%2BV.%26atitle%3DDevelopment%2520of%2520radicicol%2520analogues%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2003%26volume%3D3%26spage%3D359%26epage%3D369%26doi%3D10.2174%2F1568009033481859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgognoni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N. G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northfield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walmsley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span> </span><span class="NLM_article-title">4,5-Diarylisoxazole hsp90 chaperone inhibitors: Potential therapeutic agents for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span><span class="refDoi"> DOI: 10.1021/jm701018h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701018h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWqsL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=196-218&author=P.+A.+Broughauthor=W.+Aherneauthor=X.+Barrilauthor=J.+Borgognoniauthor=K.+Boxallauthor=J.+E.+Cansfieldauthor=K.+M.+Cheungauthor=I.+Collinsauthor=N.+G.+M.+Daviesauthor=M.+J.+Drysdaleauthor=B.+Dymockauthor=S.+A.+Ecclesauthor=H.+Finchauthor=A.+Finkauthor=A.+Hayesauthor=R.+Howesauthor=R.+E.+Hubbardauthor=K.+Jamesauthor=A.+M.+Jordanauthor=A.+Lockieauthor=V.+Martinsauthor=A.+Masseyauthor=T.+P.+Matthewsauthor=E.+McDonaldauthor=C.+J.+Northfieldauthor=L.+H.+Pearlauthor=C.+Prodromouauthor=S.+Rayauthor=F.+I.+Raynaudauthor=S.+D.+Roughleyauthor=S.+Y.+Sharpauthor=A.+Surgenorauthor=D.+L.+Walmsleyauthor=P.+Webbauthor=M.+Woodauthor=P.+Workmanauthor=L.+Wright&title=4%2C5-Diarylisoxazole+hsp90+chaperone+inhibitors%3A+Potential+therapeutic+agents+for+the+treatment+of+cancer&doi=10.1021%2Fjm701018h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer</span></div><div class="casAuthors">Brough, Paul A.; Aherne, Wynne; Barril, Xavier; Borgognoni, Jennifer; Boxall, Kathy; Cansfield, Julie E.; Cheung, Kwai-Ming J.; Collins, Ian; Davies, Nicholas G. M.; Drysdale, Martin J.; Dymock, Brian; Eccles, Suzanne A.; Finch, Harry; Fink, Alexandra; Hayes, Angela; Howes, Robert; Hubbard, Roderick E.; James, Karen; Jordan, Allan M.; Lockie, Andrea; Martins, Vanessa; Massey, Andrew; Matthews, Thomas P.; McDonald, Edward; Northfield, Christopher J.; Pearl, Laurence H.; Prodromou, Chrisostomos; Ray, Stuart; Raynaud, Florence I.; Roughley, Stephen D.; Sharp, Swee Y.; Surgenor, Allan; Walmsley, D. Lee; Webb, Paul; Wood, Mike; Workman, Paul; Wright, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">196-218</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the Hsp90 [heat shock protein 90] mol. chaperone show considerable promise as potential chemotherapeutic agents for cancer.  The structure-based design, synthesis, structure-activity relationships, and pharmacokinetics of potent small-mol. inhibitors of Hsp90 based on the 4,5-diarylisoxazole scaffold were studied.  Analogs from this series have high affinity for Hsp90, as measured in a fluorescence polarization competitive binding assay, and are active in cancer cell lines where they inhibit proliferation and exhibit a characteristic profile of depletion of oncogenic proteins and concomitant elevation of Hsp72.  The [(morpholinomethyl)phenyl]isoxazolecarboxamide I (VER-52296/NVP-AUY922) is potent in the Hsp90 FP binding assay and inhibits proliferation of various human cancer cell lines in vitro, with GI50 averaging 9 nM.  I is retained in tumors in vivo when administered i.p., as evaluated by cassette dosing in tumor-bearing mice.  In a human colon cancer xenograft model, I inhibits tumor growth by ∼50%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTNA9AoWb8gLVg90H21EOLACvtfcHk0ljDDf2_BysaVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWqsL%252FK&md5=fdb98dec600987e862b9b05555427948</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm701018h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701018h%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DDavies%26aufirst%3DN.%2BG.%2BM.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFinch%26aufirst%3DH.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DLockie%26aufirst%3DA.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWalmsley%26aufirst%3DD.%2BL.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26atitle%3D4%252C5-Diarylisoxazole%2520hsp90%2520chaperone%2520inhibitors%253A%2520Potential%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D196%26epage%3D218%26doi%3D10.1021%2Fjm701018h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgognoni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N. G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fromont, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padfield, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radimerski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmonite, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walls, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span> </span><span class="NLM_article-title">Combining hit identification strategies: Fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the hsp90 molecular chaperone</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4794</span><span class="NLM_x">–</span> <span class="NLM_lpage">4809</span><span class="refDoi"> DOI: 10.1021/jm900357y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900357y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1ehsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4794-4809&author=P.+A.+Broughauthor=X.+Barrilauthor=J.+Borgognoniauthor=P.+Cheneauthor=N.+G.+M.+Daviesauthor=B.+Davisauthor=M.+J.+Drysdaleauthor=B.+Dymockauthor=S.+A.+Ecclesauthor=C.+Garcia-Echeverriaauthor=C.+Fromontauthor=A.+Hayesauthor=R.+E.+Hubbardauthor=A.+M.+Jordanauthor=M.+R.+Jensenauthor=A.+Masseyauthor=A.+Merrettauthor=A.+Padfieldauthor=R.+Parsonsauthor=T.+Radimerskiauthor=F.+I.+Raynaudauthor=A.+Robertsonauthor=S.+D.+Roughleyauthor=J.+Schoepferauthor=H.+Simmoniteauthor=S.+Y.+Sharpauthor=A.+Surgenorauthor=M.+Valentiauthor=S.+Wallsauthor=P.+Webbauthor=M.+Woodauthor=P.+Workmanauthor=L.+Wright&title=Combining+hit+identification+strategies%3A+Fragment-based+and+in+silico+approaches+to+orally+active+2-aminothieno%5B2%2C3-d%5Dpyrimidine+inhibitors+of+the+hsp90+molecular+chaperone&doi=10.1021%2Fjm900357y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-d]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone</span></div><div class="casAuthors">Brough, Paul A.; Barril, Xavier; Borgognoni, Jenifer; Chene, Patrick; Davies, Nicholas G. M.; Davis, Ben; Drysdale, Martin J.; Dymock, Brian; Eccles, Suzanne A.; Garcia-Echeverria, Carlos; Fromont, Christophe; Hayes, Angela; Hubbard, Roderick E.; Jordan, Allan M.; Jensen, Michael Rugaard; Massey, Andrew; Merrett, Angela; Padfield, Antony; Parsons, Rachel; Radimerski, Thomas; Raynaud, Florence I.; Robertson, Alan; Roughley, Stephen D.; Schoepfer, Joseph; Simmonite, Heather; Sharp, Swee Y.; Surgenor, Allan; Valenti, Melanie; Walls, Steven; Webb, Paul; Wood, Mike; Workman, Paul; Wright, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4794-4809</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the Hsp90 mol. chaperone are showing considerable promise as potential mol. therapeutic agents for the treatment of cancer.  Here we describe novel 2-aminothieno[2,3-d]pyrimidine ATP competitive Hsp90 inhibitors, which were designed by combining structural elements of distinct low affinity hits generated from fragment-based and in silico screening exercises in concert with structural information from X-ray protein crystallog.  Examples from this series have high affinity (IC50 = 50-100 nM) for Hsp90 as measured in a fluorescence polarization (FP) competitive binding assay and are active in human cancer cell lines where they inhibit cell proliferation and exhibit a characteristic profile of depletion of oncogenic proteins and concomitant elevation of Hsp72.  Several compds. caused tumor growth regression at well tolerated doses when administered orally in a human BT474 human breast cancer xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqofpAier7tW7Vg90H21EOLACvtfcHk0lgFcB3Zci-5qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1ehsbs%253D&md5=4d1988060b0f87dc776e1972ea14808e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm900357y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900357y%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DDavies%26aufirst%3DN.%2BG.%2BM.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26aulast%3DFromont%26aufirst%3DC.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMerrett%26aufirst%3DA.%26aulast%3DPadfield%26aufirst%3DA.%26aulast%3DParsons%26aufirst%3DR.%26aulast%3DRadimerski%26aufirst%3DT.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobertson%26aufirst%3DA.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DSchoepfer%26aufirst%3DJ.%26aulast%3DSimmonite%26aufirst%3DH.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWalls%26aufirst%3DS.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26atitle%3DCombining%2520hit%2520identification%2520strategies%253A%2520Fragment-based%2520and%2520in%2520silico%2520approaches%2520to%2520orally%2520active%25202-aminothieno%255B2%252C3-d%255Dpyrimidine%2520inhibitors%2520of%2520the%2520hsp90%2520molecular%2520chaperone%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4794%26epage%3D4809%26doi%3D10.1021%2Fjm900357y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Davies, N. G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoffrey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansell, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scriven, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmonite, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P.</span><span> </span><span class="NLM_article-title">Targeting conserved water molecules: design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6770</span><span class="NLM_x">–</span> <span class="NLM_lpage">6789</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.08.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1016%2Fj.bmc.2012.08.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=23018093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVSltrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=6770-6789&author=N.+G.+M.+Daviesauthor=H.+Browneauthor=B.+Davisauthor=M.+J.+Drysdaleauthor=N.+Foloppeauthor=S.+Geoffreyauthor=B.+Gibbonsauthor=T.+Hartauthor=R.+Hubbardauthor=M.+R.+Jensenauthor=H.+Mansellauthor=A.+Masseyauthor=N.+Matassovaauthor=J.+D.+Mooreauthor=J.+Murrayauthor=R.+Prattauthor=S.+Rayauthor=A.+Robertsonauthor=S.+D.+Roughleyauthor=J.+Schoepferauthor=K.+Scrivenauthor=H.+Simmoniteauthor=S.+Stokesauthor=A.+Surgenorauthor=P.+Webbauthor=M.+Woodauthor=L.+Wrightauthor=P.+Brough&title=Targeting+conserved+water+molecules%3A+design+of+4-aryl-5-cyanopyrrolo%5B2%2C3-d%5Dpyrimidine+Hsp90+inhibitors+using+fragment-based+screening+and+structure-based+optimization&doi=10.1016%2Fj.bmc.2012.08.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting conserved water molecules: Design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimization</span></div><div class="casAuthors">Davies, Nicholas G. M.; Browne, Helen; Davis, Ben; Drysdale, Martin J.; Foloppe, Nicolas; Geoffrey, Stephanie; Gibbons, Ben; Hart, Terance; Hubbard, Roderick; Jensen, Michael Rugaard; Mansell, Howard; Massey, Andrew; Matassova, Natalia; Moore, Jonathan D.; Murray, James; Pratt, Robert; Ray, Stuart; Robertson, Alan; Roughley, Stephen D.; Schoepfer, Joseph; Scriven, Kirsten; Simmonite, Heather; Stokes, Stephen; Surgenor, Allan; Webb, Paul; Wood, Mike; Wright, Lisa; Brough, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6770-6789</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibitors of the Hsp90 mol. chaperone are showing promise as anti-cancer agents.  Here the authors describe a series of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine ATP competitive Hsp90 inhibitors that were identified following structure-driven optimization of purine hits revealed by NMR based screening of a proprietary fragment library.  Ligand-Hsp90 x-ray structures combined with mol. modeling led to the rational displacement of a conserved water mol. leading to enhanced affinity for Hsp90 as measured by fluorescence polarization, isothermal titrn. calorimetry and surface plasmon resonance assays.  This displacement was achieved with a nitrile group, presenting an example of efficient gain in binding affinity with minimal increase in mol. wt.  Some compds. in this chem. series inhibit the proliferation of human cancer cell lines in vitro and cause depletion of oncogenic Hsp90 client proteins and concomitant elevation of the co-chaperone Hsp70.  In addn., one compd. was demonstrated to be orally bioavailable in the mouse.  This work demonstrates the power of structure-based design for the rapid evolution of potent Hsp90 inhibitors and the importance of considering conserved water mols. in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMAwVhZUzKD7Vg90H21EOLACvtfcHk0lgFcB3Zci-5qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVSltrvN&md5=69c85da95d07bd488f07eaf503c978f4</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.08.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.08.050%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DN.%2BG.%2BM.%26aulast%3DBrowne%26aufirst%3DH.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DGeoffrey%26aufirst%3DS.%26aulast%3DGibbons%26aufirst%3DB.%26aulast%3DHart%26aufirst%3DT.%26aulast%3DHubbard%26aufirst%3DR.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DMansell%26aufirst%3DH.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMatassova%26aufirst%3DN.%26aulast%3DMoore%26aufirst%3DJ.%2BD.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DPratt%26aufirst%3DR.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DRobertson%26aufirst%3DA.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DSchoepfer%26aufirst%3DJ.%26aulast%3DScriven%26aufirst%3DK.%26aulast%3DSimmonite%26aufirst%3DH.%26aulast%3DStokes%26aufirst%3DS.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DBrough%26aufirst%3DP.%26atitle%3DTargeting%2520conserved%2520water%2520molecules%253A%2520design%2520of%25204-aryl-5-cyanopyrrolo%255B2%252C3-d%255Dpyrimidine%2520Hsp90%2520inhibitors%2520using%2520fragment-based%2520screening%2520and%2520structure-based%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D6770%26epage%3D6789%26doi%3D10.1016%2Fj.bmc.2012.08.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span> </span><span class="NLM_article-title">How well can fragments explore accessed chemical space? A case study from heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3989</span><span class="NLM_x">–</span> <span class="NLM_lpage">4005</span><span class="refDoi"> DOI: 10.1021/jm200350g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200350g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFymurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3989-4005&author=S.+D.+Roughleyauthor=R.+E.+Hubbard&title=How+well+can+fragments+explore+accessed+chemical+space%3F+A+case+study+from+heat+shock+protein+90&doi=10.1021%2Fjm200350g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">How Well Can Fragments Explore Accessed Chemical Space? A Case Study from Heat Shock Protein 90</span></div><div class="casAuthors">Roughley, Stephen D.; Hubbard, Roderick E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3989-4005</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This article summerizes the published literature on the generation of inhibitors and design of drug against the mol. chaperone, heat shock protein 90 (Hsp90), as potential therapeutics to treat cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocGw-54Mo8SrVg90H21EOLACvtfcHk0lhA1gIxKfKFhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFymurs%253D&md5=90c2c8028cb460c0c6fdc956e7daae28</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm200350g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200350g%26sid%3Dliteratum%253Aachs%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26atitle%3DHow%2520well%2520can%2520fragments%2520explore%2520accessed%2520chemical%2520space%253F%2520A%2520case%2520study%2520from%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3989%26epage%3D4005%26doi%3D10.1021%2Fjm200350g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Barker, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, R. K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corden, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falque, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelin, E. M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesterkamp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichihara, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minucci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalbetti, C. A. G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittaker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarnold, C. J.</span><span> </span><span class="NLM_article-title">Fragment-based identification of hsp90 inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span><span class="refDoi"> DOI: 10.1002/cmdc.200900011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1002%2Fcmdc.200900011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=19301319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmslChtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=963-966&author=J.+J.+Barkerauthor=O.+Barkerauthor=R.+Boggioauthor=V.+Chauhanauthor=R.+K.+Y.+Chengauthor=V.+Cordenauthor=S.+M.+Courtneyauthor=N.+Edwardsauthor=V.+M.+Falqueauthor=F.+Fusarauthor=M.+Gardinerauthor=E.+M.+N.+Hamelinauthor=T.+Hesterkampauthor=O.+Ichiharaauthor=R.+S.+Jonesauthor=O.+Matherauthor=C.+Mercurioauthor=S.+Minucciauthor=C.+A.+G.+N.+Montalbettiauthor=A.+Mullerauthor=D.+Patelauthor=B.+G.+Phillipsauthor=M.+Varasiauthor=M.+Whittakerauthor=D.+Winklerauthor=C.+J.+Yarnold&title=Fragment-based+identification+of+hsp90+inhibitors&doi=10.1002%2Fcmdc.200900011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based Identification of Hsp90 Inhibitors</span></div><div class="casAuthors">Barker, John J.; Barker, Oliver; Boggio, Roberto; Chauhan, Viddhata; Cheng, Robert K. Y.; Corden, Vincent; Courtney, Stephen M.; Edwards, Neil; Falque, Virginie M.; Fusar, Fulvia; Gardiner, Mihaly; Hamelin, Estelle M. N.; Hesterkamp, Thomas; Ichihara, Osamu; Jones, Richard S.; Mather, Owen; Mercurio, Ciro; Minucci, Saverio; Montalbetti, Christian A. G. N.; Muller, Annett; Patel, Deepti; Phillips, Banu G.; Varasi, Mario; Whittaker, Mark; Winkler, Dirk; Yarnold, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">963-966</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) plays a key role in stress response and protection of the cell against the effects of mutation.  Herein we report the identification of an Hsp90 inhibitor identified by fragment screening using a high-concn. biochem. assay, as well as its optimization by in silico searching coupled with a structure-based drug design (SBDD) approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsaGeZbmBYH7Vg90H21EOLACvtfcHk0lhA1gIxKfKFhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmslChtbk%253D&md5=c44357e5d1b341c6bc540798951a687f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900011%26sid%3Dliteratum%253Aachs%26aulast%3DBarker%26aufirst%3DJ.%2BJ.%26aulast%3DBarker%26aufirst%3DO.%26aulast%3DBoggio%26aufirst%3DR.%26aulast%3DChauhan%26aufirst%3DV.%26aulast%3DCheng%26aufirst%3DR.%2BK.%2BY.%26aulast%3DCorden%26aufirst%3DV.%26aulast%3DCourtney%26aufirst%3DS.%2BM.%26aulast%3DEdwards%26aufirst%3DN.%26aulast%3DFalque%26aufirst%3DV.%2BM.%26aulast%3DFusar%26aufirst%3DF.%26aulast%3DGardiner%26aufirst%3DM.%26aulast%3DHamelin%26aufirst%3DE.%2BM.%2BN.%26aulast%3DHesterkamp%26aufirst%3DT.%26aulast%3DIchihara%26aufirst%3DO.%26aulast%3DJones%26aufirst%3DR.%2BS.%26aulast%3DMather%26aufirst%3DO.%26aulast%3DMercurio%26aufirst%3DC.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DMontalbetti%26aufirst%3DC.%2BA.%2BG.%2BN.%26aulast%3DMuller%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DPhillips%26aufirst%3DB.%2BG.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DWhittaker%26aufirst%3DM.%26aulast%3DWinkler%26aufirst%3DD.%26aulast%3DYarnold%26aufirst%3DC.%2BJ.%26atitle%3DFragment-based%2520identification%2520of%2520hsp90%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D963%26epage%3D966%26doi%3D10.1002%2Fcmdc.200900011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Roughley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span> </span><span class="NLM_article-title">Hsp90 inhibitors and drugs from fragment and virtual screening</span> <span class="citation_source-journal">Top. Curr. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1007/128_2011_181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1007%2F128_2011_181" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2011&pages=61-82&author=S.+Roughleyauthor=L.+Wrightauthor=P.+Broughauthor=A.+Masseyauthor=R.+E.+Hubbard&title=Hsp90+inhibitors+and+drugs+from+fragment+and+virtual+screening&doi=10.1007%2F128_2011_181"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2F128_2011_181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F128_2011_181%26sid%3Dliteratum%253Aachs%26aulast%3DRoughley%26aufirst%3DS.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DBrough%26aufirst%3DP.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26atitle%3DHsp90%2520inhibitors%2520and%2520drugs%2520from%2520fragment%2520and%2520virtual%2520screening%26jtitle%3DTop.%2520Curr.%2520Chem.%26date%3D2011%26volume%3D317%26spage%3D61%26epage%3D82%26doi%3D10.1007%2F128_2011_181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Shapiro, G. I</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dezube, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayrton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahadevan, D.</span><span> </span><span class="NLM_article-title">First-in-human phase I dose escalation study of a second-generation non-ansamycin HSP90 inhibitor, AT13387, in patients with advanced solid tumors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-0979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1158%2F1078-0432.CCR-14-0979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=25336693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC2MXis12ltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=87-97&author=G.+I+Shapiroauthor=E.+Kwakauthor=B.+J.+Dezubeauthor=M.+Yuleauthor=J.+Ayrtonauthor=J.+Lyonsauthor=D.+Mahadevan&title=First-in-human+phase+I+dose+escalation+study+of+a+second-generation+non-ansamycin+HSP90+inhibitor%2C+AT13387%2C+in+patients+with+advanced+solid+tumors&doi=10.1158%2F1078-0432.CCR-14-0979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">First-in-Human Phase I Dose Escalation Study of a Second-Generation Non-Ansamycin HSP90 Inhibitor, AT13387, in Patients with Advanced Solid Tumors</span></div><div class="casAuthors">Shapiro, Geoffrey I.; Kwak, Eunice; Dezube, Bruce J.; Yule, Murray; Ayrton, John; Lyons, John; Mahadevan, Daruka</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-97</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: AT13387 is a potent second-generation, fragment-derived HSP90 inhibitor.  This phase I study investigated the max. tolerated dose (MTD)/recommended phase II dose (RP2D) and safety, pharmacokinetic, and pharmacodynamic profiles of two AT13387 regimens in a refractory solid tumor population.  Exptl. Design: Std. 3+3 dose escalation was used.  MTD and RP2D detns. were based on the occurrence of dose-limiting toxicities (DLT) and overall toxicity, resp.  Pharmacokinetic parameters were measured after single and multiple doses.  AT13387-mediated induction of HSP70 was evaluated in plasma, peripheral blood mononuclear cells, and paired tumor biopsies.  Results: Sixty-two patients were treated with doses ranging from 10 to 120 mg/m2 twice weekly and 150 to 310 mg/m2 once weekly (both for 3 wk every 28 days).  One DLT of visual disturbance occurred at 120 mg/m2, which was considered the MTD and RP2D for the twice-weekly regimen.  No formal DLTs occurred in the once-weekly regimen, but multiple moderately severe toxicities, including diarrhea, nausea, vomiting, fatigue, and systemic infusion reactions, led to selection of 260 mg/m2 as the RP2D.  Exposures of AT13387 increased proportionally with dose.  Target engagement as measured by HSP70 induction occurred in plasma and tumor biopsy samples.  One patient with gastrointestinal stromal tumor (GIST) who had progressive disease on imatinib had a partial response and remained on treatment for 10 mo.  Twenty-one patients (34%) had stable disease, which lasted >120 days in 7 patients.  Conclusion: AT13387 administered once or twice weekly has an acceptable safety profile and demonstrated evidence of target engagement and preliminary antitumor activity.  Clin Cancer Res; 21(1); 87-97. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB7A3RmZpiAbVg90H21EOLACvtfcHk0lhA1gIxKfKFhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXis12ltA%253D%253D&md5=7683701e7cde5f4b599c2e6bdb8cd6ac</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-0979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-0979%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DG.%2BI%26aulast%3DKwak%26aufirst%3DE.%26aulast%3DDezube%26aufirst%3DB.%2BJ.%26aulast%3DYule%26aufirst%3DM.%26aulast%3DAyrton%26aufirst%3DJ.%26aulast%3DLyons%26aufirst%3DJ.%26aulast%3DMahadevan%26aufirst%3DD.%26atitle%3DFirst-in-human%2520phase%2520I%2520dose%2520escalation%2520study%2520of%2520a%2520second-generation%2520non-ansamycin%2520HSP90%2520inhibitor%252C%2520AT13387%252C%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26spage%3D87%26epage%3D97%26doi%3D10.1158%2F1078-0432.CCR-14-0979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Woodhead, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angove, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyle, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosme, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parra, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trewartha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinkovic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolford, A. J. A.</span><span> </span><span class="NLM_article-title">Discovery of (2,4-Dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone hsp90 by fragment based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5956</span><span class="NLM_x">–</span> <span class="NLM_lpage">5969</span><span class="refDoi"> DOI: 10.1021/jm100060b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100060b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVCitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5956-5969&author=A.+J.+Woodheadauthor=H.+Angoveauthor=M.+G.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=J.+E.+Coyleauthor=J.+Cosmeauthor=B.+Grahamauthor=P.+J.+Dayauthor=R.+Downhamauthor=L.+Fazalauthor=R.+Feltellauthor=E.+Figueroaauthor=M.+Fredericksonauthor=J.+Lewisauthor=R.+McMenaminauthor=C.+W.+Murrayauthor=M.+A.+O%E2%80%99Brienauthor=L.+Parraauthor=S.+Patelauthor=T.+Phillipsauthor=D.+C.+Reesauthor=S.+Richauthor=D.+M.+Smithauthor=G.+Trewarthaauthor=M.+Vinkovicauthor=B.+Williamsauthor=A.+J.+A.+Woolford&title=Discovery+of+%282%2C4-Dihydroxy-5-isopropylphenyl%29-%5B5-%284-methylpiperazin-1-ylmethyl%29-1%2C3-dihydroisoindol-2-yl%5Dmethanone+%28AT13387%29%2C+a+novel+inhibitor+of+the+molecular+chaperone+hsp90+by+fragment+based+drug+design&doi=10.1021%2Fjm100060b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (2,4-Dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a Novel Inhibitor of the Molecular Chaperone Hsp90 by Fragment Based Drug Design</span></div><div class="casAuthors">Woodhead, Andrew J.; Angove, Hayley; Carr, Maria G.; Chessari, Gianni; Congreve, Miles; Coyle, Joseph E.; Cosme, Jose; Graham, Brent; Day, Philip J.; Downham, Robert; Fazal, Lynsey; Feltell, Ruth; Figueroa, Eva; Frederickson, Martyn; Lewis, Jonathan; McMenamin, Rachel; Murray, Christopher W.; O'Brien, M. Alistair; Parra, Lina; Patel, Sahil; Phillips, Theresa; Rees, David C.; Rich, Sharna; Smith, Donna-Michelle; Trewartha, Gary; Vinkovic, Mladen; Williams, Brian; Woolford, Alison J.-A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5956-5969</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the mol. chaperone heat shock protein 90 (Hsp90) are currently generating significant interest in clin. development as potential treatments for cancer.  In a preceding publication (DOI: 10.1021/jm100059d) we describe Astex's approach to screening fragments against Hsp90 and the subsequent optimization of two hits into leads with inhibitory activities in the low nanomolar range.  This paper describes the structure guided optimization of the 2,4-dihydroxybenzamide lead mol. 1 and details some of the drug discovery strategies employed in the identification of AT13387 (35), which has progressed through preclin. development and is currently being tested in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEEtcgAmkVk7Vg90H21EOLACvtfcHk0lienX12D1AuWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVCitrg%253D&md5=a2d2ac6dd9e9ba4cb89f83c32727a1d8</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm100060b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100060b%26sid%3Dliteratum%253Aachs%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DAngove%26aufirst%3DH.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DCosme%26aufirst%3DJ.%26aulast%3DGraham%26aufirst%3DB.%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DDownham%26aufirst%3DR.%26aulast%3DFazal%26aufirst%3DL.%26aulast%3DFeltell%26aufirst%3DR.%26aulast%3DFigueroa%26aufirst%3DE.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%2BA.%26aulast%3DParra%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPhillips%26aufirst%3DT.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DRich%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DD.%2BM.%26aulast%3DTrewartha%26aufirst%3DG.%26aulast%3DVinkovic%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DB.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%2BA.%26atitle%3DDiscovery%2520of%2520%25282%252C4-Dihydroxy-5-isopropylphenyl%2529-%255B5-%25284-methylpiperazin-1-ylmethyl%2529-1%252C3-dihydroisoindol-2-yl%255Dmethanone%2520%2528AT13387%2529%252C%2520a%2520novel%2520inhibitor%2520of%2520the%2520molecular%2520chaperone%2520hsp90%2520by%2520fragment%2520based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5956%26epage%3D5969%26doi%3D10.1021%2Fjm100060b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span><span class="refDoi"> DOI: 10.1016/j.ab.2004.05.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1016%2Fj.ab.2004.05.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=15325294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFeltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2004&pages=261-273&author=Z.+Nikolovska-Coleskaauthor=R.+Wangauthor=X.+Fangauthor=H.+Panauthor=Y.+Tomitaauthor=P.+Liauthor=P.+P.+Rollerauthor=K.+Krajewskiauthor=N.+G.+Saitoauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Development+and+optimization+of+a+binding+assay+for+the+XIAP+BIR3+domain+using+fluorescence+polarization&doi=10.1016%2Fj.ab.2004.05.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization</span></div><div class="casAuthors">Nikolovska-Coleska, Zaneta; Wang, Renxiao; Fang, Xueliang; Pan, Hongguang; Tomita, York; Li, Peng; Roller, Peter P.; Krajewski, Krzysztof; Saito, Naoyuki G.; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">261-273</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The X-linked inhibitor of apoptosis protein (XIAP) is a potent cellular inhibitor of apoptosis.  Designing small-mol. inhibitors that target the BIR3 domain of XIAP, where Smac/DIABLO (second mitochondria-derived activator of caspase/direct IAP-binding protein with low pI) and caspase-9 bind, is a promising strategy for inhibiting the antiapoptotic activity of XIAP and for overcoming apoptosis resistance of cancer cells mediated by XIAP.  Herein, we report the development of a homogeneous high-throughput assay based on fluorescence polarization for measuring the binding affinities of small-mol. inhibitors to the BIR3 domain of XIAP.  Among four fluorescent probes tested, a mutated N-terminal Smac peptide (AbuRPFK-(5-Fam)-NH2) showed the highest affinity (Kd = 17.92 nM) and a large dynamic range (ΔmP=231±0.9), and was selected as the most suitable probe for the binding assay.  The binding conditions (DMSO tolerance and stability) have been investigated.  Under optimized conditions, a Z' factor of 0.88 was achieved in a 96-well format for high-throughput screening.  It was found that the popular Cheng-Prusoff equation is invalid for the calcn. of the competitive inhibition consts. (Ki values) for inhibitors in the FP-based competitive binding assay conditions, and accordingly, a new math. equation was developed, validated, and used to compute the Ki values.  An assocd. Web-based computer program was also developed for this task.  Several known Smac peptides with high and low affinities have been evaluated under the assay conditions and the results obtained indicated that the FP-based competitive binding assay performs correctly as designed: it can quant. and accurately det. the binding affinities of Smac-based peptide inhibitors with a wide range of affinities, and is suitable for high-throughput screening of inhibitors binding to the XIAP BIR3 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWjEsqtWsZRbVg90H21EOLACvtfcHk0lienX12D1AuWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFeltL0%253D&md5=23cade47a4996c7ca4c01278d3e0d3a6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2004.05.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2004.05.055%26sid%3Dliteratum%253Aachs%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DPan%26aufirst%3DH.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DN.%2BG.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDevelopment%2520and%2520optimization%2520of%2520a%2520binding%2520assay%2520for%2520the%2520XIAP%2520BIR3%2520domain%2520using%2520fluorescence%2520polarization%26jtitle%3DAnal.%2520Biochem.%26date%3D2004%26volume%3D332%26spage%3D261%26epage%3D273%26doi%3D10.1016%2Fj.ab.2004.05.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Murray, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span> </span><span class="NLM_article-title">Off-Rate Screening (ORS) By Surface Plasmon Resonance. An efficient method to kinetically sample hit to lead chemical space from unpurified reaction products</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2845</span><span class="NLM_x">–</span> <span class="NLM_lpage">2850</span><span class="refDoi"> DOI: 10.1021/jm401848a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401848a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVWguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2845-2850&author=J.+B.+Murrayauthor=S.+D.+Roughleyauthor=N.+Matassovaauthor=P.+A.+Brough&title=Off-Rate+Screening+%28ORS%29+By+Surface+Plasmon+Resonance.+An+efficient+method+to+kinetically+sample+hit+to+lead+chemical+space+from+unpurified+reaction+products&doi=10.1021%2Fjm401848a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Off-Rate Screening (ORS) By Surface Plasmon Resonance. An Efficient Method to Kinetically Sample Hit to Lead Chemical Space from Unpurified Reaction Products</span></div><div class="casAuthors">Murray, James B.; Roughley, Stephen D.; Matassova, Natalia; Brough, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2845-2850</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dissocn. rate const. kd (off-rate) is the component of ligand-protein binding with the most significant potential to enhance compd. potency.  Here we provide theor. and empirical data to show that this parameter can be detd. accurately from unpurified reaction products contg. designed test compds.  This screening protocol is amenable to parallel chem., provides efficiencies of time and materials, and complements existing methodologies for the hit-to-lead phase in fragment-based drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGounOUxQkuyZLVg90H21EOLACvtfcHk0lienX12D1AuWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVWguro%253D&md5=d3744f00df767e349024641e876e8100</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm401848a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401848a%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DJ.%2BB.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DMatassova%26aufirst%3DN.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26atitle%3DOff-Rate%2520Screening%2520%2528ORS%2529%2520By%2520Surface%2520Plasmon%2520Resonance.%2520An%2520efficient%2520method%2520to%2520kinetically%2520sample%2520hit%2520to%2520lead%2520chemical%2520space%2520from%2520unpurified%2520reaction%2520products%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2845%26epage%3D2850%26doi%3D10.1021%2Fjm401848a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Brough, P. A.; Macias, A.; Roughley, S. D.; Stokes, S.; Davies, N. G. M.</span><span> </span><span class="NLM_article-title">Preparation of tetrahydroisoquinoline compounds and their use as pyruvate dehydrogenase kinase inhibitors</span>. PCT international application WO2015040424,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=P.+A.+Brough&author=A.+Macias&author=S.+D.+Roughley&author=S.+Stokes&author=N.+G.+M.+Davies&title=Preparation+of+tetrahydroisoquinoline+compounds+and+their+use+as+pyruvate+dehydrogenase+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26atitle%3DPreparation%2520of%2520tetrahydroisoquinoline%2520compounds%2520and%2520their%2520use%2520as%2520pyruvate%2520dehydrogenase%2520kinase%2520inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Brough, P. A.; Macias, A.; Roughley, S. D.; Wang, Y.; Parsons, R. J.; Northfield, C. J.</span><span> </span><span class="NLM_article-title">Preparation of resorcinol N-aryl amide compounds, for use as pyruvate dehydrogenase kinase inhibitors</span>. PCT international application WO2015040425,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=P.+A.+Brough&author=A.+Macias&author=S.+D.+Roughley&author=Y.+Wang&author=R.+J.+Parsons&author=C.+J.+Northfield&title=Preparation+of+resorcinol+N-aryl+amide+compounds%2C+for+use+as+pyruvate+dehydrogenase+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26atitle%3DPreparation%2520of%2520resorcinol%2520N-aryl%2520amide%2520compounds%252C%2520for%2520use%2520as%2520pyruvate%2520dehydrogenase%2520kinase%2520inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Kukimoto-Niino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokmakov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohbayashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiromizu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsusue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirouzu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, S.</span><span> </span><span class="NLM_article-title">Inhibitor-bound structures of human pyruvate dehydrogenase kinase 4</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">763</span><span class="NLM_x">–</span> <span class="NLM_lpage">773</span><span class="refDoi"> DOI: 10.1107/S090744491102405X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1107%2FS090744491102405X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=763-773&author=M.+Kukimoto-Niinoauthor=A.+Tokmakovauthor=T.+Teradaauthor=N.+Ohbayashiauthor=T.+Fujimotoauthor=S.+Gomiauthor=I.+Shiromizuauthor=M.+Kawamotoauthor=T.+Matsusueauthor=M.+Shirouzuauthor=S.+Yokoyama&title=Inhibitor-bound+structures+of+human+pyruvate+dehydrogenase+kinase+4&doi=10.1107%2FS090744491102405X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1107%2FS090744491102405X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS090744491102405X%26sid%3Dliteratum%253Aachs%26aulast%3DKukimoto-Niino%26aufirst%3DM.%26aulast%3DTokmakov%26aufirst%3DA.%26aulast%3DTerada%26aufirst%3DT.%26aulast%3DOhbayashi%26aufirst%3DN.%26aulast%3DFujimoto%26aufirst%3DT.%26aulast%3DGomi%26aufirst%3DS.%26aulast%3DShiromizu%26aufirst%3DI.%26aulast%3DKawamoto%26aufirst%3DM.%26aulast%3DMatsusue%26aufirst%3DT.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DYokoyama%26aufirst%3DS.%26atitle%3DInhibitor-bound%2520structures%2520of%2520human%2520pyruvate%2520dehydrogenase%2520kinase%25204%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D763%26epage%3D773%26doi%3D10.1107%2FS090744491102405X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Stockwin, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollingshead, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, D. L.</span><span> </span><span class="NLM_article-title">Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">2510</span><span class="NLM_x">–</span> <span class="NLM_lpage">2519</span><span class="refDoi"> DOI: 10.1002/ijc.25499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1002%2Fijc.25499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=20533281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGhtrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2010&pages=2510-2519&author=L.+H.+Stockwinauthor=S.+X.+Yuauthor=S.+Borgelauthor=C.+Hancockauthor=T.+L.+Wolfeauthor=L.+R.+Phillipsauthor=M.+G.+Hollingsheadauthor=D.+L.+Newton&title=Sodium+dichloroacetate+selectively+targets+cells+with+defects+in+the+mitochondrial+ETC&doi=10.1002%2Fijc.25499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC</span></div><div class="casAuthors">Stockwin, Luke H.; Yu, Sherry X.; Borgel, Suzanne; Hancock, Chad; Wolfe, Tracy L.; Phillips, Lawrence R.; Hollingshead, Melinda G.; Newton, Dianne L.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2510-2519</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The "Warburg effect," also termed aerobic glycolysis, describes the increased reliance of cancer cells on glycolysis for ATP prodn., even in the presence of oxygen.  Consequently, there is continued interest in inhibitors of glycolysis as cancer therapeutics.  One example is dichloroacetate (DCA), a pyruvate mimetic that stimulates oxidative phosphorylation through inhibition of pyruvate dehydrogenase kinase.  In this study, the mechanistic basis for DCA anti-cancer activity was re-evaluated in vitro using biochem., cellular and proteomic approaches.  Results demonstrated that DCA is relatively inactive (IC50 ≥ 17 mM, 48 h), induces apoptosis only at high concns. (≥25 mM, 48 h) and is not cancer cell selective.  Subsequent 2D-PAGE proteomic anal. confirmed DCA-induced growth suppression without apoptosis induction.  Furthermore, DCA depolarizes mitochondria and promotes reactive oxygen species (ROS) generation in all cell types.  However, DCA was found to have selective activity against rho(0) cells [mitochondrial DNA (mtDNA) deficient] and to synergize with 2-deoxyglucose in complex IV deficient HCT116 p53(-/-) cells.  DCA also synergized in vitro with cisplatin and topotecan, two antineoplastic agents known to damage mitochondrial DNA.  These data suggest that in cells "hardwired" to selectively utilize glycolysis for ATP generation (e.g., through mtDNA mutations), the ability of DCA to force oxidative phosphorylation confers selective toxicity.  In conclusion, although we provide a mechanism distinct from that reported previously, the ability of DCA to target cell lines with defects in the electron transport chain and to synergize with existing chemotherapeutics supports further preclin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojrd7D9gluIrVg90H21EOLACvtfcHk0lgGA3tsOp81Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGhtrfP&md5=dd0c533822210cb089cc7cba351004f9</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fijc.25499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.25499%26sid%3Dliteratum%253Aachs%26aulast%3DStockwin%26aufirst%3DL.%2BH.%26aulast%3DYu%26aufirst%3DS.%2BX.%26aulast%3DBorgel%26aufirst%3DS.%26aulast%3DHancock%26aufirst%3DC.%26aulast%3DWolfe%26aufirst%3DT.%2BL.%26aulast%3DPhillips%26aufirst%3DL.%2BR.%26aulast%3DHollingshead%26aufirst%3DM.%2BG.%26aulast%3DNewton%26aufirst%3DD.%2BL.%26atitle%3DSodium%2520dichloroacetate%2520selectively%2520targets%2520cells%2520with%2520defects%2520in%2520the%2520mitochondrial%2520ETC%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2010%26volume%3D127%26spage%3D2510%26epage%3D2519%26doi%3D10.1002%2Fijc.25499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Bonnet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allalunis-Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haromy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopaschuk, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puttagunta, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thebaud, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelakis, E. D.</span><span> </span><span class="NLM_article-title">A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1016/j.ccr.2006.10.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1016%2Fj.ccr.2006.10.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=17222789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFClsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=37-51&author=S.+Bonnetauthor=S.+L.+Archerauthor=J.+Allalunis-Turnerauthor=A.+Haromyauthor=C.+Beaulieuauthor=R.+Thompsonauthor=C.+T.+Leeauthor=G.+D.+Lopaschukauthor=L.+Puttaguntaauthor=S.+Bonnetauthor=G.+Harryauthor=K.+Hashimotoauthor=C.+J.+Porterauthor=M.+A.+Andradeauthor=B.+Thebaudauthor=E.+D.+Michelakis&title=A+mitochondria-K%2B+channel+axis+is+suppressed+in+cancer+and+its+normalization+promotes+apoptosis+and+inhibits+cancer+growth&doi=10.1016%2Fj.ccr.2006.10.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth</span></div><div class="casAuthors">Bonnet, Sebastien; Archer, Stephen L.; Allalunis-Turner, Joan; Haromy, Alois; Beaulieu, Christian; Thompson, Richard; Lee, Christopher T.; Lopaschuk, Gary D.; Puttagunta, Lakshmi; Bonnet, Sandra; Harry, Gwyneth; Hashimoto, Kyoko; Porter, Christopher J.; Andrade, Miguel A.; Thebaud, Bernard; Michelakis, Evangelos D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-51</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The unique metabolic profile of cancer (aerobic glycolysis) might confer apoptosis resistance and be therapeutically targeted.  Compared to normal cells, several human cancers have high mitochondrial membrane potential (ΔΨm) and low expression of the K+ channel Kv1.5, both contributing to apoptosis resistance.  Dichloroacetate (DCA) inhibits mitochondrial pyruvate dehydrogenase kinase (PDK), shifts metab. from glycolysis to glucose oxidn., decreases ΔΨm, increases mitochondrial H2O2, and activates Kv channels in all cancer, but not normal, cells; DCA upregulates Kv1.5 by an NFAT1-dependent mechanism.  DCA induces apoptosis, decreases proliferation, and inhibits tumor growth, without apparent toxicity.  Mol. inhibition of PDK2 by siRNA mimics DCA.  The mitochondria-NFAT-Kv axis and PDK are important therapeutic targets in cancer; the orally available DCA is a promising selective anticancer agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocAukkjsEmZLVg90H21EOLACvtfcHk0lgGA3tsOp81Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFClsLg%253D&md5=ce8b45e3292469a3ce1af91803785bee</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.10.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.10.020%26sid%3Dliteratum%253Aachs%26aulast%3DBonnet%26aufirst%3DS.%26aulast%3DArcher%26aufirst%3DS.%2BL.%26aulast%3DAllalunis-Turner%26aufirst%3DJ.%26aulast%3DHaromy%26aufirst%3DA.%26aulast%3DBeaulieu%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.%2BT.%26aulast%3DLopaschuk%26aufirst%3DG.%2BD.%26aulast%3DPuttagunta%26aufirst%3DL.%26aulast%3DBonnet%26aufirst%3DS.%26aulast%3DHarry%26aufirst%3DG.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DPorter%26aufirst%3DC.%2BJ.%26aulast%3DAndrade%26aufirst%3DM.%2BA.%26aulast%3DThebaud%26aufirst%3DB.%26aulast%3DMichelakis%26aufirst%3DE.%2BD.%26atitle%3DA%2520mitochondria-K%252B%2520channel%2520axis%2520is%2520suppressed%2520in%2520cancer%2520and%2520its%2520normalization%2520promotes%2520apoptosis%2520and%2520inhibits%2520cancer%2520growth%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D11%26spage%3D37%26epage%3D51%26doi%3D10.1016%2Fj.ccr.2006.10.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Moore, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staniszewska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Alessandro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macias, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, P. C.</span><span> </span><span class="NLM_article-title">VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">12862</span><span class="NLM_x">–</span> <span class="NLM_lpage">12876</span><span class="refDoi"> DOI: 10.18632/oncotarget.2656</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.18632%2Foncotarget.2656" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=25404640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A280%3ADC%252BC2M3ovVyjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=12862-12876&author=J.+D.+Mooreauthor=A.+Staniszewskaauthor=T.+Shawauthor=J.+D%E2%80%99Alessandroauthor=B.+Davisauthor=A.+Surgenorauthor=L.+Bakerauthor=N.+Matassovaauthor=J.+Murrayauthor=A.+Maciasauthor=P.+Broughauthor=M.+Woodauthor=P.+C.+Mahon&title=VER-246608%2C+a+novel+pan-isoform+ATP+competitive+inhibitor+of+pyruvate+dehydrogenase+kinase%2C+disrupts+Warburg+metabolism+and+induces+context-dependent+cytostasis+in+cancer+cells&doi=10.18632%2Foncotarget.2656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells</span></div><div class="casAuthors">Moore Jonathan D; Staniszewska Anna; Shaw Terence; D'Alessandro Jalanie; Davis Ben; Surgenor Alan; Baker Lisa; Matassova Natalia; Murray James; Macias Alba; Brough Paul; Wood Mike; Mahon Patrick C</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">12862-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pyruvate dehydrogenase kinase (PDK) is a pivotal enzyme in cellular energy metabolism that has previously been implicated in cancer through both RNAi based studies and clinical correlations with poor prognosis in several cancer types.  Here, we report the discovery of a novel and selective ATP competitive pan-isoform inhibitor of PDK, VER-246608.  Consistent with a PDK mediated MOA, VER-246608 increased pyruvate dehydrogenase complex (PDC) activity, oxygen consumption and attenuated glycolytic activity.  However, these effects were only observed under D-glucose-depleted conditions and required almost complete ablation of PDC E1α subunit phosphorylation.  VER-246608 was weakly anti-proliferative to cancer cells in standard culture media; however, depletion of either serum or combined D-glucose/L-glutamine resulted in enhanced cellular potency.  Furthermore, this condition-selective cytostatic effect correlated with reduced intracellular pyruvate levels and an attenuated compensatory response involving deamination of L-alanine.  In addition, VER-246608 was found to potentiate the activity of doxorubicin.  In contrast, the lipoamide site inhibitor, Nov3r, demonstrated sub-maximal inhibition of PDK activity and no evidence of cellular activity.  These studies suggest that PDK inhibition may be effective under the nutrient-depleted conditions found in the tumour microenvironment and that combination treatments should be explored to reveal the full potential of this therapeutic strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQq_Bxi2o-MqOxsqfvU0ziafW6udTcc2ebpkePrbRRnN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3ovVyjtQ%253D%253D&md5=6480086dc38b2ebcbfa93b2e611d40f1</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2656%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DJ.%2BD.%26aulast%3DStaniszewska%26aufirst%3DA.%26aulast%3DShaw%26aufirst%3DT.%26aulast%3DD%25E2%2580%2599Alessandro%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DBaker%26aufirst%3DL.%26aulast%3DMatassova%26aufirst%3DN.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DMacias%26aufirst%3DA.%26aulast%3DBrough%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DMahon%26aufirst%3DP.%2BC.%26atitle%3DVER-246608%252C%2520a%2520novel%2520pan-isoform%2520ATP%2520competitive%2520inhibitor%2520of%2520pyruvate%2520dehydrogenase%2520kinase%252C%2520disrupts%2520Warburg%2520metabolism%2520and%2520induces%2520context-dependent%2520cytostasis%2520in%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D12862%26epage%3D12876%26doi%3D10.18632%2Foncotarget.2656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Madhavi Sastry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adzhigirey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annabhimoju, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, W.</span><span> </span><span class="NLM_article-title">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span><span class="refDoi"> DOI: 10.1007/s10822-013-9644-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1007%2Fs10822-013-9644-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=23579614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslalu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=221-234&author=G.+Madhavi+Sastryauthor=M.+Adzhigireyauthor=T.+Dayauthor=R.+Annabhimojuauthor=W.+Sherman&title=Protein+and+ligand+preparation%3A+parameters%2C+protocols%2C+and+influence+on+virtual+screening+enrichments&doi=10.1007%2Fs10822-013-9644-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span></div><div class="casAuthors">Madhavi Sastry, G.; Adzhigirey, Matvey; Day, Tyler; Annabhimoju, Ramakrishna; Sherman, Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-234</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Structure-based virtual screening plays an important role in drug discovery and complements other screening approaches.  In general, protein crystal structures are prepd. prior to docking in order to add hydrogen atoms, optimize hydrogen bonds, remove at. clashes, and perform other operations that are not part of the x-ray crystal structure refinement process.  In addn., ligands must be prepd. to create 3-dimensional geometries, assign proper bond orders, and generate accessible tautomer and ionization states prior to virtual screening.  While the prerequisite for proper system prepn. is generally accepted in the field, an extensive study of the prepn. steps and their effect on virtual screening enrichments has not been performed.  In this work, we systematically explore each of the steps involved in prepg. a system for virtual screening.  We first explore a large no. of parameters using the Glide validation set of 36 crystal structures and 1,000 decoys.  We then apply a subset of protocols to the DUD database.  We show that database enrichment is improved with proper prepn. and that neglecting certain steps of the prepn. process produces a systematic degrdn. in enrichments, which can be large for some targets.  We provide examples illustrating the structural changes introduced by the prepn. that impact database enrichment.  While the work presented here was performed with the Protein Prepn. Wizard and Glide, the insights and guidance are expected to be generalizable to structure-based virtual screening with other docking methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruqN5nIOJtR7Vg90H21EOLACvtfcHk0liAmrlb5F_I-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslalu7c%253D&md5=259a6d547ef3e1310e091fb50fe8de16</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9644-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9644-8%26sid%3Dliteratum%253Aachs%26aulast%3DMadhavi%2BSastry%26aufirst%3DG.%26aulast%3DAdzhigirey%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAnnabhimoju%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DProtein%2520and%2520ligand%2520preparation%253A%2520parameters%252C%2520protocols%252C%2520and%2520influence%2520on%2520virtual%2520screening%2520enrichments%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D221%26epage%3D234%26doi%3D10.1007%2Fs10822-013-9644-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Holdgate, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A. L.</span><span> </span><span class="NLM_article-title">Kinetic efficiency: the missing metric for enhancing compound quality?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">910</span><span class="NLM_x">–</span> <span class="NLM_lpage">913</span><span class="refDoi"> DOI: 10.1016/j.drudis.2011.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1016%2Fj.drudis.2011.09.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=910-913&author=G.+A.+Holdgateauthor=A.+L.+Gill&title=Kinetic+efficiency%3A+the+missing+metric+for+enhancing+compound+quality%3F&doi=10.1016%2Fj.drudis.2011.09.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DHoldgate%26aufirst%3DG.%2BA.%26aulast%3DGill%26aufirst%3DA.%2BL.%26atitle%3DKinetic%2520efficiency%253A%2520the%2520missing%2520metric%2520for%2520enhancing%2520compound%2520quality%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D910%26epage%3D913%26doi%3D10.1016%2Fj.drudis.2011.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Meng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regenass, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilpert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">Discovery and optimization of 4,5-diarylisoxazoles as potent dual inhibitors of pyruvate dehydrogenase kinase and heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9832</span><span class="NLM_x">–</span> <span class="NLM_lpage">9843</span><span class="refDoi"> DOI: 10.1021/jm5010144</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5010144" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyrurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9832-9843&author=T.+Mengauthor=D.+Zhangauthor=Z.+Xieauthor=T.+Yuauthor=S.+Wuauthor=U.+Regenassauthor=K.+Hilpertauthor=M.+Huangauthor=M.+Gengauthor=J.+Shen&title=Discovery+and+optimization+of+4%2C5-diarylisoxazoles+as+potent+dual+inhibitors+of+pyruvate+dehydrogenase+kinase+and+heat+shock+protein+90&doi=10.1021%2Fjm5010144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and optimization of 4,5-diarylisoxazoles as potent dual inhibitors of pyruvate dehydrogenase kinase and heat shock protein 90</span></div><div class="casAuthors">Meng, Tao; Zhang, Dadong; Xie, Zuoquan; Yu, Ting; Wu, Shuchao; Regenass, Urs; Hilpert, Kurt; Huang, Min; Geng, Meiyu; Shen, Jingkang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9832-9843</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Upregulation of pyruvate dehydrogenase kinase (PDHK) has been obsd. in a variety of cancers.  Inhibition of PDHK offers an attractive opportunity for the development of novel cancer therapies.  To obtain novel PDHK inhibitors, the authors took advantage of the homol. of the ATP-binding pocket between Heat Shock Protein 90 (HSP90) and PDHK, and utilized 4,5-diarylisoxazole based HSP90 inhibitor for structural design.  The efforts led to the identification of I that inhibited PDHK1 with an IC50 value of 17 nM, which, however, showed marginal cellular activity.  Further structural optimization resulted in compd. II with improved cellular activity which could effectively modulate the metabolic profile of cancer cells and lead to the inhibition of cancer cell proliferation, evidenced by the increased oxidative phosphorylation and decreased glycolysis and assocd. oxidative stress.  The results suggested II as an excellent lead compd. and a favorable biol. tool to further evaluate the therapeutic potential of PDHK and HSP90 dual inhibitors in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpX1cvlKuuz7Vg90H21EOLACvtfcHk0liAmrlb5F_I-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyrurnK&md5=ab2f08b46344868b81247a228b149755</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm5010144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5010144%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DRegenass%26aufirst%3DU.%26aulast%3DHilpert%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520optimization%2520of%25204%252C5-diarylisoxazoles%2520as%2520potent%2520dual%2520inhibitors%2520of%2520pyruvate%2520dehydrogenase%2520kinase%2520and%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9832%26epage%3D9843%26doi%3D10.1021%2Fjm5010144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Baker, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasten, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, T. E.</span><span> </span><span class="NLM_article-title">Marked differences between two isoforms of human pyruvate dehydrogenase kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">15773</span><span class="NLM_x">–</span> <span class="NLM_lpage">15781</span><span class="refDoi"> DOI: 10.1074/jbc.M909488199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1074%2Fjbc.M909488199" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=15773-15781&author=J.+C.+Bakerauthor=X.+Yanauthor=T.+Pengauthor=S.+Kastenauthor=T.+E.+Roche&title=Marked+differences+between+two+isoforms+of+human+pyruvate+dehydrogenase+kinase&doi=10.1074%2Fjbc.M909488199"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M909488199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M909488199%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DJ.%2BC.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DT.%26aulast%3DKasten%26aufirst%3DS.%26aulast%3DRoche%26aufirst%3DT.%2BE.%26atitle%3DMarked%2520differences%2520between%2520two%2520isoforms%2520of%2520human%2520pyruvate%2520dehydrogenase%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D15773%26epage%3D15781%26doi%3D10.1074%2Fjbc.M909488199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Bao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasten, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, T. E.</span><span> </span><span class="NLM_article-title">Pyruvate dehydrogenase kinase isoform 2 activity limited and further inhibited by slowing down the rate of dissociation of ADP</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">13432</span><span class="NLM_x">–</span> <span class="NLM_lpage">13441</span><span class="refDoi"> DOI: 10.1021/bi049488x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi049488x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=13432-13441&author=H.+Baoauthor=S.+A.+Kastenauthor=X.+Yanauthor=T.+E.+Roche&title=Pyruvate+dehydrogenase+kinase+isoform+2+activity+limited+and+further+inhibited+by+slowing+down+the+rate+of+dissociation+of+ADP&doi=10.1021%2Fbi049488x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fbi049488x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi049488x%26sid%3Dliteratum%253Aachs%26aulast%3DBao%26aufirst%3DH.%26aulast%3DKasten%26aufirst%3DS.%2BA.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DRoche%26aufirst%3DT.%2BE.%26atitle%3DPyruvate%2520dehydrogenase%2520kinase%2520isoform%25202%2520activity%2520limited%2520and%2520further%2520inhibited%2520by%2520slowing%2520down%2520the%2520rate%2520of%2520dissociation%2520of%2520ADP%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D13432%26epage%3D13441%26doi%3D10.1021%2Fbi049488x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Weikl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muschler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span> </span><span class="NLM_article-title">C-terminal regions of hsp90 are important for trapping the nucleotide during the ATPase cycle</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">583</span><span class="NLM_x">–</span> <span class="NLM_lpage">592</span><span class="refDoi"> DOI: 10.1006/jmbi.2000.4157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1006%2Fjmbi.2000.4157" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2000&pages=583-592&author=T.+Weiklauthor=P.+Muschlerauthor=K.+Richterauthor=T.+Veitauthor=J.+Reinsteinauthor=J.+Buchner&title=C-terminal+regions+of+hsp90+are+important+for+trapping+the+nucleotide+during+the+ATPase+cycle&doi=10.1006%2Fjmbi.2000.4157"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.2000.4157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.2000.4157%26sid%3Dliteratum%253Aachs%26aulast%3DWeikl%26aufirst%3DT.%26aulast%3DMuschler%26aufirst%3DP.%26aulast%3DRichter%26aufirst%3DK.%26aulast%3DVeit%26aufirst%3DT.%26aulast%3DReinstein%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DC-terminal%2520regions%2520of%2520hsp90%2520are%2520important%2520for%2520trapping%2520the%2520nucleotide%2520during%2520the%2520ATPase%2520cycle%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2000%26volume%3D303%26spage%3D583%26epage%3D592%26doi%3D10.1006%2Fjmbi.2000.4157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tso, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gui, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernstedt-Asterholm, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morlock, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherer, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tambar, U. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, D. T.</span><span> </span><span class="NLM_article-title">Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">4432</span><span class="NLM_x">–</span> <span class="NLM_lpage">4443</span><span class="refDoi"> DOI: 10.1074/jbc.M113.533885</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1074%2Fjbc.M113.533885" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=24356970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFSgs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=4432-4443&author=S.+C.+Tsoauthor=X.+Qiauthor=W.+J.+Guiauthor=C.+Y.+Wuauthor=J.+L.+Chuangauthor=I.+Wernstedt-Asterholmauthor=L.+K.+Morlockauthor=K.+R.+Owensauthor=P.+E.+Schererauthor=N.+S.+Williamsauthor=U.+K.+Tambarauthor=R.+M.+Wynnauthor=D.+T.+Chuang&title=Structure-guided+development+of+specific+pyruvate+dehydrogenase+kinase+inhibitors+targeting+the+ATP-binding+pocket&doi=10.1074%2Fjbc.M113.533885"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48aR"><div class="casContent"><span class="casTitleNuber">48a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided Development of Specific Pyruvate Dehydrogenase Kinase Inhibitors Targeting the ATP-binding Pocket</span></div><div class="casAuthors">Tso, Shih-Chia; Qi, Xiangbing; Gui, Wen-Jun; Wu, Cheng-Yang; Chuang, Jacinta L.; Wernstedt-Asterholm, Ingrid; Morlock, Lorraine K.; Owens, Kyle R.; Scherer, Philipp E.; Williams, Noelle S.; Tambar, Uttam K.; Wynn, R. Max; Chuang, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4432-4443</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinase isoforms (PDKs 1-4) neg. regulate activity of the mitochondrial pyruvate dehydrogenase complex by reversible phosphorylation.  PDK isoforms are up-regulated in obesity, diabetes, heart failure, and cancer and are potential therapeutic targets for these important human diseases.  Here, the authors employed a structure-guided design to convert a known Hsp90 inhibitor to a series of highly specific PDK inhibitors, based on structural conservation in the ATP-binding pocket.  The key step involved the substitution of a carbonyl group in the parent compd. with a sulfonyl in the PDK inhibitors.  The final compd. of this series, 2-[(2,4-dihydroxyphenyl)sulfonyl]isoindoline-4,6-diol, designated PS10, inhibits all four PDK isoforms with IC50 = 0.8 μm for PDK2.  The administration of PS10 (70 mg/kg) to diet-induced obese mice significantly augments pyruvate dehydrogenase complex activity with reduced phosphorylation in different tissues.  Prolonged PS10 treatments result in improved glucose tolerance and notably lessened hepatic steatosis in the mouse model.  The results support the pharmacol. approach of targeting PDK to control both glucose and fat levels in obesity and type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEmYMKZrXKTrVg90H21EOLACvtfcHk0lgfeC_dTFEnTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFSgs7w%253D&md5=e3bd48326cc1ab39c76f7bd19734a361</span></div><a href="/servlet/linkout?suffix=cit48a&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.533885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.533885%26sid%3Dliteratum%253Aachs%26aulast%3DTso%26aufirst%3DS.%2BC.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DGui%26aufirst%3DW.%2BJ.%26aulast%3DWu%26aufirst%3DC.%2BY.%26aulast%3DChuang%26aufirst%3DJ.%2BL.%26aulast%3DWernstedt-Asterholm%26aufirst%3DI.%26aulast%3DMorlock%26aufirst%3DL.%2BK.%26aulast%3DOwens%26aufirst%3DK.%2BR.%26aulast%3DScherer%26aufirst%3DP.%2BE.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DTambar%26aufirst%3DU.%2BK.%26aulast%3DWynn%26aufirst%3DR.%2BM.%26aulast%3DChuang%26aufirst%3DD.%2BT.%26atitle%3DStructure-guided%2520development%2520of%2520specific%2520pyruvate%2520dehydrogenase%2520kinase%2520inhibitors%2520targeting%2520the%2520ATP-binding%2520pocket%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D4432%26epage%3D4443%26doi%3D10.1074%2Fjbc.M113.533885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit48b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tso, S. C.; Lou, M.; Wu, C. Y.; Gui, W. J.; Chuang, J. L.; Morlock, L. K.; Williams, N. S.; Wynn, R. M.; Qi, X.; Chuang, D. T.</span><span> </span><span class="NLM_article-title">Development of dihydroxyphenyl sulfonylisoindoline derivatives as liver-targeting pyruvate dehydrogenase Kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span> Published Online: January 13, 2017. <a href="http://pubs.acs.org/doi/abs/10.1021%2Facs.jmedchem.6b01540" class="extLink">http://pubs.acs.org/doi/abs/10.1021%2Facs.jmedchem.6b01540</a> (accessed January 13,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=S.+C.+Tso&author=M.+Lou&author=C.+Y.+Wu&author=W.+J.+Gui&author=J.+L.+Chuang&author=L.+K.+Morlock&author=N.+S.+Williams&author=R.+M.+Wynn&author=X.+Qi&author=D.+T.+Chuang&title=Development+of+dihydroxyphenyl+sulfonylisoindoline+derivatives+as+liver-targeting+pyruvate+dehydrogenase+Kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTso%26aufirst%3DS.%2BC.%26atitle%3DDevelopment%2520of%2520dihydroxyphenyl%2520sulfonylisoindoline%2520derivatives%2520as%2520liver-targeting%2520pyruvate%2520dehydrogenase%2520Kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voltan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melloni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tisato, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celeghini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantinati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secchiero, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zauli, G.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01165</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01165" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=147-156&author=C.+Trapellaauthor=R.+Voltanauthor=E.+Melloniauthor=V.+Tisatoauthor=C.+Celeghiniauthor=S.+Biancoauthor=A.+Fantinatiauthor=S.+Salvadoriauthor=R.+Guerriniauthor=P.+Secchieroauthor=G.+Zauli&title=Design%2C+synthesis%2C+and+biological+characterization+of+novel+mitochondria+targeted+dichloroacetate-loaded+compounds+with+antileukemic+activity&doi=10.1021%2Facs.jmedchem.5b01165"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01165%26sid%3Dliteratum%253Aachs%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DVoltan%26aufirst%3DR.%26aulast%3DMelloni%26aufirst%3DE.%26aulast%3DTisato%26aufirst%3DV.%26aulast%3DCeleghini%26aufirst%3DC.%26aulast%3DBianco%26aufirst%3DS.%26aulast%3DFantinati%26aufirst%3DA.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DSecchiero%26aufirst%3DP.%26aulast%3DZauli%26aufirst%3DG.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520characterization%2520of%2520novel%2520mitochondria%2520targeted%2520dichloroacetate-loaded%2520compounds%2520with%2520antileukemic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D147%26epage%3D156%26doi%3D10.1021%2Facs.jmedchem.5b01165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Zhang, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, K. Y.</span><span> </span><span class="NLM_article-title">Unexpected discovery of dichloroacetate derived adenosine triphosphate competitors targeting pyruvate dehydrogenase kinase to inhibit cancer proliferation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">3562</span><span class="NLM_x">–</span> <span class="NLM_lpage">3568</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01828</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01828" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1eis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3562-3568&author=S.+L.+Zhangauthor=X.+Huauthor=W.+Zhangauthor=K.+Y.+Tam&title=Unexpected+discovery+of+dichloroacetate+derived+adenosine+triphosphate+competitors+targeting+pyruvate+dehydrogenase+kinase+to+inhibit+cancer+proliferation&doi=10.1021%2Facs.jmedchem.5b01828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Unexpected Discovery of Dichloroacetate Derived Adenosine Triphosphate Competitors Targeting Pyruvate Dehydrogenase Kinase To Inhibit Cancer Proliferation</span></div><div class="casAuthors">Zhang, Shao-Lin; Hu, Xiaohui; Zhang, Wen; Tam, Kin Yip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3562-3568</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinases (PDKs) have recently emerged as an attractive target for cancer therapy.  Herein, the authors prepd. a series of compds. derived from dichloroacetate (DCA) which inhibited cancer cells proliferation.  For the first time, the authors have successfully developed DCA derived inhibitors that preferentially bind to the ATP pocket of PDK isoform 1 (PDK1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmY3Q84QJe_bVg90H21EOLACvtfcHk0ljvvRXkJeirFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1eis7k%253D&md5=fa825a672c4c481c0cc55f59da38b43f</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01828%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%2BL.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DTam%26aufirst%3DK.%2BY.%26atitle%3DUnexpected%2520discovery%2520of%2520dichloroacetate%2520derived%2520adenosine%2520triphosphate%2520competitors%2520targeting%2520pyruvate%2520dehydrogenase%2520kinase%2520to%2520inhibit%2520cancer%2520proliferation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3562%26epage%3D3568%26doi%3D10.1021%2Facs.jmedchem.5b01828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48a','cit48b'],'ref49':['cit49'],'ref50':['cit50']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 17 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Gaochan Wu, Tong Zhao, Dongwei Kang, Jian Zhang, Yuning Song, Vigneshwaran Namasivayam, Jacob Kongsted, Christophe Pannecouque, Erik De Clercq, Vasanthanathan Poongavanam, Xinyong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Peng Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of Recent Strategic Advances in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9375-9414. <a href="https://doi.org/10.1021/acs.jmedchem.9b00359" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00359%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOverview%252Bof%252BRecent%252BStrategic%252BAdvances%252Bin%252BMedicinal%252BChemistry%26aulast%3DWu%26aufirst%3DGaochan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26022019%26date%3D28052019%26date%3D03052019%26volume%3D62%26issue%3D21%26spage%3D9375%26epage%3D9414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hanna Cho, Injae Shin, Kyungseon Cho, Hojong Yoon, Eun Kyung Yoo, Mi-Jin Kim, Sungmi Park, In-Kyu Lee, Nam Doo Kim, <span class="NLM_string-name hlFld-ContribAuthor">Taebo Sim</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Novel Resorcinol Amide Derivatives as Potent and Specific Pyruvate Dehydrogenase Kinase (PDHK) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (18)
                                     , 8461-8479. <a href="https://doi.org/10.1021/acs.jmedchem.9b00565" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00565</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00565%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BNovel%252BResorcinol%252BAmide%252BDerivatives%252Bas%252BPotent%252Band%252BSpecific%252BPyruvate%252BDehydrogenase%252BKinase%252B%252528PDHK%252529%252BInhibitors%26aulast%3DCho%26aufirst%3DHanna%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D02042019%26date%3D13092019%26date%3D30082019%26volume%3D62%26issue%3D18%26spage%3D8461%26epage%3D8479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hyeon
Jeong Shin, Ji Hye Lee, Yong Duk Kim, Injae Shin, Taebo Sim, <span class="NLM_string-name hlFld-ContribAuthor">Dong-Kwon Lim</span>. </span><span class="cited-content_cbyCitation_article-title">Raman-Based in Situ Monitoring of Changes in Molecular Signatures during Mitochondrially Mediated Apoptosis. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (5)
                                     , 8188-8195. <a href="https://doi.org/10.1021/acsomega.9b00629" title="DOI URL">https://doi.org/10.1021/acsomega.9b00629</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b00629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b00629%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DRaman-Based%252Bin%252BSitu%252BMonitoring%252Bof%252BChanges%252Bin%252BMolecular%252BSignatures%252Bduring%252BMitochondrially%252BMediated%252BApoptosis%26aulast%3DShin%26aufirst%3DHyeon%2BJeong%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D06032019%26date%3D22042019%26volume%3D4%26issue%3D5%26spage%3D8188%26epage%3D8195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Paul N. Mortenson, Daniel A. Erlanson, Iwan J. P. de Esch, Wolfgang Jahnke, <span class="NLM_string-name hlFld-ContribAuthor">Christopher N. Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2017. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (8)
                                     , 3857-3872. <a href="https://doi.org/10.1021/acs.jmedchem.8b01472" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01472%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-to-Lead%252BMedicinal%252BChemistry%252BPublications%252Bin%252B2017%26aulast%3DMortenson%26aufirst%3DPaul%2BN.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D21092018%26date%3D21112018%26volume%3D62%26issue%3D8%26spage%3D3857%26epage%3D3872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alexey
V. Samokhvalov, Irina V. Safenkova, Sergei A. Eremin, Anatoly V. Zherdev, <span class="NLM_string-name hlFld-ContribAuthor">Boris B. Dzantiev</span>. </span><span class="cited-content_cbyCitation_article-title">Measurement of (Aptamer–Small Target) KD Using the Competition between Fluorescently Labeled and Unlabeled Targets and the Detection of Fluorescence Anisotropy. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2018,</strong> <em>90 </em>
                                    (15)
                                     , 9189-9198. <a href="https://doi.org/10.1021/acs.analchem.8b01699" title="DOI URL">https://doi.org/10.1021/acs.analchem.8b01699</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.8b01699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.8b01699%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DMeasurement%252Bof%252B%252528Aptamer%2525E2%252580%252593Small%252BTarget%252529%252BKD%252BUsing%252Bthe%252BCompetition%252Bbetween%252BFluorescently%252BLabeled%252Band%252BUnlabeled%252BTargets%252Band%252Bthe%252BDetection%252Bof%252BFluorescence%252BAnisotropy%26aulast%3DSamokhvalov%26aufirst%3DAlexey%2BV.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D16042018%26date%3D01072018%26date%3D13072018%26date%3D01072018%26volume%3D90%26issue%3D15%26spage%3D9189%26epage%3D9198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatsuo  Akaki</span>, <span class="hlFld-ContribAuthor ">Yuki  Bessho</span>, <span class="hlFld-ContribAuthor ">Takashi  Ito</span>, <span class="hlFld-ContribAuthor ">Shingo  Fujioka</span>, <span class="hlFld-ContribAuthor ">Minoru  Ubukata</span>, <span class="hlFld-ContribAuthor ">Genki  Mori</span>, <span class="hlFld-ContribAuthor ">Kenji  Yamanaka</span>, <span class="hlFld-ContribAuthor ">Takuya  Orita</span>, <span class="hlFld-ContribAuthor ">Satoki  Doi</span>, <span class="hlFld-ContribAuthor ">Tomoko  Iwanaga</span>, <span class="hlFld-ContribAuthor ">Kazutaka  Ikegashira</span>, <span class="hlFld-ContribAuthor ">Yoshiji  Hantani</span>, <span class="hlFld-ContribAuthor ">Isao  Nakanishi</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Adachi</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-based lead discovery to identify novel inhibitors that target the ATP binding site of pyruvate dehydrogenase kinases. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>44 </em>, 116283. <a href="https://doi.org/10.1016/j.bmc.2021.116283" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116283</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116283%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DFragment-based%252Blead%252Bdiscovery%252Bto%252Bidentify%252Bnovel%252Binhibitors%252Bthat%252Btarget%252Bthe%252BATP%252Bbinding%252Bsite%252Bof%252Bpyruvate%252Bdehydrogenase%252Bkinases%26aulast%3DAkaki%26aufirst%3DTatsuo%26date%3D2021%26volume%3D44%26spage%3D116283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment‐Based Lead Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-35. <a href="https://doi.org/10.1002/0471266949.bmc265" title="DOI URL">https://doi.org/10.1002/0471266949.bmc265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc265%26sid%3Dliteratum%253Aachs%26atitle%3DFragment%2525E2%252580%252590Based%252BLead%252BDiscovery%26aulast%3DHubbard%26aufirst%3DRoderick%2BE.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D35%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Biao  Xu</span>, <span class="hlFld-ContribAuthor ">Zhi-Peng  Wang</span>, <span class="hlFld-ContribAuthor ">Qingwang  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Yang</span>, <span class="hlFld-ContribAuthor ">Xuemin  Li</span>, <span class="hlFld-ContribAuthor ">Ding  Huang</span>, <span class="hlFld-ContribAuthor ">Yanfei  Qiu</span>, <span class="hlFld-ContribAuthor ">Kin Yip  Tam</span>, <span class="hlFld-ContribAuthor ">Shao-Lin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yun  He</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation and structure-activity relationship of novel dichloroacetophenones targeting pyruvate dehydrogenase kinases with potent anticancer activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113225. <a href="https://doi.org/10.1016/j.ejmech.2021.113225" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113225</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113225%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bstructure-activity%252Brelationship%252Bof%252Bnovel%252Bdichloroacetophenones%252Btargeting%252Bpyruvate%252Bdehydrogenase%252Bkinases%252Bwith%252Bpotent%252Banticancer%252Bactivity%26aulast%3DXu%26aufirst%3DBiao%26date%3D2021%26volume%3D214%26spage%3D113225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Md  Ashraf-Uz-Zaman</span>, <span class="hlFld-ContribAuthor ">Sadisna  Shahi</span>, <span class="hlFld-ContribAuthor ">Racheal  Akwii</span>, <span class="hlFld-ContribAuthor ">Md Sanaullah  Sajib</span>, <span class="hlFld-ContribAuthor ">Mohammad Jodeiri  Farshbaf</span>, <span class="hlFld-ContribAuthor ">Raja Reddy  Kallem</span>, <span class="hlFld-ContribAuthor ">William  Putnam</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Ruiwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Karina  Alvina</span>, <span class="hlFld-ContribAuthor ">Paul C.  Trippier</span>, <span class="hlFld-ContribAuthor ">Constantinos M.  Mikelis</span>, <span class="hlFld-ContribAuthor ">Nadezhda A.  German</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112866. <a href="https://doi.org/10.1016/j.ejmech.2020.112866" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112866</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112866%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bstructure-activity%252Brelationship%252Bstudy%252Bof%252Bnovel%252Burea%252Bcompounds%252Bas%252BFGFR1%252Binhibitors%252Bto%252Btreat%252Bmetastatic%252Btriple-negative%252Bbreast%252Bcancer%26aulast%3DAshraf-Uz-Zaman%26aufirst%3DMd%26date%3D2021%26volume%3D209%26spage%3D112866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisa M.  Baker</span>, <span class="hlFld-ContribAuthor ">Anthony  Aimon</span>, <span class="hlFld-ContribAuthor ">James B.  Murray</span>, <span class="hlFld-ContribAuthor ">Allan E.  Surgenor</span>, <span class="hlFld-ContribAuthor ">Natalia  Matassova</span>, <span class="hlFld-ContribAuthor ">Stephen D.  Roughley</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Collins</span>, <span class="hlFld-ContribAuthor ">Tobias  Krojer</span>, <span class="hlFld-ContribAuthor ">Frank  von Delft</span>, <span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures. </span><span class="cited-content_cbyCitation_journal-name">Communications Chemistry</span><span> <strong>2020,</strong> <em>3 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s42004-020-00367-0" title="DOI URL">https://doi.org/10.1038/s42004-020-00367-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s42004-020-00367-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs42004-020-00367-0%26sid%3Dliteratum%253Aachs%26jtitle%3DCommunications%2520Chemistry%26atitle%3DRapid%252Boptimisation%252Bof%252Bfragments%252Band%252Bhits%252Bto%252Blead%252Bcompounds%252Bfrom%252Bscreening%252Bof%252Bcrude%252Breaction%252Bmixtures%26aulast%3DBaker%26aufirst%3DLisa%2BM.%26date%3D2020%26date%3D2020%26volume%3D3%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen D.  Roughley</span>. </span><span class="cited-content_cbyCitation_article-title">Five Years of the KNIME Vernalis Cheminformatics Community Contribution. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>27 </em>
                                    (38)
                                     , 6495-6522. <a href="https://doi.org/10.2174/0929867325666180904113616" title="DOI URL">https://doi.org/10.2174/0929867325666180904113616</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666180904113616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666180904113616%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DFive%252BYears%252Bof%252Bthe%252BKNIME%252BVernalis%252BCheminformatics%252BCommunity%252BContribution%26aulast%3DRoughley%26aufirst%3DStephen%2BD.%26date%3D2020%26volume%3D27%26issue%3D38%26spage%3D6495%26epage%3D6522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Cao</span>, <span class="hlFld-ContribAuthor ">Zhan  Wang</span>, <span class="hlFld-ContribAuthor ">Xingwen  Han</span>, <span class="hlFld-ContribAuthor ">Jianhua  Liu</span>, <span class="hlFld-ContribAuthor ">Wenji  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro cytotoxicity screening to identify novel anti-osteosarcoma therapeutics targeting pyruvate dehydrogenase kinase 2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (20)
                                     , 126665. <a href="https://doi.org/10.1016/j.bmcl.2019.126665" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126665</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126665%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIn%252Bvitro%252Bcytotoxicity%252Bscreening%252Bto%252Bidentify%252Bnovel%252Banti-osteosarcoma%252Btherapeutics%252Btargeting%252Bpyruvate%252Bdehydrogenase%252Bkinase%252B2%26aulast%3DCao%26aufirst%3DWei%26date%3D2019%26volume%3D29%26issue%3D20%26spage%3D126665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rashmi  Dahiya</span>, <span class="hlFld-ContribAuthor ">Taj  Mohammad</span>, <span class="hlFld-ContribAuthor ">Preeti  Gupta</span>, <span class="hlFld-ContribAuthor ">Anzarul  Haque</span>, <span class="hlFld-ContribAuthor ">Mohamed F.  Alajmi</span>, <span class="hlFld-ContribAuthor ">Afzal  Hussain</span>, <span class="hlFld-ContribAuthor ">Md. Imtaiyaz  Hassan</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular interaction studies on ellagic acid for its anticancer potential targeting pyruvate dehydrogenase kinase 3. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (40)
                                     , 23302-23315. <a href="https://doi.org/10.1039/C9RA02864A" title="DOI URL">https://doi.org/10.1039/C9RA02864A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA02864A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA02864A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DMolecular%252Binteraction%252Bstudies%252Bon%252Bellagic%252Bacid%252Bfor%252Bits%252Banticancer%252Bpotential%252Btargeting%252Bpyruvate%252Bdehydrogenase%252Bkinase%252B3%26aulast%3DDahiya%26aufirst%3DRashmi%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D40%26spage%3D23302%26epage%3D23315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong-Mei  Wu</span>, <span class="hlFld-ContribAuthor ">Yong-Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Shao-Hua  Fan</span>, <span class="hlFld-ContribAuthor ">Zi-Feng  Zhang</span>, <span class="hlFld-ContribAuthor ">Qun  Shan</span>, <span class="hlFld-ContribAuthor ">Jun  Lu</span>, <span class="hlFld-ContribAuthor ">Gui-Quan  Chen</span>, <span class="hlFld-ContribAuthor ">Yuan-Lin  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">High-throughput screening of novel pyruvate dehydrogenase kinases inhibitors and biological evaluation of their in vitro and in vivo antiproliferative activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 252-262. <a href="https://doi.org/10.1016/j.ejmech.2018.12.051" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.051%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHigh-throughput%252Bscreening%252Bof%252Bnovel%252Bpyruvate%252Bdehydrogenase%252Bkinases%252Binhibitors%252Band%252Bbiological%252Bevaluation%252Bof%252Btheir%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%252Bantiproliferative%252Bactivity%26aulast%3DWu%26aufirst%3DDong-Mei%26date%3D2019%26volume%3D164%26spage%3D252%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel A.  Erlanson</span>, <span class="hlFld-ContribAuthor ">Ben J.  Davis</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Jahnke</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Drug Discovery: Advancing Fragments in the Absence of Crystal Structures. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2019,</strong> <em>26 </em>
                                    (1)
                                     , 9-15. <a href="https://doi.org/10.1016/j.chembiol.2018.10.001" title="DOI URL">https://doi.org/10.1016/j.chembiol.2018.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2018.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2018.10.001%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DFragment-Based%252BDrug%252BDiscovery%25253A%252BAdvancing%252BFragments%252Bin%252Bthe%252BAbsence%252Bof%252BCrystal%252BStructures%26aulast%3DErlanson%26aufirst%3DDaniel%2BA.%26date%3D2019%26volume%3D26%26issue%3D1%26spage%3D9%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyun-Hwi  Kim</span>, <span class="hlFld-ContribAuthor ">Ja-Shil  Hyun</span>, <span class="hlFld-ContribAuthor ">Joonhyeok  Choi</span>, <span class="hlFld-ContribAuthor ">Kwang-Eun  Choi</span>, <span class="hlFld-ContribAuthor ">Jun-Goo  Jee</span>, <span class="hlFld-ContribAuthor ">Sung Jean  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Structural ensemble-based docking simulation and biophysical studies discovered new inhibitors of Hsp90 N-terminal domain. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-18332-8" title="DOI URL">https://doi.org/10.1038/s41598-017-18332-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-18332-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-18332-8%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DStructural%252Bensemble-based%252Bdocking%252Bsimulation%252Band%252Bbiophysical%252Bstudies%252Bdiscovered%252Bnew%252Binhibitors%252Bof%252BHsp90%252BN-terminal%252Bdomain%26aulast%3DKim%26aufirst%3DHyun-Hwi%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Bo  Wang</span>, <span class="hlFld-ContribAuthor ">Baichun  Hu</span>, <span class="hlFld-ContribAuthor ">Hailun  Jiang</span>, <span class="hlFld-ContribAuthor ">Bate  Lai</span>, <span class="hlFld-ContribAuthor ">Ning  Li</span>, <span class="hlFld-ContribAuthor ">Maosheng  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">In Silicon Approach for Discovery of Chemopreventive Agents. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmacology Reports</span><span> <strong>2017,</strong> <em>3 </em>
                                    (4)
                                     , 184-195. <a href="https://doi.org/10.1007/s40495-017-0094-1" title="DOI URL">https://doi.org/10.1007/s40495-017-0094-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40495-017-0094-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40495-017-0094-1%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmacology%2520Reports%26atitle%3DIn%252BSilicon%252BApproach%252Bfor%252BDiscovery%252Bof%252BChemopreventive%252BAgents%26aulast%3DWang%26aufirst%3DJian%26date%3D2017%26date%3D2017%26volume%3D3%26issue%3D4%26spage%3D184%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of compounds known to bind PDHK.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic overlay of the binding sites in PDHK-2 of <b>1</b>, (brown), <b>2</b> (yellow), ATP (magenta), and <b>5</b> (white).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Fragment hit (<b>6</b>) and related resorcinol amide PDHK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Overlay of X-ray crystal structures (ATP binding region) of compound <b>10</b> in PDHK-2 (blue; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4K">5M4K</a>) and HSP90 (yellow; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4E">5M4E</a>), illustrating the different positions of the ligand in the two proteins due to the proximity of residues Ile96 and Lys58 in HSP90.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0013.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Resorcinol Amide ORS Library<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span><i>Reagents and conditions</i>: (a) oxalyl chloride, cat. DMF, DCM; (b) R<sub>1</sub>R<sub>2</sub>NH, Et<sub>3</sub>N, DCM, 16 h; (c) NH<sub>3</sub>, MeOH.</p></p></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Structure of compounds with <i>k</i><sub>d</sub> ≤ 0.25 s<sup>–1</sup> against PDHK-1 as measured by SPR of the crude reaction products of a parallel library. LC purities (% at 254 nm) are shown for the ORS library sample. Purity of reprepared material is >95%. (B) Dissociation phase of crude samples of <b>15</b>, <b>16</b>, <b>17</b>, and <b>18</b> and the dual PDHK/HSP90 inhibitor control compound <b>19</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> by SPR. The compounds displayed bind to His-His-PDHK-1 immobilized on the NTA chip at 25 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structure and SPR data associated with the crude ORS library compounds <b>20</b> and <b>21</b>. LC purities (% at 254 nm) are shown for the ORS library sample. Purity of reprepared material is >95% (see <a class="ref internalNav" href="#notes-1" aria-label="SI">SI</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. X-ray crystallography structure of compound <b>21</b> bound to HSP90 (orange; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4H">5M4H</a>). <b>21</b> forms hydrogen bonds with Asp93 and buried waters, and favorable vdW contacts with numerous residues including Ile96. Superimposed X-ray structure of PDHK-2 protein (blue) shows two key residues near the ligand which differ between the two (Ile96 and Met98 in HSP90; Gly285 and Val287 in PDHK-2). Weaker binding to PDHK-2 could be due to the lack of a residue that can mimic the vdW interactions made between the HSP90 Ile96 and <b>21</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0014.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Tetrahydroquinoline Amide PDHK Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span><i>Reagents and Conditions</i>: (a) Ac<sub>2</sub>O, DCM, 16 h; (b) NBS, DMF, 16 h; (c) Zn(OAc)<sub>2</sub>, Zn, Pd<sub>2</sub>(dba)<sub>3</sub>, dppf, Zn(CN)<sub>2</sub>, DMF, 100 °C, 3.5 h; (d) <i>c.</i>HCl (aq), 100 °C, 16 h; (e) BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 16 h; (f) (<i>i</i>) oxalyl chloride, cat. DMF, DCM, rt, 35 min. (<i>ii</i>) <b>26</b>, Et<sub>3</sub>N, DCM, 0 °C to rt, 2 h; (g) Pd(C), H<sub>2</sub>, EtOAc, 2 h; (h) (<i>i</i>) oxalyl chloride, cat. DMF, DCM (<i>ii</i>) NHR<sub>1</sub>R<sub>2</sub>, Et<sub>3</sub>N, DCM, 0 °C to rt; (i) NH<sub>3</sub>, MeOH, 2.5–16 h; (j) <i>c.</i>HCl, H<sub>2</sub>O, 100 °C, 5 h; (k) (<i>i</i>) <b>12</b>, oxalyl chloride, cat. DMF, DCM, rt, 2 h; (<i>ii</i>) <b>30</b>, Et<sub>3</sub>N, DCM, 0 °C to rt; (l) tricyclohexylphosphine, Pd<sub>2</sub>(dba)<sub>3</sub>, <i>bis</i>-pinacolatodiboron, KOAc, 1,4-dioxane, 80 °C, 16 h; (m) ArCl, K<sub>2</sub>CO<sub>3</sub>, PdCl<sub>2</sub>(dppf)<sub>2</sub>, THF, H<sub>2</sub>O, Δ; (n) NH<sub>3</sub>, MeOH, rt 16 h.</p></p></figure><figure data-id="sch3a" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0015.jpeg" id="rightTab-GRAPHIC-d132e1665-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <i>N</i>-Aryl Amide PDHK Inhibitors Substituted with (a) Amides or (b) Heterocycles at the 4 N-Aryl Position<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=sch3a"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span><i>Reagents and Conditions</i>: Part a: (a) (<i>i</i>) oxalyl chloride, DCM; (<i>ii</i>) NHR<sub>1</sub>R<sub>2</sub>, Et<sub>3</sub>N, DCM, 0 °C to rt; (b) NH<sub>3</sub>, MeOH, 16 h. Part b: (a) ArB(OH)<sub>2</sub>, Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, THF, H<sub>2</sub>O, K<sub>2</sub>CO<sub>3</sub>, Δ; (b) NH<sub>3</sub>, MeOH, 16 h.</p></p></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0008.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Selected compounds from hit to lead campaign. Oxygen atoms labeled * can interact with Arg 250 in ligand–protein X-ray structures. Pyrimidine and pyridine 2-nitrogen can also make this interaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0009.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures of ligands bound to PDHK-2, highlighting the ATP lid (orange), which is partially ordered but with different conformations when bound with <b>38</b> (cyan, disordered residues 305–314; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4M4N">4M4N</a>) and <b>35a</b> (green, disordered residues 305–313; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4M">5M4M</a>), while it is completely disordered when bound to <b>33a</b> (magenta, disordered residues 305–319; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4N">5M4N</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0010.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of optimized PDHK inhibitors. Synthesis is described in <a href="/doi/suppl/10.1021/acs.jmedchem.6b01478/suppl_file/jm6b01478_si_001.pdf" class="ext-link">SI</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0011.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Interactions between compound <b>40</b> and PDHK-2. Hydrogen atoms were added and optimized to <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V25">4V25</a> to show the hydrogen bond network.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/medium/jm-2016-01478g_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0012.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structures of HSP90 inhibitor AUY922 (<b>41)</b>, dual HSP90/PDHK inhibitor (<b>42)</b>, resorcinol sulphonamide inhibitor (<b>43)</b>, and DCA<b>-</b>amides (<b>44</b> and <b>45</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01478/20170317/images/large/jm-2016-01478g_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01478&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i53">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62321" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62321" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 50 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Bowker-Kinley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, K. M.</span><span> </span><span class="NLM_article-title">Evidence that pyruvate dehydrogenase kinase belongs to the ATPase/kinase superfamily</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span><span class="refDoi"> DOI: 10.1042/bj3440047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1042%2Fbj3440047" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=1999&pages=47-53&author=M.+Bowker-Kinleyauthor=K.+M.+Popov&title=Evidence+that+pyruvate+dehydrogenase+kinase+belongs+to+the+ATPase%2Fkinase+superfamily&doi=10.1042%2Fbj3440047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1042%2Fbj3440047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3440047%26sid%3Dliteratum%253Aachs%26aulast%3DBowker-Kinley%26aufirst%3DM.%26aulast%3DPopov%26aufirst%3DK.%2BM.%26atitle%3DEvidence%2520that%2520pyruvate%2520dehydrogenase%2520kinase%2520belongs%2520to%2520the%2520ATPase%252Fkinase%2520superfamily%26jtitle%3DBiochem.%2520J.%26date%3D1999%26volume%3D344%26spage%3D47%26epage%3D53%26doi%3D10.1042%2Fbj3440047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Steussy, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowker-Kinley, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, R. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, J. A.</span><span> </span><span class="NLM_article-title">Structure of pyruvate dehydrogenase kinase. Novel folding pattern for a serine protein kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">37443</span><span class="NLM_x">–</span> <span class="NLM_lpage">37450</span><span class="refDoi"> DOI: 10.1074/jbc.M104285200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1074%2Fjbc.M104285200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=37443-37450&author=C.+N.+Steussyauthor=K.+M.+Popovauthor=M.+M.+Bowker-Kinleyauthor=R.+B.+Sloanauthor=R.+A.+Harrisauthor=J.+A.+Hamilton&title=Structure+of+pyruvate+dehydrogenase+kinase.+Novel+folding+pattern+for+a+serine+protein+kinase&doi=10.1074%2Fjbc.M104285200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M104285200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M104285200%26sid%3Dliteratum%253Aachs%26aulast%3DSteussy%26aufirst%3DC.%2BN.%26aulast%3DPopov%26aufirst%3DK.%2BM.%26aulast%3DBowker-Kinley%26aufirst%3DM.%2BM.%26aulast%3DSloan%26aufirst%3DR.%2BB.%26aulast%3DHarris%26aufirst%3DR.%2BA.%26aulast%3DHamilton%26aufirst%3DJ.%2BA.%26atitle%3DStructure%2520of%2520pyruvate%2520dehydrogenase%2520kinase.%2520Novel%2520folding%2520pattern%2520for%2520a%2520serine%2520protein%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D37443%26epage%3D37450%26doi%3D10.1074%2Fjbc.M104285200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Patel, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korotchkina, L. G.</span><span> </span><span class="NLM_article-title">Regulation of the pyruvate dehydrogenase complex</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span><span class="refDoi"> DOI: 10.1042/BST0340217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1042%2FBST0340217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=16545080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1ersro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=217-222&author=M.+S.+Patelauthor=L.+G.+Korotchkina&title=Regulation+of+the+pyruvate+dehydrogenase+complex&doi=10.1042%2FBST0340217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of the pyruvate dehydrogenase complex</span></div><div class="casAuthors">Patel, M. S.; Korotchkina, L. G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">217-222</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The pyruvate dehydrogenase complex (PDC) plays a central role in the maintenance of glucose homoeostasis in mammals.  C flux through PDC is meticulously controlled by elaborate mechanisms involving post-translational (short-term) phosphorylation/dephosphorylation and transcriptional (long-term) controls.  The former regulatory mechanism involving multiple phosphorylation sites and tissue-specific distribution of the dedicated kinases and phosphatases is not only dependent on the interactions among the catalytic and regulatory components of the complex but also sensitive to the intramitochondrial redox state and metabolite levels as indicators of the energy status.  Furthermore, differential transcriptional controls of the regulatory components of PDC further add to the complexity needed for long-term tuning of PDC activity for the maintenance of glucose homoeostasis during normal and disease states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxgyCnDeW--LVg90H21EOLACvtfcHk0lgtHySX8Ow-UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1ersro%253D&md5=41176d0204bbd5687736b93993cf78b5</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1042%2FBST0340217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0340217%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DM.%2BS.%26aulast%3DKorotchkina%26aufirst%3DL.%2BG.%26atitle%3DRegulation%2520of%2520the%2520pyruvate%2520dehydrogenase%2520complex%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2006%26volume%3D34%26spage%3D217%26epage%3D222%26doi%3D10.1042%2FBST0340217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inskeep, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowker-Kinley, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. A.</span><span> </span><span class="NLM_article-title">Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1593</span><span class="NLM_x">–</span> <span class="NLM_lpage">1599</span><span class="refDoi"> DOI: 10.2337/diabetes.48.8.1593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.2337%2Fdiabetes.48.8.1593" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1999&pages=1593-1599&author=P.+Wuauthor=K.+Inskeepauthor=M.+M.+Bowker-Kinleyauthor=K.+M.+Popovauthor=R.+A.+Harris&title=Mechanism+responsible+for+inactivation+of+skeletal+muscle+pyruvate+dehydrogenase+complex+in+starvation+and+diabetes&doi=10.2337%2Fdiabetes.48.8.1593"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.48.8.1593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.48.8.1593%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DInskeep%26aufirst%3DK.%26aulast%3DBowker-Kinley%26aufirst%3DM.%2BM.%26aulast%3DPopov%26aufirst%3DK.%2BM.%26aulast%3DHarris%26aufirst%3DR.%2BA.%26atitle%3DMechanism%2520responsible%2520for%2520inactivation%2520of%2520skeletal%2520muscle%2520pyruvate%2520dehydrogenase%2520complex%2520in%2520starvation%2520and%2520diabetes%26jtitle%3DDiabetes%26date%3D1999%26volume%3D48%26spage%3D1593%26epage%3D1599%26doi%3D10.2337%2Fdiabetes.48.8.1593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Morrell, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orme, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butlin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayers, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilgour, E.</span><span> </span><span class="NLM_article-title">AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1168</span><span class="NLM_x">–</span> <span class="NLM_lpage">1170</span><span class="refDoi"> DOI: 10.1042/bst0311168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1042%2Fbst0311168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=14641019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps12jsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=1168-1170&author=J.+A.+Morrellauthor=J.+Ormeauthor=R.+J.+Butlinauthor=T.+E.+Rocheauthor=R.+M.+Mayersauthor=E.+Kilgour&title=AZD7545+is+a+selective+inhibitor+of+pyruvate+dehydrogenase+kinase+2&doi=10.1042%2Fbst0311168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2</span></div><div class="casAuthors">Morrell, J. A.; Orme, J.; Butlin, R. J.; Roche, T. E.; Mayers, R. M.; Kilgour, E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1168-1170</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The PDH (pyruvate dehydrogenase) multi-enzyme complex catalyzes a key regulatory step in oxidative glycolysis.  Phosphorylation of the E1 subunit of the complex on serine residues results in the inactivation of enzyme activity.  A family of four dedicated PDH kinase isoenzymes exists, each of which displays a distinct tissue-specific expression profile.  AZD7545 is one of a series of PDH kinase inhibitors developed for the treatment of type 2 diabetes.  The isoenzyme-selectivity profile of AZD7545 and related compds. is described and the consequences for their in vivo mode of action are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRKIXN95mX-bVg90H21EOLACvtfcHk0lhiS1Hj8fpceA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps12jsr8%253D&md5=86c9fe03c05f86792c14953c381d3beb</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1042%2Fbst0311168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0311168%26sid%3Dliteratum%253Aachs%26aulast%3DMorrell%26aufirst%3DJ.%2BA.%26aulast%3DOrme%26aufirst%3DJ.%26aulast%3DButlin%26aufirst%3DR.%2BJ.%26aulast%3DRoche%26aufirst%3DT.%2BE.%26aulast%3DMayers%26aufirst%3DR.%2BM.%26aulast%3DKilgour%26aufirst%3DE.%26atitle%3DAZD7545%2520is%2520a%2520selective%2520inhibitor%2520of%2520pyruvate%2520dehydrogenase%2520kinase%25202%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2003%26volume%3D31%26spage%3D1168%26epage%3D1170%26doi%3D10.1042%2Fbst0311168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Aicher, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebernitz, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewell, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knorr, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperbeck, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brand, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strohschein, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinluan, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shetty, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelGrande, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozito, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maniara, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, W. R.</span><span> </span><span class="NLM_article-title">R)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionamides are orally active inhibitors of pyruvate dehydrogenase kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2741</span><span class="NLM_x">–</span> <span class="NLM_lpage">2746</span><span class="refDoi"> DOI: 10.1021/jm9902584</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9902584" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=2741-2746&author=T.+D.+Aicherauthor=R.+C.+Andersonauthor=G.+R.+Bebernitzauthor=G.+M.+Coppolaauthor=C.+F.+Jewellauthor=D.+C.+Knorrauthor=C.+Liuauthor=D.+M.+Sperbeckauthor=L.+J.+Brandauthor=R.+J.+Strohscheinauthor=J.+Gaoauthor=C.+C.+Vinluanauthor=S.+S.+Shettyauthor=C.+Draglandauthor=E.+L.+Kaplanauthor=D.+DelGrandeauthor=A.+Islamauthor=X.+Liuauthor=R.+J.+Lozitoauthor=W.+M.+Maniaraauthor=R.+E.+Walterauthor=W.+R.+Mann&title=R%29-3%2C3%2C3-Trifluoro-2-hydroxy-2-methylpropionamides+are+orally+active+inhibitors+of+pyruvate+dehydrogenase+kinase&doi=10.1021%2Fjm9902584"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm9902584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9902584%26sid%3Dliteratum%253Aachs%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DAnderson%26aufirst%3DR.%2BC.%26aulast%3DBebernitz%26aufirst%3DG.%2BR.%26aulast%3DCoppola%26aufirst%3DG.%2BM.%26aulast%3DJewell%26aufirst%3DC.%2BF.%26aulast%3DKnorr%26aufirst%3DD.%2BC.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DSperbeck%26aufirst%3DD.%2BM.%26aulast%3DBrand%26aufirst%3DL.%2BJ.%26aulast%3DStrohschein%26aufirst%3DR.%2BJ.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DVinluan%26aufirst%3DC.%2BC.%26aulast%3DShetty%26aufirst%3DS.%2BS.%26aulast%3DDragland%26aufirst%3DC.%26aulast%3DKaplan%26aufirst%3DE.%2BL.%26aulast%3DDelGrande%26aufirst%3DD.%26aulast%3DIslam%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLozito%26aufirst%3DR.%2BJ.%26aulast%3DManiara%26aufirst%3DW.%2BM.%26aulast%3DWalter%26aufirst%3DR.%2BE.%26aulast%3DMann%26aufirst%3DW.%2BR.%26atitle%3DR%2529-3%252C3%252C3-Trifluoro-2-hydroxy-2-methylpropionamides%2520are%2520orally%2520active%2520inhibitors%2520of%2520pyruvate%2520dehydrogenase%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D2741%26epage%3D2746%26doi%3D10.1021%2Fjm9902584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Aicher, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shetty, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knorr, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperbeck, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brand, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinluan, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragland, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaselli, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozito, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maniara, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillers, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelGrande, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, W. R.</span><span> </span><span class="NLM_article-title">Secondary amides of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">236</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span><span class="refDoi"> DOI: 10.1021/jm990358+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990358%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=236-249&author=T.+D.+Aicherauthor=R.+C.+Andersonauthor=J.+Gaoauthor=S.+S.+Shettyauthor=G.+M.+Coppolaauthor=J.+L.+Stantonauthor=D.+C.+Knorrauthor=D.+M.+Sperbeckauthor=L.+J.+Brandauthor=C.+C.+Vinluanauthor=E.+L.+Kaplanauthor=C.+J.+Draglandauthor=H.+C.+Tomaselliauthor=A.+Islamauthor=R.+J.+Lozitoauthor=X.+Liuauthor=W.+M.+Maniaraauthor=W.+S.+Fillersauthor=D.+DelGrandeauthor=R.+E.+Walterauthor=W.+R.+Mann&title=Secondary+amides+of+%28R%29-3%2C3%2C3-trifluoro-2-hydroxy-2-methylpropionic+acid+as+inhibitors+of+pyruvate+dehydrogenase+kinase&doi=10.1021%2Fjm990358%2B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm990358%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990358%252B%26sid%3Dliteratum%253Aachs%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DAnderson%26aufirst%3DR.%2BC.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DShetty%26aufirst%3DS.%2BS.%26aulast%3DCoppola%26aufirst%3DG.%2BM.%26aulast%3DStanton%26aufirst%3DJ.%2BL.%26aulast%3DKnorr%26aufirst%3DD.%2BC.%26aulast%3DSperbeck%26aufirst%3DD.%2BM.%26aulast%3DBrand%26aufirst%3DL.%2BJ.%26aulast%3DVinluan%26aufirst%3DC.%2BC.%26aulast%3DKaplan%26aufirst%3DE.%2BL.%26aulast%3DDragland%26aufirst%3DC.%2BJ.%26aulast%3DTomaselli%26aufirst%3DH.%2BC.%26aulast%3DIslam%26aufirst%3DA.%26aulast%3DLozito%26aufirst%3DR.%2BJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DManiara%26aufirst%3DW.%2BM.%26aulast%3DFillers%26aufirst%3DW.%2BS.%26aulast%3DDelGrande%26aufirst%3DD.%26aulast%3DWalter%26aufirst%3DR.%2BE.%26aulast%3DMann%26aufirst%3DW.%2BR.%26atitle%3DSecondary%2520amides%2520of%2520%2528R%2529-3%252C3%252C3-trifluoro-2-hydroxy-2-methylpropionic%2520acid%2520as%2520inhibitors%2520of%2520pyruvate%2520dehydrogenase%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D236%26epage%3D249%26doi%3D10.1021%2Fjm990358%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kim, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, C. V.</span><span> </span><span class="NLM_article-title">Cancer’s molecular sweet tooth and the Warburg effect</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">8927</span><span class="NLM_x">–</span> <span class="NLM_lpage">8930</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-06-1501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1158%2F0008-5472.CAN-06-1501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=16982728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1aitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=8927-8930&author=J.+W.+Kimauthor=C.+V.+Dang&title=Cancer%E2%80%99s+molecular+sweet+tooth+and+the+Warburg+effect&doi=10.1158%2F0008-5472.CAN-06-1501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer's Molecular Sweet Tooth and the Warburg Effect</span></div><div class="casAuthors">Kim, Jung-Whan; Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8927-8930</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  More than 80 years ago, the renowned biochemist Otto Warburg described how cancer cells avidly consume glucose and produce lactic acid under aerobic conditions.  Recent studies arguing that cancer cells benefit from this phenomenon, termed the Warburg effect, have renewed discussions about its exact role as cause, correlate, or facilitator of cancer.  Mol. advances in this area may reveal tactics to exploit the cancer cell's "sweet tooth" for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqohObedUNtO7Vg90H21EOLACvtfcHk0lg_o9qm8hRgkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1aitL4%253D&md5=96e33e46621768b0119cdfe08c3bd46a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-1501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-1501%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DCancer%25E2%2580%2599s%2520molecular%2520sweet%2520tooth%2520and%2520the%2520Warburg%2520effect%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D8927%26epage%3D8930%26doi%3D10.1158%2F0008-5472.CAN-06-1501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Warburg, O.</span><span> </span><span class="NLM_article-title">Uber den Stoffwechsel der Carcinomzelle</span> <span class="citation_source-journal">Klin. Wochenschr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1925</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span><span class="refDoi"> DOI: 10.1007/BF01726151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1007%2FBF01726151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADyaB2MXhvValsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1925&pages=534-536&author=O.+Warburg&title=Uber+den+Stoffwechsel+der+Carcinomzelle&doi=10.1007%2FBF01726151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The metabolism of carcinoma cells</span></div><div class="casAuthors">Warburg, Otto</div><div class="citationInfo"><span class="NLM_cas:title">Klinische Wochenschrift</span>
        (<span class="NLM_cas:date">1925</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">534-6</span>CODEN:
                <span class="NLM_cas:coden">KLWOAZ</span>;
        ISSN:<span class="NLM_cas:issn">0023-2173</span>.
    </div><div class="casAbstract">Carcinoma cells not only oxidize glucose but they convert (glucolysis) a large part of it into lactic acid (10-12% of their own wt. per hr.).  This differentiates them sharply from embryonic tissue and from resting and active epithelium.  The metabolism of carcinoma cells is predominantly glucolytic, subordinately oxidative.  The reverse is true of normal body cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvePgMrHSg6bVg90H21EOLACvtfcHk0lg_o9qm8hRgkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaB2MXhvValsg%253D%253D&md5=7bcae1fd77934207a87a16bcd9abb50a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2FBF01726151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01726151%26sid%3Dliteratum%253Aachs%26aulast%3DWarburg%26aufirst%3DO.%26atitle%3DUber%2520den%2520Stoffwechsel%2520der%2520Carcinomzelle%26jtitle%3DKlin.%2520Wochenschr.%26date%3D1925%26volume%3D4%26spage%3D534%26epage%3D536%26doi%3D10.1007%2FBF01726151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Kim, J. w.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchernyshyov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenza, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, C. V.</span><span> </span><span class="NLM_article-title">HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1016/j.cmet.2006.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1016%2Fj.cmet.2006.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=16517405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislyhtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=177-185&author=J.+w.+Kimauthor=I.+Tchernyshyovauthor=G.+L.+Semenzaauthor=C.+V.+Dang&title=HIF-1-mediated+expression+of+pyruvate+dehydrogenase+kinase%3A+a+metabolic+switch+required+for+cellular+adaptation+to+hypoxia&doi=10.1016%2Fj.cmet.2006.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia</span></div><div class="casAuthors">Kim, Jung-whan; Tchernyshyov, Irina; Semenza, Gregg L.; Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">177-185</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Activation of glycolytic genes by HIF-1 is considered crit. for metabolic adaptation to hypoxia through increased conversion of glucose to pyruvate and subsequently to lactate.  We found that HIF-1 also actively suppresses metab. through the tricarboxylic acid cycle (TCA) by directly trans-activating the gene encoding pyruvate dehydrogenase kinase 1 (PDK1).  PDK1 inactivates the TCA cycle enzyme, pyruvate dehydrogenase (PDH), which converts pyruvate to acetyl-CoA.  Forced PDK1 expression in hypoxic HIF-1α null cells increases ATP levels, attenuates hypoxic ROS generation, and rescues these cells from hypoxia-induced apoptosis.  These studies reveal a hypoxia-induced metabolic switch that shunts glucose metabolites from the mitochondria to glycolysis to maintain ATP prodn. and to prevent toxic ROS prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkmBOJaCXUx7Vg90H21EOLACvtfcHk0lg_o9qm8hRgkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislyhtrw%253D&md5=783b85071f8a48f5262ba9522d1715b0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2006.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2006.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2Bw.%26aulast%3DTchernyshyov%26aufirst%3DI.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DHIF-1-mediated%2520expression%2520of%2520pyruvate%2520dehydrogenase%2520kinase%253A%2520a%2520metabolic%2520switch%2520required%2520for%2520cellular%2520adaptation%2520to%2520hypoxia%26jtitle%3DCell%2520Metab.%26date%3D2006%26volume%3D3%26spage%3D177%26epage%3D185%26doi%3D10.1016%2Fj.cmet.2006.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, S.</span><span> </span><span class="NLM_article-title">Overexpression of pyruvate dehydrogenase kinase 3 increases drug resistance and early recurrence in colon cancer</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">1405</span><span class="NLM_x">–</span> <span class="NLM_lpage">1414</span><span class="refDoi"> DOI: 10.1016/j.ajpath.2011.05.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1016%2Fj.ajpath.2011.05.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=21763680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2jsb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2011&pages=1405-1414&author=C.+Luauthor=S.+Linauthor=C.+Chienauthor=S.+Linauthor=C.+Leeauthor=B.+Linauthor=J.+Leeauthor=S.+Tsai&title=Overexpression+of+pyruvate+dehydrogenase+kinase+3+increases+drug+resistance+and+early+recurrence+in+colon+cancer&doi=10.1016%2Fj.ajpath.2011.05.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of pyruvate dehydrpgenase kinase 3 increases drug resistance and early recurrence in colon cancer</span></div><div class="casAuthors">Lu, Chun-Wun; Lin, Shau-Chieh; Chien, Chun-Wei; Lin, Shih-Chieh; Lee, Chung-Ta; Lin, Bo-Wen; Lee, Jenq-Chang; Tsai, Shaw-Jenq</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1405-1414</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The switch of cellular metab. from mitochondrial respiration to glycolysis is the hallmark of cancer cells and is assocd. with tumor malignancy.  Pyruvate dehydrogenase kinase-1 (PDK1) and PDK3 participate in the metabolic switch of cancer cells; however, the medical significance of PDK1 and PDK3 in cancer progression is not known.  Here, we assessed the expression profiles of PDK1 and PDK3 in colorectal cancer.  Western blot anal. (n = 74) demonstrated that PDK3 was markedly increased in colon cancer compared to that in adjacent normal tissues, whereas PDK1 was decreased in cancer cells.  In addn., PDK3 expression was pos. correlated with that of hypoxia inducible factor-1α (HIF-1α) in cancer cells.  Further anal. using immunohistochem. staining revealed that PDK3 levels were pos. assocd. with severity of cancer and neg. assocd. with disease-free survival.  In vitro studies using several colon cancer cell lines showed that PDK3 expression was controlled by HIF-1α and contributed to hypoxia-induced increased drug resistance, perhaps explaining why patients with PDK3 overexpression have a greater incidence of treatment failure.  Taken together, our findings suggest that PDK3 plays an important role in the metabolic switch and drug resistance of colon cancer and is potentially a novel target for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQmjhmaIUuIrVg90H21EOLACvtfcHk0lgt4Mwn_H9-CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2jsb%252FI&md5=44cb57fc1b370446524ecaa0a5a0fa05</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2011.05.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2011.05.050%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DTsai%26aufirst%3DS.%26atitle%3DOverexpression%2520of%2520pyruvate%2520dehydrogenase%2520kinase%25203%2520increases%2520drug%2520resistance%2520and%2520early%2520recurrence%2520in%2520colon%2520cancer%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2011%26volume%3D179%26spage%3D1405%26epage%3D1414%26doi%3D10.1016%2Fj.ajpath.2011.05.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">McFate, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohyeldin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriques, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halim, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teahan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Califano, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeoung, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, A.</span><span> </span><span class="NLM_article-title">Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">22700</span><span class="NLM_x">–</span> <span class="NLM_lpage">22708</span><span class="refDoi"> DOI: 10.1074/jbc.M801765200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1074%2Fjbc.M801765200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=22700-22708&author=T.+McFateauthor=A.+Mohyeldinauthor=H.+Luauthor=J.+Thakarauthor=J.+Henriquesauthor=N.+D.+Halimauthor=H.+Wuauthor=M.+J.+Schellauthor=T.+M.+Tsangauthor=O.+Teahanauthor=S.+Zhouauthor=J.+A.+Califanoauthor=N.+H.+Jeoungauthor=R.+A.+Harrisauthor=A.+Verma&title=Pyruvate+dehydrogenase+complex+activity+controls+metabolic+and+malignant+phenotype+in+cancer+cells&doi=10.1074%2Fjbc.M801765200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M801765200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M801765200%26sid%3Dliteratum%253Aachs%26aulast%3DMcFate%26aufirst%3DT.%26aulast%3DMohyeldin%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DThakar%26aufirst%3DJ.%26aulast%3DHenriques%26aufirst%3DJ.%26aulast%3DHalim%26aufirst%3DN.%2BD.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DSchell%26aufirst%3DM.%2BJ.%26aulast%3DTsang%26aufirst%3DT.%2BM.%26aulast%3DTeahan%26aufirst%3DO.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DCalifano%26aufirst%3DJ.%2BA.%26aulast%3DJeoung%26aufirst%3DN.%2BH.%26aulast%3DHarris%26aufirst%3DR.%2BA.%26aulast%3DVerma%26aufirst%3DA.%26atitle%3DPyruvate%2520dehydrogenase%2520complex%2520activity%2520controls%2520metabolic%2520and%2520malignant%2520phenotype%2520in%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D22700%26epage%3D22708%26doi%3D10.1074%2Fjbc.M801765200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Papandreou, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontana, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denko, N. C.</span><span> </span><span class="NLM_article-title">HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span><span class="refDoi"> DOI: 10.1016/j.cmet.2006.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1016%2Fj.cmet.2006.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=16517406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislyhtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=187-197&author=I.+Papandreouauthor=R.+A.+Cairnsauthor=L.+Fontanaauthor=A.+L.+Limauthor=N.+C.+Denko&title=HIF-1+mediates+adaptation+to+hypoxia+by+actively+downregulating+mitochondrial+oxygen+consumption&doi=10.1016%2Fj.cmet.2006.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption</span></div><div class="casAuthors">Papandreou, Ioanna; Cairns, Rob A.; Fontana, Lucrezia; Lim, Ai Lin; Denko, Nicholas C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-197</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The HIF-1 transcription factor drives hypoxic gene expression changes that are thought to be adaptive for cells exposed to a reduced-oxygen environment.  For example, HIF-1 induces the expression of glycolytic genes.  It is presumed that increased glycolysis is necessary to produce energy when low oxygen will not support oxidative phosphorylation at the mitochondria.  However, we find that while HIF-1 stimulates glycolysis, it also actively represses mitochondrial function and oxygen consumption by inducing pyruvate dehydrogenase kinase 1 (PDK1).  PDK1 phosphorylates and inhibits pyruvate dehydrogenase from using pyruvate to fuel the mitochondrial TCA cycle.  This causes a drop in mitochondrial oxygen consumption and results in a relative increase in intracellular oxygen tension.  We show by genetic means that HIF-1-dependent block to oxygen utilization results in increased oxygen availability, decreased cell death when total oxygen is limiting, and reduced cell death in response to the hypoxic cytotoxin tirapazamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohIkKC5qqbwLVg90H21EOLACvtfcHk0lgt4Mwn_H9-CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislyhtr0%253D&md5=1e6d9a6dcf39366211043e1f37cd9716</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2006.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2006.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DPapandreou%26aufirst%3DI.%26aulast%3DCairns%26aufirst%3DR.%2BA.%26aulast%3DFontana%26aufirst%3DL.%26aulast%3DLim%26aufirst%3DA.%2BL.%26aulast%3DDenko%26aufirst%3DN.%2BC.%26atitle%3DHIF-1%2520mediates%2520adaptation%2520to%2520hypoxia%2520by%2520actively%2520downregulating%2520mitochondrial%2520oxygen%2520consumption%26jtitle%3DCell%2520Metab.%26date%3D2006%26volume%3D3%26spage%3D187%26epage%3D197%26doi%3D10.1016%2Fj.cmet.2006.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Wigfield, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giatromanolaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koukourakis, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. L.</span><span> </span><span class="NLM_article-title">PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">1975</span><span class="NLM_x">–</span> <span class="NLM_lpage">1984</span><span class="refDoi"> DOI: 10.1038/sj.bjc.6604356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1038%2Fsj.bjc.6604356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=18542064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvV2ht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2008&pages=1975-1984&author=S.+M.+Wigfieldauthor=S.+C.+Winterauthor=A.+Giatromanolakiauthor=J.+Taylorauthor=M.+L.+Koukourakisauthor=A.+L.+Harris&title=PDK-1+regulates+lactate+production+in+hypoxia+and+is+associated+with+poor+prognosis+in+head+and+neck+squamous+cancer&doi=10.1038%2Fsj.bjc.6604356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer</span></div><div class="casAuthors">Wigfield, S. M.; Winter, S. C.; Giatromanolaki, A.; Taylor, J.; Koukourakis, M. L.; Harris, A. L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1975-1984</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Here we describe the expression and function of a HIF-1-regulated protein pyruvate dehydrogenase kinase-1 (PDK-1) in head and neck squamous cancer (HNSCC).  Using RNAi to downregulate hypoxia-inducible PDK-1, we found that lactate and pyruvate excretion after 16-48 h of hypoxia was suppressed to normoxic levels.  This indicates that PDK-1 plays an important role in maintaining glycolysis.  Knockdown had no effect on proliferation or survival under hypoxia.  The immunohistochem. expression of PDK-1 was assessed in 140 cases of HNSCC.  PDK-1 expression was not expressed in normal tissues but was upregulated in HNSCC and found to be predominantly cytoplasmic with occasional strong focal nuclear expression.  It was strongly related to poor outcome (P=0.005 split by median).  These results indicate that HIF regulation of PDK-1 has a key role in maintaining lactate prodn. in human cancer and that the investigation of PDK-1 inhibitors should be investigated for antitumor effects.  British Journal of Cancer (2008) 98, 1975-1984. doi:10.1038/sj.bjc.6604356 www.bjcancer.com Published online 10 June 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMry8iR1mdVbVg90H21EOLACvtfcHk0lgt4Mwn_H9-CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvV2ht7s%253D&md5=fb7ee783af4d76335fc6e307140a67fe</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604356%26sid%3Dliteratum%253Aachs%26aulast%3DWigfield%26aufirst%3DS.%2BM.%26aulast%3DWinter%26aufirst%3DS.%2BC.%26aulast%3DGiatromanolaki%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DKoukourakis%26aufirst%3DM.%2BL.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DPDK-1%2520regulates%2520lactate%2520production%2520in%2520hypoxia%2520and%2520is%2520associated%2520with%2520poor%2520prognosis%2520in%2520head%2520and%2520neck%2520squamous%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2008%26volume%3D98%26spage%3D1975%26epage%3D1984%26doi%3D10.1038%2Fsj.bjc.6604356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Stacpoole, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornhauser, D. M.</span><span> </span><span class="NLM_article-title">Metabolic effects of dichloroacetate in patients with diabetes mellitus and hyperlipoproteinemia</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">526</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span><span class="refDoi"> DOI: 10.1056/NEJM197803092981002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1056%2FNEJM197803092981002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=625308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADyaE1cXhvVeisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=1978&pages=526-530&author=P.+W.+Stacpooleauthor=G.+W.+Mooreauthor=D.+M.+Kornhauser&title=Metabolic+effects+of+dichloroacetate+in+patients+with+diabetes+mellitus+and+hyperlipoproteinemia&doi=10.1056%2FNEJM197803092981002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic effects of dichloroacetate in patients with diabetes mellitus and hyperlipoproteinemia</span></div><div class="casAuthors">Stacpoole, Peter W.; Moore, George W.; Kornhauser, David M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">526-30</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">Oral administration of 3-4 g Na dichloroacetate (I) [2156-56-1]/day for 3 days decreased fasting hyperglycemia and plasma lactate [50-21-5] and alanine [56-41-7] levels in subjects with diabetes and (or) hyperlipoproteinemia.  I also decreased plasma cholesterol [57-88-5] and triglycerides and slightly increased plasma ketone bodies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcjrs4BUDDr7Vg90H21EOLACvtfcHk0lgOgpUw9GnWyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhvVeisLc%253D&md5=d7b98e86a8026f8f995eb7a77aa61b04</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1056%2FNEJM197803092981002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM197803092981002%26sid%3Dliteratum%253Aachs%26aulast%3DStacpoole%26aufirst%3DP.%2BW.%26aulast%3DMoore%26aufirst%3DG.%2BW.%26aulast%3DKornhauser%26aufirst%3DD.%2BM.%26atitle%3DMetabolic%2520effects%2520of%2520dichloroacetate%2520in%2520patients%2520with%2520diabetes%2520mellitus%2520and%2520hyperlipoproteinemia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1978%26volume%3D298%26spage%3D526%26epage%3D530%26doi%3D10.1056%2FNEJM197803092981002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Abdelmalak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramezani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shroads, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coats, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langaee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankar, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neiberger, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramony, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stacpoole, P. W.</span><span> </span><span class="NLM_article-title">Long-term safety of dichloroacetate in congenital lactic acidosis</span> <span class="citation_source-journal">Mol. Genet. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span><span class="refDoi"> DOI: 10.1016/j.ymgme.2013.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1016%2Fj.ymgme.2013.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=23611579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt12ju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2013&pages=139-143&author=M.+Abdelmalakauthor=A.+Lewauthor=R.+Ramezaniauthor=A.+L.+Shroadsauthor=B.+S.+Coatsauthor=T.+Langaeeauthor=M.+N.+Shankarauthor=R.+E.+Neibergerauthor=S.+H.+Subramonyauthor=P.+W.+Stacpoole&title=Long-term+safety+of+dichloroacetate+in+congenital+lactic+acidosis&doi=10.1016%2Fj.ymgme.2013.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term safety of dichloroacetate in congenital lactic acidosis</span></div><div class="casAuthors">Abdelmalak, Monica; Lew, Alicia; Ramezani, Ryan; Shroads, Albert L.; Coats, Bonnie S.; Langaee, Taimour; Shankar, Meena N.; Neiberger, Richard E.; Subramony, S. H.; Stacpoole, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Genetics and Metabolism</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-143</span>CODEN:
                <span class="NLM_cas:coden">MGMEFF</span>;
        ISSN:<span class="NLM_cas:issn">1096-7192</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We followed 8 patients (4 males) with biochem. and/or mol. genetically proven deficiencies of the E1α subunit of the pyruvate dehydrogenase complex (PDC; 3 patients) or respiratory chain complexes I (1 patient), IV (3 patients) or I + IV (1 patient) who received oral dichloroacetate (DCA; 12.5 mg/kg/12 h) for 9.7 to 16.5 years.  All subjects originally participated in randomized controlled trials of DCA and were continued on an open-label chronic safety study.  Patients (1 adult) ranged in age from 3.5 to 40.2 years at the start of DCA administration and are currently aged 16.9 to 49.9 years (mean ± SD: 23.5 ± 10.9 years).  Subjects were either normal or below normal body wt. for age and gender.  The 3 PDC deficient patients did not consume high fat (ketogenic) diets.  DCA maintained normal blood lactate concns., even in PDC deficient children on essentially unrestricted diets.  Hematol., electrolyte, renal and hepatic status remained stable.  Nerve conduction either did not change or decreased modestly and led to redn. or temporary discontinuation of DCA in 3 patients, although symptomatic worsening of peripheral neuropathy did not occur.  We conclude that chronic DCA administration is generally well-tolerated in patients with congenital causes of lactic acidosis and is effective in maintaining normal blood lactate levels, even in PDC-deficient children not consuming strict ketogenic diets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp26R7P5zGnwLVg90H21EOLACvtfcHk0lgOgpUw9GnWyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt12ju7o%253D&md5=ab1d2158d9c3fb5cba8ec7a444de419f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ymgme.2013.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymgme.2013.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DAbdelmalak%26aufirst%3DM.%26aulast%3DLew%26aufirst%3DA.%26aulast%3DRamezani%26aufirst%3DR.%26aulast%3DShroads%26aufirst%3DA.%2BL.%26aulast%3DCoats%26aufirst%3DB.%2BS.%26aulast%3DLangaee%26aufirst%3DT.%26aulast%3DShankar%26aufirst%3DM.%2BN.%26aulast%3DNeiberger%26aufirst%3DR.%2BE.%26aulast%3DSubramony%26aufirst%3DS.%2BH.%26aulast%3DStacpoole%26aufirst%3DP.%2BW.%26atitle%3DLong-term%2520safety%2520of%2520dichloroacetate%2520in%2520congenital%2520lactic%2520acidosis%26jtitle%3DMol.%2520Genet.%2520Metab.%26date%3D2013%26volume%3D109%26spage%3D139%26epage%3D143%26doi%3D10.1016%2Fj.ymgme.2013.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Bersin, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stacpoole, P. W.</span><span> </span><span class="NLM_article-title">Dichloroacetate as metabolic therapy for myocardial ischemia and failure</span> <span class="citation_source-journal">Am. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span><span class="refDoi"> DOI: 10.1016/S0002-8703(97)80007-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1016%2FS0002-8703%2897%2980007-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=1997&pages=841-855&author=R.+M.+Bersinauthor=P.+W.+Stacpoole&title=Dichloroacetate+as+metabolic+therapy+for+myocardial+ischemia+and+failure&doi=10.1016%2FS0002-8703%2897%2980007-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0002-8703%2897%2980007-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-8703%252897%252980007-5%26sid%3Dliteratum%253Aachs%26aulast%3DBersin%26aufirst%3DR.%2BM.%26aulast%3DStacpoole%26aufirst%3DP.%2BW.%26atitle%3DDichloroacetate%2520as%2520metabolic%2520therapy%2520for%2520myocardial%2520ischemia%2520and%2520failure%26jtitle%3DAm.%2520Heart%2520J.%26date%3D1997%26volume%3D134%26spage%3D841%26epage%3D855%26doi%3D10.1016%2FS0002-8703%2897%2980007-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Sutendra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelakis, E. D.</span><span> </span><span class="NLM_article-title">Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology</span> <span class="citation_source-journal">Front. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="refDoi"> DOI: 10.3389/fonc.2013.00038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.3389%2Ffonc.2013.00038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=23471124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A280%3ADC%252BC3svksVWnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=38&author=G.+Sutendraauthor=E.+D.+Michelakis&title=Pyruvate+dehydrogenase+kinase+as+a+novel+therapeutic+target+in+oncology&doi=10.3389%2Ffonc.2013.00038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology</span></div><div class="casAuthors">Sutendra Gopinath; Michelakis Evangelos D</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">38</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Current drug development in oncology is non-selective as it typically focuses on pathways essential for the survival of all dividing cells.  The unique metabolic profile of cancer, which is characterized by increased glycolysis and suppressed mitochondrial glucose oxidation (GO) provides cancer cells with a proliferative advantage, conducive with apoptosis resistance and even increased angiogenesis.  Recent evidence suggests that targeting the cancer-specific metabolic and mitochondrial remodeling may offer selectivity in cancer treatment.  Pyruvate dehydrogenase kinase (PDK) is a mitochondrial enzyme that is activated in a variety of cancers and results in the selective inhibition of pyruvate dehydrogenase, a complex of enzymes that converts cytosolic pyruvate to mitochondrial acetyl-CoA, the substrate for the Krebs' cycle.  Inhibition of PDK with either small interfering RNAs or the orphan drug dichloroacetate (DCA) shifts the metabolism of cancer cells from glycolysis to GO and reverses the suppression of mitochondria-dependent apoptosis.  In addition, this therapeutic strategy increases the production of diffusible Krebs' cycle intermediates and mitochondria-derived reactive oxygen species, activating p53 or inhibiting pro-proliferative and pro-angiogenic transcription factors like nuclear factor of activated T cells and hypoxia-inducible factor 1α.  These effects result in decreased tumor growth and angiogenesis in a variety of cancers with high selectivity.  In a small but mechanistic clinical trial in patients with glioblastoma, a highly aggressive and vascular form of brain cancer, DCA decreased tumor angiogenesis and tumor growth, suggesting that metabolic-targeting therapies can be translated directly to patients.  More recently, the M2 isoform of pyruvate kinase (PKM2), which is highly expressed in cancer, is associated with suppressed mitochondrial function.  Similar to DCA, activation of PKM2 in many cancers results in increased mitochondrial function and decreased tumor growth.  Therefore, reversing the mitochondrial suppression with metabolic-modulating drugs, like PDK inhibitors or PKM2 activators holds promise in the rapidly expanding field of metabolic oncology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAv468BxBUDmBAiYWy6n3SfW6udTcc2eYdTqDmcd41ibntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svksVWnsg%253D%253D&md5=8a28a9f69bd677139d94ab1ae15721fb</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2013.00038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2013.00038%26sid%3Dliteratum%253Aachs%26aulast%3DSutendra%26aufirst%3DG.%26aulast%3DMichelakis%26aufirst%3DE.%2BD.%26atitle%3DPyruvate%2520dehydrogenase%2520kinase%2520as%2520a%2520novel%2520therapeutic%2520target%2520in%2520oncology%26jtitle%3DFront.%2520Oncol.%26date%3D2013%26volume%3D3%26spage%3D38%26doi%3D10.3389%2Ffonc.2013.00038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Michelakis, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, J. R.</span><span> </span><span class="NLM_article-title">Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">989</span><span class="NLM_x">–</span> <span class="NLM_lpage">994</span><span class="refDoi"> DOI: 10.1038/sj.bjc.6604554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1038%2Fsj.bjc.6604554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=18766181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFyqt7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=989-994&author=E.+D.+Michelakisauthor=L.+Websterauthor=J.+R.+Mackey&title=Dichloroacetate+%28DCA%29+as+a+potential+metabolic-targeting+therapy+for+cancer&doi=10.1038%2Fsj.bjc.6604554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer</span></div><div class="casAuthors">Michelakis, E. D.; Webster, L.; Mackey, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">989-994</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The unique metab. of most solid tumors (aerobic glycolysis, i.e., Warburg effect) is not only the basis of diagnosing cancer with metabolic imaging but might also be assocd. with the resistance to apoptosis that characterizes cancer.  The glycolytic phenotype in cancer appears to be the common denominator of diverse mol. abnormalities in cancer and may be assocd. with a (potentially reversible) suppression of mitochondrial function.  The generic drug dichloroacetate is an orally available small mol. that, by inhibiting the pyruvate dehydrogenase kinase, increases the flux of pyruvate into the mitochondria, promoting glucose oxidn. over glycolysis.  This reverses the suppressed mitochondrial apoptosis in cancer and results in suppression of tumor growth in vitro and in vivo.  Here, we review the scientific and clin. rationale supporting the rapid translation of this promising metabolic modulator in early-phase cancer clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYBltOSIrw3bVg90H21EOLACvtfcHk0ljnPB-r7eqjkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFyqt7vN&md5=2b08b0b34ca23ba50fb22cf49e8c0544</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604554%26sid%3Dliteratum%253Aachs%26aulast%3DMichelakis%26aufirst%3DE.%2BD.%26aulast%3DWebster%26aufirst%3DL.%26aulast%3DMackey%26aufirst%3DJ.%2BR.%26atitle%3DDichloroacetate%2520%2528DCA%2529%2520as%2520a%2520potential%2520metabolic-targeting%2520therapy%2520for%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2008%26volume%3D99%26spage%3D989%26epage%3D994%26doi%3D10.1038%2Fsj.bjc.6604554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Michelakis, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutendra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dromparis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haromy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niven, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gammer, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdulkarim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMurtry, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petruk, K. C.</span><span> </span><span class="NLM_article-title">Metabolic modulation of glioblastoma with dichloroacetate</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3000677</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1126%2Fscitranslmed.3000677" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=31-34&author=E.+D.+Michelakisauthor=G.+Sutendraauthor=P.+Dromparisauthor=L.+Websterauthor=A.+Haromyauthor=E.+Nivenauthor=C.+Maguireauthor=T.+L.+Gammerauthor=J.+R.+Mackeyauthor=D.+Fultonauthor=B.+Abdulkarimauthor=M.+S.+McMurtryauthor=K.+C.+Petruk&title=Metabolic+modulation+of+glioblastoma+with+dichloroacetate&doi=10.1126%2Fscitranslmed.3000677"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3000677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3000677%26sid%3Dliteratum%253Aachs%26aulast%3DMichelakis%26aufirst%3DE.%2BD.%26aulast%3DSutendra%26aufirst%3DG.%26aulast%3DDromparis%26aufirst%3DP.%26aulast%3DWebster%26aufirst%3DL.%26aulast%3DHaromy%26aufirst%3DA.%26aulast%3DNiven%26aufirst%3DE.%26aulast%3DMaguire%26aufirst%3DC.%26aulast%3DGammer%26aufirst%3DT.%2BL.%26aulast%3DMackey%26aufirst%3DJ.%2BR.%26aulast%3DFulton%26aufirst%3DD.%26aulast%3DAbdulkarim%26aufirst%3DB.%26aulast%3DMcMurtry%26aufirst%3DM.%2BS.%26aulast%3DPetruk%26aufirst%3DK.%2BC.%26atitle%3DMetabolic%2520modulation%2520of%2520glioblastoma%2520with%2520dichloroacetate%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2010%26volume%3D2%26spage%3D31%26epage%3D34%26doi%3D10.1126%2Fscitranslmed.3000677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Stacpoole, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornhauser, D. M.</span><span> </span><span class="NLM_article-title">Toxicity of chronic dichloroacetate</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">300</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="refDoi"> DOI: 10.1056/NEJM197902153000726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1056%2FNEJM197902153000726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=215910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A280%3ADyaE1M%252Fptl2jsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=1979&pages=372&author=P.+W.+Stacpooleauthor=G.+W.+Mooreauthor=D.+M.+Kornhauser&title=Toxicity+of+chronic+dichloroacetate&doi=10.1056%2FNEJM197902153000726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity of chronic dichloroacetate</span></div><div class="casAuthors">Stacpoole P W; Moore G W; Kornhauser D M</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">300</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">372</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTsOA6VwfoPtO98rul4nhSdfW6udTcc2eYdTqDmcd41ibntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE1M%252Fptl2jsA%253D%253D&md5=36db9003ceea21ee311c58915ff32ca4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1056%2FNEJM197902153000726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM197902153000726%26sid%3Dliteratum%253Aachs%26aulast%3DStacpoole%26aufirst%3DP.%2BW.%26aulast%3DMoore%26aufirst%3DG.%2BW.%26aulast%3DKornhauser%26aufirst%3DD.%2BM.%26atitle%3DToxicity%2520of%2520chronic%2520dichloroacetate%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1979%26volume%3D300%26spage%3D372%26doi%3D10.1056%2FNEJM197902153000726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Knoechel, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bungay, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasten, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. G.</span><span> </span><span class="NLM_article-title">Regulatory roles of the N-terminal domain based on crystal structures of human Pyruvate Dehydrogenase Kinase 2 containing physiological and synthetic ligands</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span><span class="refDoi"> DOI: 10.1021/bi051402s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi051402s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlajtr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=402-415&author=T.+R.+Knoechelauthor=A.+D.+Tuckerauthor=C.+M.+Robinsonauthor=C.+Phillipsauthor=W.+Taylorauthor=P.+J.+Bungayauthor=S.+A.+Kastenauthor=T.+E.+Rocheauthor=D.+G.+Brown&title=Regulatory+roles+of+the+N-terminal+domain+based+on+crystal+structures+of+human+Pyruvate+Dehydrogenase+Kinase+2+containing+physiological+and+synthetic+ligands&doi=10.1021%2Fbi051402s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Regulatory Roles of the N-Terminal Domain Based on Crystal Structures of Human Pyruvate Dehydrogenase Kinase 2 Containing Physiological and Synthetic Ligands</span></div><div class="casAuthors">Knoechel, Thorsten R.; Tucker, Alec D.; Robinson, Colin M.; Phillips, Chris; Taylor, Wendy; Bungay, Peter J.; Kasten, Shane A.; Roche, Thomas E.; Brown, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">402-415</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinase (PDHK) regulates the activity of the pyruvate dehydrogenase multienzyme complex.  PDHK inhibition provides a route for therapeutic intervention in diabetes and cardiovascular disorders.  We report crystal structures of human PDHK isoenzyme 2 (PDHK2) complexed with physiol. and synthetic ligands.  Several of the PDHK2 structures disclosed have C-terminal cross arms that span a large trough region between the N-terminal regulatory (R) domains of the PDHK2 dimers.  The structures contg. bound ATP and ADP demonstrate variation in the conformation of the active site lid, residues 316-321, which enclose the nucleotide β and γ phosphates at the active site in the C-terminal catalytic domain.  We have identified three novel ligand binding sites located in the R domain of PDHK2.  Dichloroacetate (DCA) binds at the pyruvate binding site in the center of the R domain, which together with ADP, induces significant changes at the active site.  Nov3r and AZ12 inhibitors bind at the lipoamide binding site that is located at one end of the R domain.  Pfz3 (an allosteric inhibitor) binds in an extended site at the other end of the R domain.  We conclude that the N-terminal domain of PDHK has a key regulatory function and propose that the different inhibitor classes act by discrete mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI0BAYhcMgn7Vg90H21EOLACvtfcHk0lizCzLDLY7Y7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlajtr7L&md5=62e6162ff1191e7b5ae88014dcb71830</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fbi051402s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi051402s%26sid%3Dliteratum%253Aachs%26aulast%3DKnoechel%26aufirst%3DT.%2BR.%26aulast%3DTucker%26aufirst%3DA.%2BD.%26aulast%3DRobinson%26aufirst%3DC.%2BM.%26aulast%3DPhillips%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DW.%26aulast%3DBungay%26aufirst%3DP.%2BJ.%26aulast%3DKasten%26aufirst%3DS.%2BA.%26aulast%3DRoche%26aufirst%3DT.%2BE.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26atitle%3DRegulatory%2520roles%2520of%2520the%2520N-terminal%2520domain%2520based%2520on%2520crystal%2520structures%2520of%2520human%2520Pyruvate%2520Dehydrogenase%2520Kinase%25202%2520containing%2520physiological%2520and%2520synthetic%2520ligands%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D402%26epage%3D415%26doi%3D10.1021%2Fbi051402s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Kato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, D. T.</span><span> </span><span class="NLM_article-title">Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">992</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span><span class="refDoi"> DOI: 10.1016/j.str.2007.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1016%2Fj.str.2007.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=17683942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFyjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=992-1004&author=M.+Katoauthor=J.+Liauthor=J.+L.+Chuangauthor=D.+T.+Chuang&title=Distinct+structural+mechanisms+for+inhibition+of+pyruvate+dehydrogenase+kinase+isoforms+by+AZD7545%2C+dichloroacetate%2C+and+radicicol&doi=10.1016%2Fj.str.2007.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct Structural Mechanisms for Inhibition of Pyruvate Dehydrogenase Kinase Isoforms by AZD7545, Dichloroacetate, and Radicicol</span></div><div class="casAuthors">Kato, Masato; Li, Jun; Chuang, Jacinta L.; Chuang, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">992-1004</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinase (PDK) isoforms are mol. switches that downregulate the pyruvate dehydrogenase complex (PDC) by reversible phosphorylation in mitochondria.  We have detd. structures of human PDK1 or PDK3 bound to the inhibitors AZD7545, dichloroacetate (DCA), and radicicol.  We show that the trifluoromethylpropanamide end of AZD7545 projects into the lipoyl-binding pocket of PDK1.  This interaction results in inhibition of PDK1 and PDK3 activities by aborting kinase binding to the PDC scaffold.  Paradoxically, AZD7545 at satg. concns. robustly increases scaffold-free PDK3 activity, similar to the inner lipoyl domain.  Good DCA d. is present in the helix bundle in the N-terminal domain of PDK1.  Bound DCA promotes local conformational changes that are communicated to both nucleotide-binding and lipoyl-binding pockets of PDK1, leading to the inactivation of kinase activity. Finally, radicicol inhibits kinase activity by binding directly to the ATP-binding pocket of PDK3, similar to Hsp90 and Topo VI from the same ATPase/kinase superfamily.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCpzfnlsNVarVg90H21EOLACvtfcHk0lizCzLDLY7Y7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFyjsbo%253D&md5=3efc7e8b434566932ef28ca3486c401a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2007.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2007.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChuang%26aufirst%3DJ.%2BL.%26aulast%3DChuang%26aufirst%3DD.%2BT.%26atitle%3DDistinct%2520structural%2520mechanisms%2520for%2520inhibition%2520of%2520pyruvate%2520dehydrogenase%2520kinase%2520isoforms%2520by%2520AZD7545%252C%2520dichloroacetate%252C%2520and%2520radicicol%26jtitle%3DStructure%26date%3D2007%26volume%3D15%26spage%3D992%26epage%3D1004%26doi%3D10.1016%2Fj.str.2007.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Delmotte, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delmotte-Plaque, J.</span><span> </span><span class="NLM_article-title">A new antifungal substance of fungal origin</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1953</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span><span class="refDoi"> DOI: 10.1038/171344a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1038%2F171344a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=1953&pages=344&author=P.+Delmotteauthor=J.+Delmotte-Plaque&title=A+new+antifungal+substance+of+fungal+origin&doi=10.1038%2F171344a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2F171344a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F171344a0%26sid%3Dliteratum%253Aachs%26aulast%3DDelmotte%26aufirst%3DP.%26aulast%3DDelmotte-Plaque%26aufirst%3DJ.%26atitle%3DA%2520new%2520antifungal%2520substance%2520of%2520fungal%2520origin%26jtitle%3DNature%26date%3D1953%26volume%3D171%26spage%3D344%26doi%3D10.1038%2F171344a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Soga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiotsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. V.</span><span> </span><span class="NLM_article-title">Development of radicicol analogues</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span><span class="refDoi"> DOI: 10.2174/1568009033481859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.2174%2F1568009033481859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=14529387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2is74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=359-369&author=S.+Sogaauthor=Y.+Shiotsuauthor=S.+Akinagaauthor=S.+V.+Sharma&title=Development+of+radicicol+analogues&doi=10.2174%2F1568009033481859"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Development of radicicol analogues</span></div><div class="casAuthors">Soga, Shiro; Shiotsu, Yukimasa; Akinaga, Shiro; Sharma, Sreenath V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">359-369</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Radicicol, a macrocyclic antibiotic produced by fungi, was originally isolated many years ago, and was described as tyrosine kinase inhibitor.  We also rediscovered radicicol as an inhibitor of signal transduction of oncogene products, such as K-ras and v-Src, using yeast and mammalian cell-based assays.  In a study of mechanisms of action, it was revealed that radicicol depletes the Hsp90 client signaling mols. in cells, and thus inhibit the signal transduction pathway.  In addn., direct binding of radicicol to the N-terminal ATP/ADP binding site of Hsp90 was shown, and thus radicicol has been recognized as a structurally unique antibiotic that binds and inhibits the mol. chaperone Hsp90.  Although radicicol itself has little or no activity in animals because of instability in animals, its oxime derivs. showed potent antitumor activities against human tumor xenograft models.  Hsp90 client proteins were depleted and apoptosis was induced in the tumor specimen treated with radicicol oxime derivs.  Taken together, these results suggest that the antitumor activity of radicicol oxime derivs. is mediated by binding to Hsp90 and destabilization of Hsp90 client proteins in the tumor.  Among Hsp90 clients, we focused on ErbB2 and Bcr-Abl as examples of important targets of Hsp90 inhibitors.  Radicicol oxime showed potent antitumor activity against ER neg./ErbB2 overexpressing breast cancer and Bcr-Abl expressing CML.  Putative mechanisms of action and future directions of radicicol oxime against these kinds of tumor are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-uapkd0TYQrVg90H21EOLACvtfcHk0lizCzLDLY7Y7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2is74%253D&md5=59ef4ec5535cec06665a164be0b12305</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F1568009033481859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009033481859%26sid%3Dliteratum%253Aachs%26aulast%3DSoga%26aufirst%3DS.%26aulast%3DShiotsu%26aufirst%3DY.%26aulast%3DAkinaga%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DS.%2BV.%26atitle%3DDevelopment%2520of%2520radicicol%2520analogues%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2003%26volume%3D3%26spage%3D359%26epage%3D369%26doi%3D10.2174%2F1568009033481859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgognoni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N. G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northfield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walmsley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span> </span><span class="NLM_article-title">4,5-Diarylisoxazole hsp90 chaperone inhibitors: Potential therapeutic agents for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span><span class="refDoi"> DOI: 10.1021/jm701018h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701018h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWqsL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=196-218&author=P.+A.+Broughauthor=W.+Aherneauthor=X.+Barrilauthor=J.+Borgognoniauthor=K.+Boxallauthor=J.+E.+Cansfieldauthor=K.+M.+Cheungauthor=I.+Collinsauthor=N.+G.+M.+Daviesauthor=M.+J.+Drysdaleauthor=B.+Dymockauthor=S.+A.+Ecclesauthor=H.+Finchauthor=A.+Finkauthor=A.+Hayesauthor=R.+Howesauthor=R.+E.+Hubbardauthor=K.+Jamesauthor=A.+M.+Jordanauthor=A.+Lockieauthor=V.+Martinsauthor=A.+Masseyauthor=T.+P.+Matthewsauthor=E.+McDonaldauthor=C.+J.+Northfieldauthor=L.+H.+Pearlauthor=C.+Prodromouauthor=S.+Rayauthor=F.+I.+Raynaudauthor=S.+D.+Roughleyauthor=S.+Y.+Sharpauthor=A.+Surgenorauthor=D.+L.+Walmsleyauthor=P.+Webbauthor=M.+Woodauthor=P.+Workmanauthor=L.+Wright&title=4%2C5-Diarylisoxazole+hsp90+chaperone+inhibitors%3A+Potential+therapeutic+agents+for+the+treatment+of+cancer&doi=10.1021%2Fjm701018h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer</span></div><div class="casAuthors">Brough, Paul A.; Aherne, Wynne; Barril, Xavier; Borgognoni, Jennifer; Boxall, Kathy; Cansfield, Julie E.; Cheung, Kwai-Ming J.; Collins, Ian; Davies, Nicholas G. M.; Drysdale, Martin J.; Dymock, Brian; Eccles, Suzanne A.; Finch, Harry; Fink, Alexandra; Hayes, Angela; Howes, Robert; Hubbard, Roderick E.; James, Karen; Jordan, Allan M.; Lockie, Andrea; Martins, Vanessa; Massey, Andrew; Matthews, Thomas P.; McDonald, Edward; Northfield, Christopher J.; Pearl, Laurence H.; Prodromou, Chrisostomos; Ray, Stuart; Raynaud, Florence I.; Roughley, Stephen D.; Sharp, Swee Y.; Surgenor, Allan; Walmsley, D. Lee; Webb, Paul; Wood, Mike; Workman, Paul; Wright, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">196-218</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the Hsp90 [heat shock protein 90] mol. chaperone show considerable promise as potential chemotherapeutic agents for cancer.  The structure-based design, synthesis, structure-activity relationships, and pharmacokinetics of potent small-mol. inhibitors of Hsp90 based on the 4,5-diarylisoxazole scaffold were studied.  Analogs from this series have high affinity for Hsp90, as measured in a fluorescence polarization competitive binding assay, and are active in cancer cell lines where they inhibit proliferation and exhibit a characteristic profile of depletion of oncogenic proteins and concomitant elevation of Hsp72.  The [(morpholinomethyl)phenyl]isoxazolecarboxamide I (VER-52296/NVP-AUY922) is potent in the Hsp90 FP binding assay and inhibits proliferation of various human cancer cell lines in vitro, with GI50 averaging 9 nM.  I is retained in tumors in vivo when administered i.p., as evaluated by cassette dosing in tumor-bearing mice.  In a human colon cancer xenograft model, I inhibits tumor growth by ∼50%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTNA9AoWb8gLVg90H21EOLACvtfcHk0liMkhYltZ5iYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWqsL%252FK&md5=fdb98dec600987e862b9b05555427948</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm701018h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701018h%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DDavies%26aufirst%3DN.%2BG.%2BM.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFinch%26aufirst%3DH.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DLockie%26aufirst%3DA.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWalmsley%26aufirst%3DD.%2BL.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26atitle%3D4%252C5-Diarylisoxazole%2520hsp90%2520chaperone%2520inhibitors%253A%2520Potential%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D196%26epage%3D218%26doi%3D10.1021%2Fjm701018h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgognoni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N. G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fromont, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padfield, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radimerski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmonite, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walls, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span> </span><span class="NLM_article-title">Combining hit identification strategies: Fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the hsp90 molecular chaperone</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4794</span><span class="NLM_x">–</span> <span class="NLM_lpage">4809</span><span class="refDoi"> DOI: 10.1021/jm900357y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900357y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1ehsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4794-4809&author=P.+A.+Broughauthor=X.+Barrilauthor=J.+Borgognoniauthor=P.+Cheneauthor=N.+G.+M.+Daviesauthor=B.+Davisauthor=M.+J.+Drysdaleauthor=B.+Dymockauthor=S.+A.+Ecclesauthor=C.+Garcia-Echeverriaauthor=C.+Fromontauthor=A.+Hayesauthor=R.+E.+Hubbardauthor=A.+M.+Jordanauthor=M.+R.+Jensenauthor=A.+Masseyauthor=A.+Merrettauthor=A.+Padfieldauthor=R.+Parsonsauthor=T.+Radimerskiauthor=F.+I.+Raynaudauthor=A.+Robertsonauthor=S.+D.+Roughleyauthor=J.+Schoepferauthor=H.+Simmoniteauthor=S.+Y.+Sharpauthor=A.+Surgenorauthor=M.+Valentiauthor=S.+Wallsauthor=P.+Webbauthor=M.+Woodauthor=P.+Workmanauthor=L.+Wright&title=Combining+hit+identification+strategies%3A+Fragment-based+and+in+silico+approaches+to+orally+active+2-aminothieno%5B2%2C3-d%5Dpyrimidine+inhibitors+of+the+hsp90+molecular+chaperone&doi=10.1021%2Fjm900357y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-d]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone</span></div><div class="casAuthors">Brough, Paul A.; Barril, Xavier; Borgognoni, Jenifer; Chene, Patrick; Davies, Nicholas G. M.; Davis, Ben; Drysdale, Martin J.; Dymock, Brian; Eccles, Suzanne A.; Garcia-Echeverria, Carlos; Fromont, Christophe; Hayes, Angela; Hubbard, Roderick E.; Jordan, Allan M.; Jensen, Michael Rugaard; Massey, Andrew; Merrett, Angela; Padfield, Antony; Parsons, Rachel; Radimerski, Thomas; Raynaud, Florence I.; Robertson, Alan; Roughley, Stephen D.; Schoepfer, Joseph; Simmonite, Heather; Sharp, Swee Y.; Surgenor, Allan; Valenti, Melanie; Walls, Steven; Webb, Paul; Wood, Mike; Workman, Paul; Wright, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4794-4809</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the Hsp90 mol. chaperone are showing considerable promise as potential mol. therapeutic agents for the treatment of cancer.  Here we describe novel 2-aminothieno[2,3-d]pyrimidine ATP competitive Hsp90 inhibitors, which were designed by combining structural elements of distinct low affinity hits generated from fragment-based and in silico screening exercises in concert with structural information from X-ray protein crystallog.  Examples from this series have high affinity (IC50 = 50-100 nM) for Hsp90 as measured in a fluorescence polarization (FP) competitive binding assay and are active in human cancer cell lines where they inhibit cell proliferation and exhibit a characteristic profile of depletion of oncogenic proteins and concomitant elevation of Hsp72.  Several compds. caused tumor growth regression at well tolerated doses when administered orally in a human BT474 human breast cancer xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqofpAier7tW7Vg90H21EOLACvtfcHk0liMkhYltZ5iYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1ehsbs%253D&md5=4d1988060b0f87dc776e1972ea14808e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm900357y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900357y%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DDavies%26aufirst%3DN.%2BG.%2BM.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26aulast%3DFromont%26aufirst%3DC.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMerrett%26aufirst%3DA.%26aulast%3DPadfield%26aufirst%3DA.%26aulast%3DParsons%26aufirst%3DR.%26aulast%3DRadimerski%26aufirst%3DT.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobertson%26aufirst%3DA.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DSchoepfer%26aufirst%3DJ.%26aulast%3DSimmonite%26aufirst%3DH.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWalls%26aufirst%3DS.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26atitle%3DCombining%2520hit%2520identification%2520strategies%253A%2520Fragment-based%2520and%2520in%2520silico%2520approaches%2520to%2520orally%2520active%25202-aminothieno%255B2%252C3-d%255Dpyrimidine%2520inhibitors%2520of%2520the%2520hsp90%2520molecular%2520chaperone%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4794%26epage%3D4809%26doi%3D10.1021%2Fjm900357y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Davies, N. G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoffrey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansell, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scriven, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmonite, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P.</span><span> </span><span class="NLM_article-title">Targeting conserved water molecules: design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6770</span><span class="NLM_x">–</span> <span class="NLM_lpage">6789</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.08.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1016%2Fj.bmc.2012.08.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=23018093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVSltrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=6770-6789&author=N.+G.+M.+Daviesauthor=H.+Browneauthor=B.+Davisauthor=M.+J.+Drysdaleauthor=N.+Foloppeauthor=S.+Geoffreyauthor=B.+Gibbonsauthor=T.+Hartauthor=R.+Hubbardauthor=M.+R.+Jensenauthor=H.+Mansellauthor=A.+Masseyauthor=N.+Matassovaauthor=J.+D.+Mooreauthor=J.+Murrayauthor=R.+Prattauthor=S.+Rayauthor=A.+Robertsonauthor=S.+D.+Roughleyauthor=J.+Schoepferauthor=K.+Scrivenauthor=H.+Simmoniteauthor=S.+Stokesauthor=A.+Surgenorauthor=P.+Webbauthor=M.+Woodauthor=L.+Wrightauthor=P.+Brough&title=Targeting+conserved+water+molecules%3A+design+of+4-aryl-5-cyanopyrrolo%5B2%2C3-d%5Dpyrimidine+Hsp90+inhibitors+using+fragment-based+screening+and+structure-based+optimization&doi=10.1016%2Fj.bmc.2012.08.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting conserved water molecules: Design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimization</span></div><div class="casAuthors">Davies, Nicholas G. M.; Browne, Helen; Davis, Ben; Drysdale, Martin J.; Foloppe, Nicolas; Geoffrey, Stephanie; Gibbons, Ben; Hart, Terance; Hubbard, Roderick; Jensen, Michael Rugaard; Mansell, Howard; Massey, Andrew; Matassova, Natalia; Moore, Jonathan D.; Murray, James; Pratt, Robert; Ray, Stuart; Robertson, Alan; Roughley, Stephen D.; Schoepfer, Joseph; Scriven, Kirsten; Simmonite, Heather; Stokes, Stephen; Surgenor, Allan; Webb, Paul; Wood, Mike; Wright, Lisa; Brough, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6770-6789</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibitors of the Hsp90 mol. chaperone are showing promise as anti-cancer agents.  Here the authors describe a series of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine ATP competitive Hsp90 inhibitors that were identified following structure-driven optimization of purine hits revealed by NMR based screening of a proprietary fragment library.  Ligand-Hsp90 x-ray structures combined with mol. modeling led to the rational displacement of a conserved water mol. leading to enhanced affinity for Hsp90 as measured by fluorescence polarization, isothermal titrn. calorimetry and surface plasmon resonance assays.  This displacement was achieved with a nitrile group, presenting an example of efficient gain in binding affinity with minimal increase in mol. wt.  Some compds. in this chem. series inhibit the proliferation of human cancer cell lines in vitro and cause depletion of oncogenic Hsp90 client proteins and concomitant elevation of the co-chaperone Hsp70.  In addn., one compd. was demonstrated to be orally bioavailable in the mouse.  This work demonstrates the power of structure-based design for the rapid evolution of potent Hsp90 inhibitors and the importance of considering conserved water mols. in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMAwVhZUzKD7Vg90H21EOLACvtfcHk0ljfGFUKOHZxZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVSltrvN&md5=69c85da95d07bd488f07eaf503c978f4</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.08.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.08.050%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DN.%2BG.%2BM.%26aulast%3DBrowne%26aufirst%3DH.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DGeoffrey%26aufirst%3DS.%26aulast%3DGibbons%26aufirst%3DB.%26aulast%3DHart%26aufirst%3DT.%26aulast%3DHubbard%26aufirst%3DR.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DMansell%26aufirst%3DH.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMatassova%26aufirst%3DN.%26aulast%3DMoore%26aufirst%3DJ.%2BD.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DPratt%26aufirst%3DR.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DRobertson%26aufirst%3DA.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DSchoepfer%26aufirst%3DJ.%26aulast%3DScriven%26aufirst%3DK.%26aulast%3DSimmonite%26aufirst%3DH.%26aulast%3DStokes%26aufirst%3DS.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DBrough%26aufirst%3DP.%26atitle%3DTargeting%2520conserved%2520water%2520molecules%253A%2520design%2520of%25204-aryl-5-cyanopyrrolo%255B2%252C3-d%255Dpyrimidine%2520Hsp90%2520inhibitors%2520using%2520fragment-based%2520screening%2520and%2520structure-based%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D6770%26epage%3D6789%26doi%3D10.1016%2Fj.bmc.2012.08.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span> </span><span class="NLM_article-title">How well can fragments explore accessed chemical space? A case study from heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3989</span><span class="NLM_x">–</span> <span class="NLM_lpage">4005</span><span class="refDoi"> DOI: 10.1021/jm200350g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200350g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFymurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3989-4005&author=S.+D.+Roughleyauthor=R.+E.+Hubbard&title=How+well+can+fragments+explore+accessed+chemical+space%3F+A+case+study+from+heat+shock+protein+90&doi=10.1021%2Fjm200350g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">How Well Can Fragments Explore Accessed Chemical Space? A Case Study from Heat Shock Protein 90</span></div><div class="casAuthors">Roughley, Stephen D.; Hubbard, Roderick E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3989-4005</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This article summerizes the published literature on the generation of inhibitors and design of drug against the mol. chaperone, heat shock protein 90 (Hsp90), as potential therapeutics to treat cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocGw-54Mo8SrVg90H21EOLACvtfcHk0ljfGFUKOHZxZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFymurs%253D&md5=90c2c8028cb460c0c6fdc956e7daae28</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm200350g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200350g%26sid%3Dliteratum%253Aachs%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26atitle%3DHow%2520well%2520can%2520fragments%2520explore%2520accessed%2520chemical%2520space%253F%2520A%2520case%2520study%2520from%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3989%26epage%3D4005%26doi%3D10.1021%2Fjm200350g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Barker, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, R. K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corden, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falque, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelin, E. M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesterkamp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichihara, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minucci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalbetti, C. A. G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittaker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarnold, C. J.</span><span> </span><span class="NLM_article-title">Fragment-based identification of hsp90 inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span><span class="refDoi"> DOI: 10.1002/cmdc.200900011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1002%2Fcmdc.200900011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=19301319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmslChtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=963-966&author=J.+J.+Barkerauthor=O.+Barkerauthor=R.+Boggioauthor=V.+Chauhanauthor=R.+K.+Y.+Chengauthor=V.+Cordenauthor=S.+M.+Courtneyauthor=N.+Edwardsauthor=V.+M.+Falqueauthor=F.+Fusarauthor=M.+Gardinerauthor=E.+M.+N.+Hamelinauthor=T.+Hesterkampauthor=O.+Ichiharaauthor=R.+S.+Jonesauthor=O.+Matherauthor=C.+Mercurioauthor=S.+Minucciauthor=C.+A.+G.+N.+Montalbettiauthor=A.+Mullerauthor=D.+Patelauthor=B.+G.+Phillipsauthor=M.+Varasiauthor=M.+Whittakerauthor=D.+Winklerauthor=C.+J.+Yarnold&title=Fragment-based+identification+of+hsp90+inhibitors&doi=10.1002%2Fcmdc.200900011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based Identification of Hsp90 Inhibitors</span></div><div class="casAuthors">Barker, John J.; Barker, Oliver; Boggio, Roberto; Chauhan, Viddhata; Cheng, Robert K. Y.; Corden, Vincent; Courtney, Stephen M.; Edwards, Neil; Falque, Virginie M.; Fusar, Fulvia; Gardiner, Mihaly; Hamelin, Estelle M. N.; Hesterkamp, Thomas; Ichihara, Osamu; Jones, Richard S.; Mather, Owen; Mercurio, Ciro; Minucci, Saverio; Montalbetti, Christian A. G. N.; Muller, Annett; Patel, Deepti; Phillips, Banu G.; Varasi, Mario; Whittaker, Mark; Winkler, Dirk; Yarnold, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">963-966</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) plays a key role in stress response and protection of the cell against the effects of mutation.  Herein we report the identification of an Hsp90 inhibitor identified by fragment screening using a high-concn. biochem. assay, as well as its optimization by in silico searching coupled with a structure-based drug design (SBDD) approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsaGeZbmBYH7Vg90H21EOLACvtfcHk0lh1vyE3YZyX-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmslChtbk%253D&md5=c44357e5d1b341c6bc540798951a687f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900011%26sid%3Dliteratum%253Aachs%26aulast%3DBarker%26aufirst%3DJ.%2BJ.%26aulast%3DBarker%26aufirst%3DO.%26aulast%3DBoggio%26aufirst%3DR.%26aulast%3DChauhan%26aufirst%3DV.%26aulast%3DCheng%26aufirst%3DR.%2BK.%2BY.%26aulast%3DCorden%26aufirst%3DV.%26aulast%3DCourtney%26aufirst%3DS.%2BM.%26aulast%3DEdwards%26aufirst%3DN.%26aulast%3DFalque%26aufirst%3DV.%2BM.%26aulast%3DFusar%26aufirst%3DF.%26aulast%3DGardiner%26aufirst%3DM.%26aulast%3DHamelin%26aufirst%3DE.%2BM.%2BN.%26aulast%3DHesterkamp%26aufirst%3DT.%26aulast%3DIchihara%26aufirst%3DO.%26aulast%3DJones%26aufirst%3DR.%2BS.%26aulast%3DMather%26aufirst%3DO.%26aulast%3DMercurio%26aufirst%3DC.%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DMontalbetti%26aufirst%3DC.%2BA.%2BG.%2BN.%26aulast%3DMuller%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DPhillips%26aufirst%3DB.%2BG.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DWhittaker%26aufirst%3DM.%26aulast%3DWinkler%26aufirst%3DD.%26aulast%3DYarnold%26aufirst%3DC.%2BJ.%26atitle%3DFragment-based%2520identification%2520of%2520hsp90%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D963%26epage%3D966%26doi%3D10.1002%2Fcmdc.200900011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Roughley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span> </span><span class="NLM_article-title">Hsp90 inhibitors and drugs from fragment and virtual screening</span> <span class="citation_source-journal">Top. Curr. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1007/128_2011_181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1007%2F128_2011_181" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2011&pages=61-82&author=S.+Roughleyauthor=L.+Wrightauthor=P.+Broughauthor=A.+Masseyauthor=R.+E.+Hubbard&title=Hsp90+inhibitors+and+drugs+from+fragment+and+virtual+screening&doi=10.1007%2F128_2011_181"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2F128_2011_181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F128_2011_181%26sid%3Dliteratum%253Aachs%26aulast%3DRoughley%26aufirst%3DS.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DBrough%26aufirst%3DP.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26atitle%3DHsp90%2520inhibitors%2520and%2520drugs%2520from%2520fragment%2520and%2520virtual%2520screening%26jtitle%3DTop.%2520Curr.%2520Chem.%26date%3D2011%26volume%3D317%26spage%3D61%26epage%3D82%26doi%3D10.1007%2F128_2011_181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Shapiro, G. I</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dezube, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayrton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahadevan, D.</span><span> </span><span class="NLM_article-title">First-in-human phase I dose escalation study of a second-generation non-ansamycin HSP90 inhibitor, AT13387, in patients with advanced solid tumors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-0979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1158%2F1078-0432.CCR-14-0979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=25336693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC2MXis12ltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=87-97&author=G.+I+Shapiroauthor=E.+Kwakauthor=B.+J.+Dezubeauthor=M.+Yuleauthor=J.+Ayrtonauthor=J.+Lyonsauthor=D.+Mahadevan&title=First-in-human+phase+I+dose+escalation+study+of+a+second-generation+non-ansamycin+HSP90+inhibitor%2C+AT13387%2C+in+patients+with+advanced+solid+tumors&doi=10.1158%2F1078-0432.CCR-14-0979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">First-in-Human Phase I Dose Escalation Study of a Second-Generation Non-Ansamycin HSP90 Inhibitor, AT13387, in Patients with Advanced Solid Tumors</span></div><div class="casAuthors">Shapiro, Geoffrey I.; Kwak, Eunice; Dezube, Bruce J.; Yule, Murray; Ayrton, John; Lyons, John; Mahadevan, Daruka</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-97</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: AT13387 is a potent second-generation, fragment-derived HSP90 inhibitor.  This phase I study investigated the max. tolerated dose (MTD)/recommended phase II dose (RP2D) and safety, pharmacokinetic, and pharmacodynamic profiles of two AT13387 regimens in a refractory solid tumor population.  Exptl. Design: Std. 3+3 dose escalation was used.  MTD and RP2D detns. were based on the occurrence of dose-limiting toxicities (DLT) and overall toxicity, resp.  Pharmacokinetic parameters were measured after single and multiple doses.  AT13387-mediated induction of HSP70 was evaluated in plasma, peripheral blood mononuclear cells, and paired tumor biopsies.  Results: Sixty-two patients were treated with doses ranging from 10 to 120 mg/m2 twice weekly and 150 to 310 mg/m2 once weekly (both for 3 wk every 28 days).  One DLT of visual disturbance occurred at 120 mg/m2, which was considered the MTD and RP2D for the twice-weekly regimen.  No formal DLTs occurred in the once-weekly regimen, but multiple moderately severe toxicities, including diarrhea, nausea, vomiting, fatigue, and systemic infusion reactions, led to selection of 260 mg/m2 as the RP2D.  Exposures of AT13387 increased proportionally with dose.  Target engagement as measured by HSP70 induction occurred in plasma and tumor biopsy samples.  One patient with gastrointestinal stromal tumor (GIST) who had progressive disease on imatinib had a partial response and remained on treatment for 10 mo.  Twenty-one patients (34%) had stable disease, which lasted >120 days in 7 patients.  Conclusion: AT13387 administered once or twice weekly has an acceptable safety profile and demonstrated evidence of target engagement and preliminary antitumor activity.  Clin Cancer Res; 21(1); 87-97. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB7A3RmZpiAbVg90H21EOLACvtfcHk0lh1vyE3YZyX-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXis12ltA%253D%253D&md5=7683701e7cde5f4b599c2e6bdb8cd6ac</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-0979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-0979%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DG.%2BI%26aulast%3DKwak%26aufirst%3DE.%26aulast%3DDezube%26aufirst%3DB.%2BJ.%26aulast%3DYule%26aufirst%3DM.%26aulast%3DAyrton%26aufirst%3DJ.%26aulast%3DLyons%26aufirst%3DJ.%26aulast%3DMahadevan%26aufirst%3DD.%26atitle%3DFirst-in-human%2520phase%2520I%2520dose%2520escalation%2520study%2520of%2520a%2520second-generation%2520non-ansamycin%2520HSP90%2520inhibitor%252C%2520AT13387%252C%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26spage%3D87%26epage%3D97%26doi%3D10.1158%2F1078-0432.CCR-14-0979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Woodhead, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angove, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyle, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosme, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parra, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trewartha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinkovic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolford, A. J. A.</span><span> </span><span class="NLM_article-title">Discovery of (2,4-Dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone hsp90 by fragment based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5956</span><span class="NLM_x">–</span> <span class="NLM_lpage">5969</span><span class="refDoi"> DOI: 10.1021/jm100060b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100060b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVCitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5956-5969&author=A.+J.+Woodheadauthor=H.+Angoveauthor=M.+G.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=J.+E.+Coyleauthor=J.+Cosmeauthor=B.+Grahamauthor=P.+J.+Dayauthor=R.+Downhamauthor=L.+Fazalauthor=R.+Feltellauthor=E.+Figueroaauthor=M.+Fredericksonauthor=J.+Lewisauthor=R.+McMenaminauthor=C.+W.+Murrayauthor=M.+A.+O%E2%80%99Brienauthor=L.+Parraauthor=S.+Patelauthor=T.+Phillipsauthor=D.+C.+Reesauthor=S.+Richauthor=D.+M.+Smithauthor=G.+Trewarthaauthor=M.+Vinkovicauthor=B.+Williamsauthor=A.+J.+A.+Woolford&title=Discovery+of+%282%2C4-Dihydroxy-5-isopropylphenyl%29-%5B5-%284-methylpiperazin-1-ylmethyl%29-1%2C3-dihydroisoindol-2-yl%5Dmethanone+%28AT13387%29%2C+a+novel+inhibitor+of+the+molecular+chaperone+hsp90+by+fragment+based+drug+design&doi=10.1021%2Fjm100060b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (2,4-Dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a Novel Inhibitor of the Molecular Chaperone Hsp90 by Fragment Based Drug Design</span></div><div class="casAuthors">Woodhead, Andrew J.; Angove, Hayley; Carr, Maria G.; Chessari, Gianni; Congreve, Miles; Coyle, Joseph E.; Cosme, Jose; Graham, Brent; Day, Philip J.; Downham, Robert; Fazal, Lynsey; Feltell, Ruth; Figueroa, Eva; Frederickson, Martyn; Lewis, Jonathan; McMenamin, Rachel; Murray, Christopher W.; O'Brien, M. Alistair; Parra, Lina; Patel, Sahil; Phillips, Theresa; Rees, David C.; Rich, Sharna; Smith, Donna-Michelle; Trewartha, Gary; Vinkovic, Mladen; Williams, Brian; Woolford, Alison J.-A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5956-5969</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the mol. chaperone heat shock protein 90 (Hsp90) are currently generating significant interest in clin. development as potential treatments for cancer.  In a preceding publication (DOI: 10.1021/jm100059d) we describe Astex's approach to screening fragments against Hsp90 and the subsequent optimization of two hits into leads with inhibitory activities in the low nanomolar range.  This paper describes the structure guided optimization of the 2,4-dihydroxybenzamide lead mol. 1 and details some of the drug discovery strategies employed in the identification of AT13387 (35), which has progressed through preclin. development and is currently being tested in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEEtcgAmkVk7Vg90H21EOLACvtfcHk0lgCwT7Qo4iGYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVCitrg%253D&md5=a2d2ac6dd9e9ba4cb89f83c32727a1d8</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm100060b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100060b%26sid%3Dliteratum%253Aachs%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DAngove%26aufirst%3DH.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DCosme%26aufirst%3DJ.%26aulast%3DGraham%26aufirst%3DB.%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DDownham%26aufirst%3DR.%26aulast%3DFazal%26aufirst%3DL.%26aulast%3DFeltell%26aufirst%3DR.%26aulast%3DFigueroa%26aufirst%3DE.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%2BA.%26aulast%3DParra%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPhillips%26aufirst%3DT.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DRich%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DD.%2BM.%26aulast%3DTrewartha%26aufirst%3DG.%26aulast%3DVinkovic%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DB.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%2BA.%26atitle%3DDiscovery%2520of%2520%25282%252C4-Dihydroxy-5-isopropylphenyl%2529-%255B5-%25284-methylpiperazin-1-ylmethyl%2529-1%252C3-dihydroisoindol-2-yl%255Dmethanone%2520%2528AT13387%2529%252C%2520a%2520novel%2520inhibitor%2520of%2520the%2520molecular%2520chaperone%2520hsp90%2520by%2520fragment%2520based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5956%26epage%3D5969%26doi%3D10.1021%2Fjm100060b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span><span class="refDoi"> DOI: 10.1016/j.ab.2004.05.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1016%2Fj.ab.2004.05.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=15325294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFeltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2004&pages=261-273&author=Z.+Nikolovska-Coleskaauthor=R.+Wangauthor=X.+Fangauthor=H.+Panauthor=Y.+Tomitaauthor=P.+Liauthor=P.+P.+Rollerauthor=K.+Krajewskiauthor=N.+G.+Saitoauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Development+and+optimization+of+a+binding+assay+for+the+XIAP+BIR3+domain+using+fluorescence+polarization&doi=10.1016%2Fj.ab.2004.05.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization</span></div><div class="casAuthors">Nikolovska-Coleska, Zaneta; Wang, Renxiao; Fang, Xueliang; Pan, Hongguang; Tomita, York; Li, Peng; Roller, Peter P.; Krajewski, Krzysztof; Saito, Naoyuki G.; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">261-273</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The X-linked inhibitor of apoptosis protein (XIAP) is a potent cellular inhibitor of apoptosis.  Designing small-mol. inhibitors that target the BIR3 domain of XIAP, where Smac/DIABLO (second mitochondria-derived activator of caspase/direct IAP-binding protein with low pI) and caspase-9 bind, is a promising strategy for inhibiting the antiapoptotic activity of XIAP and for overcoming apoptosis resistance of cancer cells mediated by XIAP.  Herein, we report the development of a homogeneous high-throughput assay based on fluorescence polarization for measuring the binding affinities of small-mol. inhibitors to the BIR3 domain of XIAP.  Among four fluorescent probes tested, a mutated N-terminal Smac peptide (AbuRPFK-(5-Fam)-NH2) showed the highest affinity (Kd = 17.92 nM) and a large dynamic range (ΔmP=231±0.9), and was selected as the most suitable probe for the binding assay.  The binding conditions (DMSO tolerance and stability) have been investigated.  Under optimized conditions, a Z' factor of 0.88 was achieved in a 96-well format for high-throughput screening.  It was found that the popular Cheng-Prusoff equation is invalid for the calcn. of the competitive inhibition consts. (Ki values) for inhibitors in the FP-based competitive binding assay conditions, and accordingly, a new math. equation was developed, validated, and used to compute the Ki values.  An assocd. Web-based computer program was also developed for this task.  Several known Smac peptides with high and low affinities have been evaluated under the assay conditions and the results obtained indicated that the FP-based competitive binding assay performs correctly as designed: it can quant. and accurately det. the binding affinities of Smac-based peptide inhibitors with a wide range of affinities, and is suitable for high-throughput screening of inhibitors binding to the XIAP BIR3 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWjEsqtWsZRbVg90H21EOLACvtfcHk0lgCwT7Qo4iGYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFeltL0%253D&md5=23cade47a4996c7ca4c01278d3e0d3a6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2004.05.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2004.05.055%26sid%3Dliteratum%253Aachs%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DPan%26aufirst%3DH.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DN.%2BG.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDevelopment%2520and%2520optimization%2520of%2520a%2520binding%2520assay%2520for%2520the%2520XIAP%2520BIR3%2520domain%2520using%2520fluorescence%2520polarization%26jtitle%3DAnal.%2520Biochem.%26date%3D2004%26volume%3D332%26spage%3D261%26epage%3D273%26doi%3D10.1016%2Fj.ab.2004.05.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Murray, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span> </span><span class="NLM_article-title">Off-Rate Screening (ORS) By Surface Plasmon Resonance. An efficient method to kinetically sample hit to lead chemical space from unpurified reaction products</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2845</span><span class="NLM_x">–</span> <span class="NLM_lpage">2850</span><span class="refDoi"> DOI: 10.1021/jm401848a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401848a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVWguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2845-2850&author=J.+B.+Murrayauthor=S.+D.+Roughleyauthor=N.+Matassovaauthor=P.+A.+Brough&title=Off-Rate+Screening+%28ORS%29+By+Surface+Plasmon+Resonance.+An+efficient+method+to+kinetically+sample+hit+to+lead+chemical+space+from+unpurified+reaction+products&doi=10.1021%2Fjm401848a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Off-Rate Screening (ORS) By Surface Plasmon Resonance. An Efficient Method to Kinetically Sample Hit to Lead Chemical Space from Unpurified Reaction Products</span></div><div class="casAuthors">Murray, James B.; Roughley, Stephen D.; Matassova, Natalia; Brough, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2845-2850</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dissocn. rate const. kd (off-rate) is the component of ligand-protein binding with the most significant potential to enhance compd. potency.  Here we provide theor. and empirical data to show that this parameter can be detd. accurately from unpurified reaction products contg. designed test compds.  This screening protocol is amenable to parallel chem., provides efficiencies of time and materials, and complements existing methodologies for the hit-to-lead phase in fragment-based drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGounOUxQkuyZLVg90H21EOLACvtfcHk0ljJg-CZIJ_lmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVWguro%253D&md5=d3744f00df767e349024641e876e8100</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm401848a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401848a%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DJ.%2BB.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DMatassova%26aufirst%3DN.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26atitle%3DOff-Rate%2520Screening%2520%2528ORS%2529%2520By%2520Surface%2520Plasmon%2520Resonance.%2520An%2520efficient%2520method%2520to%2520kinetically%2520sample%2520hit%2520to%2520lead%2520chemical%2520space%2520from%2520unpurified%2520reaction%2520products%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2845%26epage%3D2850%26doi%3D10.1021%2Fjm401848a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Brough, P. A.; Macias, A.; Roughley, S. D.; Stokes, S.; Davies, N. G. M.</span><span> </span><span class="NLM_article-title">Preparation of tetrahydroisoquinoline compounds and their use as pyruvate dehydrogenase kinase inhibitors</span>. PCT international application WO2015040424,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=P.+A.+Brough&author=A.+Macias&author=S.+D.+Roughley&author=S.+Stokes&author=N.+G.+M.+Davies&title=Preparation+of+tetrahydroisoquinoline+compounds+and+their+use+as+pyruvate+dehydrogenase+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26atitle%3DPreparation%2520of%2520tetrahydroisoquinoline%2520compounds%2520and%2520their%2520use%2520as%2520pyruvate%2520dehydrogenase%2520kinase%2520inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Brough, P. A.; Macias, A.; Roughley, S. D.; Wang, Y.; Parsons, R. J.; Northfield, C. J.</span><span> </span><span class="NLM_article-title">Preparation of resorcinol N-aryl amide compounds, for use as pyruvate dehydrogenase kinase inhibitors</span>. PCT international application WO2015040425,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=P.+A.+Brough&author=A.+Macias&author=S.+D.+Roughley&author=Y.+Wang&author=R.+J.+Parsons&author=C.+J.+Northfield&title=Preparation+of+resorcinol+N-aryl+amide+compounds%2C+for+use+as+pyruvate+dehydrogenase+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26atitle%3DPreparation%2520of%2520resorcinol%2520N-aryl%2520amide%2520compounds%252C%2520for%2520use%2520as%2520pyruvate%2520dehydrogenase%2520kinase%2520inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Kukimoto-Niino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokmakov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohbayashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiromizu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsusue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirouzu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, S.</span><span> </span><span class="NLM_article-title">Inhibitor-bound structures of human pyruvate dehydrogenase kinase 4</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">763</span><span class="NLM_x">–</span> <span class="NLM_lpage">773</span><span class="refDoi"> DOI: 10.1107/S090744491102405X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1107%2FS090744491102405X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=763-773&author=M.+Kukimoto-Niinoauthor=A.+Tokmakovauthor=T.+Teradaauthor=N.+Ohbayashiauthor=T.+Fujimotoauthor=S.+Gomiauthor=I.+Shiromizuauthor=M.+Kawamotoauthor=T.+Matsusueauthor=M.+Shirouzuauthor=S.+Yokoyama&title=Inhibitor-bound+structures+of+human+pyruvate+dehydrogenase+kinase+4&doi=10.1107%2FS090744491102405X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1107%2FS090744491102405X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS090744491102405X%26sid%3Dliteratum%253Aachs%26aulast%3DKukimoto-Niino%26aufirst%3DM.%26aulast%3DTokmakov%26aufirst%3DA.%26aulast%3DTerada%26aufirst%3DT.%26aulast%3DOhbayashi%26aufirst%3DN.%26aulast%3DFujimoto%26aufirst%3DT.%26aulast%3DGomi%26aufirst%3DS.%26aulast%3DShiromizu%26aufirst%3DI.%26aulast%3DKawamoto%26aufirst%3DM.%26aulast%3DMatsusue%26aufirst%3DT.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DYokoyama%26aufirst%3DS.%26atitle%3DInhibitor-bound%2520structures%2520of%2520human%2520pyruvate%2520dehydrogenase%2520kinase%25204%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D763%26epage%3D773%26doi%3D10.1107%2FS090744491102405X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Stockwin, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollingshead, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, D. L.</span><span> </span><span class="NLM_article-title">Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">2510</span><span class="NLM_x">–</span> <span class="NLM_lpage">2519</span><span class="refDoi"> DOI: 10.1002/ijc.25499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1002%2Fijc.25499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=20533281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGhtrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2010&pages=2510-2519&author=L.+H.+Stockwinauthor=S.+X.+Yuauthor=S.+Borgelauthor=C.+Hancockauthor=T.+L.+Wolfeauthor=L.+R.+Phillipsauthor=M.+G.+Hollingsheadauthor=D.+L.+Newton&title=Sodium+dichloroacetate+selectively+targets+cells+with+defects+in+the+mitochondrial+ETC&doi=10.1002%2Fijc.25499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC</span></div><div class="casAuthors">Stockwin, Luke H.; Yu, Sherry X.; Borgel, Suzanne; Hancock, Chad; Wolfe, Tracy L.; Phillips, Lawrence R.; Hollingshead, Melinda G.; Newton, Dianne L.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2510-2519</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The "Warburg effect," also termed aerobic glycolysis, describes the increased reliance of cancer cells on glycolysis for ATP prodn., even in the presence of oxygen.  Consequently, there is continued interest in inhibitors of glycolysis as cancer therapeutics.  One example is dichloroacetate (DCA), a pyruvate mimetic that stimulates oxidative phosphorylation through inhibition of pyruvate dehydrogenase kinase.  In this study, the mechanistic basis for DCA anti-cancer activity was re-evaluated in vitro using biochem., cellular and proteomic approaches.  Results demonstrated that DCA is relatively inactive (IC50 ≥ 17 mM, 48 h), induces apoptosis only at high concns. (≥25 mM, 48 h) and is not cancer cell selective.  Subsequent 2D-PAGE proteomic anal. confirmed DCA-induced growth suppression without apoptosis induction.  Furthermore, DCA depolarizes mitochondria and promotes reactive oxygen species (ROS) generation in all cell types.  However, DCA was found to have selective activity against rho(0) cells [mitochondrial DNA (mtDNA) deficient] and to synergize with 2-deoxyglucose in complex IV deficient HCT116 p53(-/-) cells.  DCA also synergized in vitro with cisplatin and topotecan, two antineoplastic agents known to damage mitochondrial DNA.  These data suggest that in cells "hardwired" to selectively utilize glycolysis for ATP generation (e.g., through mtDNA mutations), the ability of DCA to force oxidative phosphorylation confers selective toxicity.  In conclusion, although we provide a mechanism distinct from that reported previously, the ability of DCA to target cell lines with defects in the electron transport chain and to synergize with existing chemotherapeutics supports further preclin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojrd7D9gluIrVg90H21EOLACvtfcHk0lijS7yg1whYZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGhtrfP&md5=dd0c533822210cb089cc7cba351004f9</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fijc.25499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.25499%26sid%3Dliteratum%253Aachs%26aulast%3DStockwin%26aufirst%3DL.%2BH.%26aulast%3DYu%26aufirst%3DS.%2BX.%26aulast%3DBorgel%26aufirst%3DS.%26aulast%3DHancock%26aufirst%3DC.%26aulast%3DWolfe%26aufirst%3DT.%2BL.%26aulast%3DPhillips%26aufirst%3DL.%2BR.%26aulast%3DHollingshead%26aufirst%3DM.%2BG.%26aulast%3DNewton%26aufirst%3DD.%2BL.%26atitle%3DSodium%2520dichloroacetate%2520selectively%2520targets%2520cells%2520with%2520defects%2520in%2520the%2520mitochondrial%2520ETC%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2010%26volume%3D127%26spage%3D2510%26epage%3D2519%26doi%3D10.1002%2Fijc.25499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Bonnet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allalunis-Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haromy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopaschuk, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puttagunta, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thebaud, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelakis, E. D.</span><span> </span><span class="NLM_article-title">A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1016/j.ccr.2006.10.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1016%2Fj.ccr.2006.10.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=17222789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFClsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=37-51&author=S.+Bonnetauthor=S.+L.+Archerauthor=J.+Allalunis-Turnerauthor=A.+Haromyauthor=C.+Beaulieuauthor=R.+Thompsonauthor=C.+T.+Leeauthor=G.+D.+Lopaschukauthor=L.+Puttaguntaauthor=S.+Bonnetauthor=G.+Harryauthor=K.+Hashimotoauthor=C.+J.+Porterauthor=M.+A.+Andradeauthor=B.+Thebaudauthor=E.+D.+Michelakis&title=A+mitochondria-K%2B+channel+axis+is+suppressed+in+cancer+and+its+normalization+promotes+apoptosis+and+inhibits+cancer+growth&doi=10.1016%2Fj.ccr.2006.10.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth</span></div><div class="casAuthors">Bonnet, Sebastien; Archer, Stephen L.; Allalunis-Turner, Joan; Haromy, Alois; Beaulieu, Christian; Thompson, Richard; Lee, Christopher T.; Lopaschuk, Gary D.; Puttagunta, Lakshmi; Bonnet, Sandra; Harry, Gwyneth; Hashimoto, Kyoko; Porter, Christopher J.; Andrade, Miguel A.; Thebaud, Bernard; Michelakis, Evangelos D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-51</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The unique metabolic profile of cancer (aerobic glycolysis) might confer apoptosis resistance and be therapeutically targeted.  Compared to normal cells, several human cancers have high mitochondrial membrane potential (ΔΨm) and low expression of the K+ channel Kv1.5, both contributing to apoptosis resistance.  Dichloroacetate (DCA) inhibits mitochondrial pyruvate dehydrogenase kinase (PDK), shifts metab. from glycolysis to glucose oxidn., decreases ΔΨm, increases mitochondrial H2O2, and activates Kv channels in all cancer, but not normal, cells; DCA upregulates Kv1.5 by an NFAT1-dependent mechanism.  DCA induces apoptosis, decreases proliferation, and inhibits tumor growth, without apparent toxicity.  Mol. inhibition of PDK2 by siRNA mimics DCA.  The mitochondria-NFAT-Kv axis and PDK are important therapeutic targets in cancer; the orally available DCA is a promising selective anticancer agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocAukkjsEmZLVg90H21EOLACvtfcHk0lijS7yg1whYZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFClsLg%253D&md5=ce8b45e3292469a3ce1af91803785bee</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.10.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.10.020%26sid%3Dliteratum%253Aachs%26aulast%3DBonnet%26aufirst%3DS.%26aulast%3DArcher%26aufirst%3DS.%2BL.%26aulast%3DAllalunis-Turner%26aufirst%3DJ.%26aulast%3DHaromy%26aufirst%3DA.%26aulast%3DBeaulieu%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.%2BT.%26aulast%3DLopaschuk%26aufirst%3DG.%2BD.%26aulast%3DPuttagunta%26aufirst%3DL.%26aulast%3DBonnet%26aufirst%3DS.%26aulast%3DHarry%26aufirst%3DG.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DPorter%26aufirst%3DC.%2BJ.%26aulast%3DAndrade%26aufirst%3DM.%2BA.%26aulast%3DThebaud%26aufirst%3DB.%26aulast%3DMichelakis%26aufirst%3DE.%2BD.%26atitle%3DA%2520mitochondria-K%252B%2520channel%2520axis%2520is%2520suppressed%2520in%2520cancer%2520and%2520its%2520normalization%2520promotes%2520apoptosis%2520and%2520inhibits%2520cancer%2520growth%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D11%26spage%3D37%26epage%3D51%26doi%3D10.1016%2Fj.ccr.2006.10.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Moore, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staniszewska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Alessandro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macias, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, P. C.</span><span> </span><span class="NLM_article-title">VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">12862</span><span class="NLM_x">–</span> <span class="NLM_lpage">12876</span><span class="refDoi"> DOI: 10.18632/oncotarget.2656</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.18632%2Foncotarget.2656" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=25404640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A280%3ADC%252BC2M3ovVyjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=12862-12876&author=J.+D.+Mooreauthor=A.+Staniszewskaauthor=T.+Shawauthor=J.+D%E2%80%99Alessandroauthor=B.+Davisauthor=A.+Surgenorauthor=L.+Bakerauthor=N.+Matassovaauthor=J.+Murrayauthor=A.+Maciasauthor=P.+Broughauthor=M.+Woodauthor=P.+C.+Mahon&title=VER-246608%2C+a+novel+pan-isoform+ATP+competitive+inhibitor+of+pyruvate+dehydrogenase+kinase%2C+disrupts+Warburg+metabolism+and+induces+context-dependent+cytostasis+in+cancer+cells&doi=10.18632%2Foncotarget.2656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells</span></div><div class="casAuthors">Moore Jonathan D; Staniszewska Anna; Shaw Terence; D'Alessandro Jalanie; Davis Ben; Surgenor Alan; Baker Lisa; Matassova Natalia; Murray James; Macias Alba; Brough Paul; Wood Mike; Mahon Patrick C</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">12862-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pyruvate dehydrogenase kinase (PDK) is a pivotal enzyme in cellular energy metabolism that has previously been implicated in cancer through both RNAi based studies and clinical correlations with poor prognosis in several cancer types.  Here, we report the discovery of a novel and selective ATP competitive pan-isoform inhibitor of PDK, VER-246608.  Consistent with a PDK mediated MOA, VER-246608 increased pyruvate dehydrogenase complex (PDC) activity, oxygen consumption and attenuated glycolytic activity.  However, these effects were only observed under D-glucose-depleted conditions and required almost complete ablation of PDC E1α subunit phosphorylation.  VER-246608 was weakly anti-proliferative to cancer cells in standard culture media; however, depletion of either serum or combined D-glucose/L-glutamine resulted in enhanced cellular potency.  Furthermore, this condition-selective cytostatic effect correlated with reduced intracellular pyruvate levels and an attenuated compensatory response involving deamination of L-alanine.  In addition, VER-246608 was found to potentiate the activity of doxorubicin.  In contrast, the lipoamide site inhibitor, Nov3r, demonstrated sub-maximal inhibition of PDK activity and no evidence of cellular activity.  These studies suggest that PDK inhibition may be effective under the nutrient-depleted conditions found in the tumour microenvironment and that combination treatments should be explored to reveal the full potential of this therapeutic strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQq_Bxi2o-MqOxsqfvU0ziafW6udTcc2eY4etgF-NRJmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3ovVyjtQ%253D%253D&md5=6480086dc38b2ebcbfa93b2e611d40f1</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2656%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DJ.%2BD.%26aulast%3DStaniszewska%26aufirst%3DA.%26aulast%3DShaw%26aufirst%3DT.%26aulast%3DD%25E2%2580%2599Alessandro%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DBaker%26aufirst%3DL.%26aulast%3DMatassova%26aufirst%3DN.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DMacias%26aufirst%3DA.%26aulast%3DBrough%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DMahon%26aufirst%3DP.%2BC.%26atitle%3DVER-246608%252C%2520a%2520novel%2520pan-isoform%2520ATP%2520competitive%2520inhibitor%2520of%2520pyruvate%2520dehydrogenase%2520kinase%252C%2520disrupts%2520Warburg%2520metabolism%2520and%2520induces%2520context-dependent%2520cytostasis%2520in%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D12862%26epage%3D12876%26doi%3D10.18632%2Foncotarget.2656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Madhavi Sastry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adzhigirey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annabhimoju, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, W.</span><span> </span><span class="NLM_article-title">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span><span class="refDoi"> DOI: 10.1007/s10822-013-9644-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1007%2Fs10822-013-9644-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=23579614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslalu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=221-234&author=G.+Madhavi+Sastryauthor=M.+Adzhigireyauthor=T.+Dayauthor=R.+Annabhimojuauthor=W.+Sherman&title=Protein+and+ligand+preparation%3A+parameters%2C+protocols%2C+and+influence+on+virtual+screening+enrichments&doi=10.1007%2Fs10822-013-9644-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span></div><div class="casAuthors">Madhavi Sastry, G.; Adzhigirey, Matvey; Day, Tyler; Annabhimoju, Ramakrishna; Sherman, Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-234</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Structure-based virtual screening plays an important role in drug discovery and complements other screening approaches.  In general, protein crystal structures are prepd. prior to docking in order to add hydrogen atoms, optimize hydrogen bonds, remove at. clashes, and perform other operations that are not part of the x-ray crystal structure refinement process.  In addn., ligands must be prepd. to create 3-dimensional geometries, assign proper bond orders, and generate accessible tautomer and ionization states prior to virtual screening.  While the prerequisite for proper system prepn. is generally accepted in the field, an extensive study of the prepn. steps and their effect on virtual screening enrichments has not been performed.  In this work, we systematically explore each of the steps involved in prepg. a system for virtual screening.  We first explore a large no. of parameters using the Glide validation set of 36 crystal structures and 1,000 decoys.  We then apply a subset of protocols to the DUD database.  We show that database enrichment is improved with proper prepn. and that neglecting certain steps of the prepn. process produces a systematic degrdn. in enrichments, which can be large for some targets.  We provide examples illustrating the structural changes introduced by the prepn. that impact database enrichment.  While the work presented here was performed with the Protein Prepn. Wizard and Glide, the insights and guidance are expected to be generalizable to structure-based virtual screening with other docking methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruqN5nIOJtR7Vg90H21EOLACvtfcHk0lhh_I9OSLDo6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslalu7c%253D&md5=259a6d547ef3e1310e091fb50fe8de16</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9644-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9644-8%26sid%3Dliteratum%253Aachs%26aulast%3DMadhavi%2BSastry%26aufirst%3DG.%26aulast%3DAdzhigirey%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAnnabhimoju%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DProtein%2520and%2520ligand%2520preparation%253A%2520parameters%252C%2520protocols%252C%2520and%2520influence%2520on%2520virtual%2520screening%2520enrichments%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D221%26epage%3D234%26doi%3D10.1007%2Fs10822-013-9644-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Holdgate, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A. L.</span><span> </span><span class="NLM_article-title">Kinetic efficiency: the missing metric for enhancing compound quality?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">910</span><span class="NLM_x">–</span> <span class="NLM_lpage">913</span><span class="refDoi"> DOI: 10.1016/j.drudis.2011.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1016%2Fj.drudis.2011.09.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=910-913&author=G.+A.+Holdgateauthor=A.+L.+Gill&title=Kinetic+efficiency%3A+the+missing+metric+for+enhancing+compound+quality%3F&doi=10.1016%2Fj.drudis.2011.09.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DHoldgate%26aufirst%3DG.%2BA.%26aulast%3DGill%26aufirst%3DA.%2BL.%26atitle%3DKinetic%2520efficiency%253A%2520the%2520missing%2520metric%2520for%2520enhancing%2520compound%2520quality%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D910%26epage%3D913%26doi%3D10.1016%2Fj.drudis.2011.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Meng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regenass, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilpert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">Discovery and optimization of 4,5-diarylisoxazoles as potent dual inhibitors of pyruvate dehydrogenase kinase and heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9832</span><span class="NLM_x">–</span> <span class="NLM_lpage">9843</span><span class="refDoi"> DOI: 10.1021/jm5010144</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5010144" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyrurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9832-9843&author=T.+Mengauthor=D.+Zhangauthor=Z.+Xieauthor=T.+Yuauthor=S.+Wuauthor=U.+Regenassauthor=K.+Hilpertauthor=M.+Huangauthor=M.+Gengauthor=J.+Shen&title=Discovery+and+optimization+of+4%2C5-diarylisoxazoles+as+potent+dual+inhibitors+of+pyruvate+dehydrogenase+kinase+and+heat+shock+protein+90&doi=10.1021%2Fjm5010144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and optimization of 4,5-diarylisoxazoles as potent dual inhibitors of pyruvate dehydrogenase kinase and heat shock protein 90</span></div><div class="casAuthors">Meng, Tao; Zhang, Dadong; Xie, Zuoquan; Yu, Ting; Wu, Shuchao; Regenass, Urs; Hilpert, Kurt; Huang, Min; Geng, Meiyu; Shen, Jingkang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9832-9843</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Upregulation of pyruvate dehydrogenase kinase (PDHK) has been obsd. in a variety of cancers.  Inhibition of PDHK offers an attractive opportunity for the development of novel cancer therapies.  To obtain novel PDHK inhibitors, the authors took advantage of the homol. of the ATP-binding pocket between Heat Shock Protein 90 (HSP90) and PDHK, and utilized 4,5-diarylisoxazole based HSP90 inhibitor for structural design.  The efforts led to the identification of I that inhibited PDHK1 with an IC50 value of 17 nM, which, however, showed marginal cellular activity.  Further structural optimization resulted in compd. II with improved cellular activity which could effectively modulate the metabolic profile of cancer cells and lead to the inhibition of cancer cell proliferation, evidenced by the increased oxidative phosphorylation and decreased glycolysis and assocd. oxidative stress.  The results suggested II as an excellent lead compd. and a favorable biol. tool to further evaluate the therapeutic potential of PDHK and HSP90 dual inhibitors in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpX1cvlKuuz7Vg90H21EOLACvtfcHk0lhh_I9OSLDo6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyrurnK&md5=ab2f08b46344868b81247a228b149755</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm5010144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5010144%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DRegenass%26aufirst%3DU.%26aulast%3DHilpert%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520optimization%2520of%25204%252C5-diarylisoxazoles%2520as%2520potent%2520dual%2520inhibitors%2520of%2520pyruvate%2520dehydrogenase%2520kinase%2520and%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9832%26epage%3D9843%26doi%3D10.1021%2Fjm5010144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Baker, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasten, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, T. E.</span><span> </span><span class="NLM_article-title">Marked differences between two isoforms of human pyruvate dehydrogenase kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">15773</span><span class="NLM_x">–</span> <span class="NLM_lpage">15781</span><span class="refDoi"> DOI: 10.1074/jbc.M909488199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1074%2Fjbc.M909488199" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=15773-15781&author=J.+C.+Bakerauthor=X.+Yanauthor=T.+Pengauthor=S.+Kastenauthor=T.+E.+Roche&title=Marked+differences+between+two+isoforms+of+human+pyruvate+dehydrogenase+kinase&doi=10.1074%2Fjbc.M909488199"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M909488199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M909488199%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DJ.%2BC.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DT.%26aulast%3DKasten%26aufirst%3DS.%26aulast%3DRoche%26aufirst%3DT.%2BE.%26atitle%3DMarked%2520differences%2520between%2520two%2520isoforms%2520of%2520human%2520pyruvate%2520dehydrogenase%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D15773%26epage%3D15781%26doi%3D10.1074%2Fjbc.M909488199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Bao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasten, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, T. E.</span><span> </span><span class="NLM_article-title">Pyruvate dehydrogenase kinase isoform 2 activity limited and further inhibited by slowing down the rate of dissociation of ADP</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">13432</span><span class="NLM_x">–</span> <span class="NLM_lpage">13441</span><span class="refDoi"> DOI: 10.1021/bi049488x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi049488x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=13432-13441&author=H.+Baoauthor=S.+A.+Kastenauthor=X.+Yanauthor=T.+E.+Roche&title=Pyruvate+dehydrogenase+kinase+isoform+2+activity+limited+and+further+inhibited+by+slowing+down+the+rate+of+dissociation+of+ADP&doi=10.1021%2Fbi049488x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fbi049488x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi049488x%26sid%3Dliteratum%253Aachs%26aulast%3DBao%26aufirst%3DH.%26aulast%3DKasten%26aufirst%3DS.%2BA.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DRoche%26aufirst%3DT.%2BE.%26atitle%3DPyruvate%2520dehydrogenase%2520kinase%2520isoform%25202%2520activity%2520limited%2520and%2520further%2520inhibited%2520by%2520slowing%2520down%2520the%2520rate%2520of%2520dissociation%2520of%2520ADP%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D13432%26epage%3D13441%26doi%3D10.1021%2Fbi049488x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Weikl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muschler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span> </span><span class="NLM_article-title">C-terminal regions of hsp90 are important for trapping the nucleotide during the ATPase cycle</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">583</span><span class="NLM_x">–</span> <span class="NLM_lpage">592</span><span class="refDoi"> DOI: 10.1006/jmbi.2000.4157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1006%2Fjmbi.2000.4157" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2000&pages=583-592&author=T.+Weiklauthor=P.+Muschlerauthor=K.+Richterauthor=T.+Veitauthor=J.+Reinsteinauthor=J.+Buchner&title=C-terminal+regions+of+hsp90+are+important+for+trapping+the+nucleotide+during+the+ATPase+cycle&doi=10.1006%2Fjmbi.2000.4157"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.2000.4157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.2000.4157%26sid%3Dliteratum%253Aachs%26aulast%3DWeikl%26aufirst%3DT.%26aulast%3DMuschler%26aufirst%3DP.%26aulast%3DRichter%26aufirst%3DK.%26aulast%3DVeit%26aufirst%3DT.%26aulast%3DReinstein%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DC-terminal%2520regions%2520of%2520hsp90%2520are%2520important%2520for%2520trapping%2520the%2520nucleotide%2520during%2520the%2520ATPase%2520cycle%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2000%26volume%3D303%26spage%3D583%26epage%3D592%26doi%3D10.1006%2Fjmbi.2000.4157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tso, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gui, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernstedt-Asterholm, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morlock, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherer, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tambar, U. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, D. T.</span><span> </span><span class="NLM_article-title">Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">4432</span><span class="NLM_x">–</span> <span class="NLM_lpage">4443</span><span class="refDoi"> DOI: 10.1074/jbc.M113.533885</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=10.1074%2Fjbc.M113.533885" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=24356970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFSgs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=4432-4443&author=S.+C.+Tsoauthor=X.+Qiauthor=W.+J.+Guiauthor=C.+Y.+Wuauthor=J.+L.+Chuangauthor=I.+Wernstedt-Asterholmauthor=L.+K.+Morlockauthor=K.+R.+Owensauthor=P.+E.+Schererauthor=N.+S.+Williamsauthor=U.+K.+Tambarauthor=R.+M.+Wynnauthor=D.+T.+Chuang&title=Structure-guided+development+of+specific+pyruvate+dehydrogenase+kinase+inhibitors+targeting+the+ATP-binding+pocket&doi=10.1074%2Fjbc.M113.533885"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48aR"><div class="casContent"><span class="casTitleNuber">48a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided Development of Specific Pyruvate Dehydrogenase Kinase Inhibitors Targeting the ATP-binding Pocket</span></div><div class="casAuthors">Tso, Shih-Chia; Qi, Xiangbing; Gui, Wen-Jun; Wu, Cheng-Yang; Chuang, Jacinta L.; Wernstedt-Asterholm, Ingrid; Morlock, Lorraine K.; Owens, Kyle R.; Scherer, Philipp E.; Williams, Noelle S.; Tambar, Uttam K.; Wynn, R. Max; Chuang, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4432-4443</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinase isoforms (PDKs 1-4) neg. regulate activity of the mitochondrial pyruvate dehydrogenase complex by reversible phosphorylation.  PDK isoforms are up-regulated in obesity, diabetes, heart failure, and cancer and are potential therapeutic targets for these important human diseases.  Here, the authors employed a structure-guided design to convert a known Hsp90 inhibitor to a series of highly specific PDK inhibitors, based on structural conservation in the ATP-binding pocket.  The key step involved the substitution of a carbonyl group in the parent compd. with a sulfonyl in the PDK inhibitors.  The final compd. of this series, 2-[(2,4-dihydroxyphenyl)sulfonyl]isoindoline-4,6-diol, designated PS10, inhibits all four PDK isoforms with IC50 = 0.8 μm for PDK2.  The administration of PS10 (70 mg/kg) to diet-induced obese mice significantly augments pyruvate dehydrogenase complex activity with reduced phosphorylation in different tissues.  Prolonged PS10 treatments result in improved glucose tolerance and notably lessened hepatic steatosis in the mouse model.  The results support the pharmacol. approach of targeting PDK to control both glucose and fat levels in obesity and type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEmYMKZrXKTrVg90H21EOLACvtfcHk0li-SvXPSp5c1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFSgs7w%253D&md5=e3bd48326cc1ab39c76f7bd19734a361</span></div><a href="/servlet/linkout?suffix=cit48a&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.533885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.533885%26sid%3Dliteratum%253Aachs%26aulast%3DTso%26aufirst%3DS.%2BC.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DGui%26aufirst%3DW.%2BJ.%26aulast%3DWu%26aufirst%3DC.%2BY.%26aulast%3DChuang%26aufirst%3DJ.%2BL.%26aulast%3DWernstedt-Asterholm%26aufirst%3DI.%26aulast%3DMorlock%26aufirst%3DL.%2BK.%26aulast%3DOwens%26aufirst%3DK.%2BR.%26aulast%3DScherer%26aufirst%3DP.%2BE.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DTambar%26aufirst%3DU.%2BK.%26aulast%3DWynn%26aufirst%3DR.%2BM.%26aulast%3DChuang%26aufirst%3DD.%2BT.%26atitle%3DStructure-guided%2520development%2520of%2520specific%2520pyruvate%2520dehydrogenase%2520kinase%2520inhibitors%2520targeting%2520the%2520ATP-binding%2520pocket%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D4432%26epage%3D4443%26doi%3D10.1074%2Fjbc.M113.533885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit48b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tso, S. C.; Lou, M.; Wu, C. Y.; Gui, W. J.; Chuang, J. L.; Morlock, L. K.; Williams, N. S.; Wynn, R. M.; Qi, X.; Chuang, D. T.</span><span> </span><span class="NLM_article-title">Development of dihydroxyphenyl sulfonylisoindoline derivatives as liver-targeting pyruvate dehydrogenase Kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span> Published Online: January 13, 2017. <a href="http://pubs.acs.org/doi/abs/10.1021%2Facs.jmedchem.6b01540" class="extLink">http://pubs.acs.org/doi/abs/10.1021%2Facs.jmedchem.6b01540</a> (accessed January 13,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=S.+C.+Tso&author=M.+Lou&author=C.+Y.+Wu&author=W.+J.+Gui&author=J.+L.+Chuang&author=L.+K.+Morlock&author=N.+S.+Williams&author=R.+M.+Wynn&author=X.+Qi&author=D.+T.+Chuang&title=Development+of+dihydroxyphenyl+sulfonylisoindoline+derivatives+as+liver-targeting+pyruvate+dehydrogenase+Kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTso%26aufirst%3DS.%2BC.%26atitle%3DDevelopment%2520of%2520dihydroxyphenyl%2520sulfonylisoindoline%2520derivatives%2520as%2520liver-targeting%2520pyruvate%2520dehydrogenase%2520Kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voltan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melloni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tisato, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celeghini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantinati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secchiero, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zauli, G.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01165</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01165" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=147-156&author=C.+Trapellaauthor=R.+Voltanauthor=E.+Melloniauthor=V.+Tisatoauthor=C.+Celeghiniauthor=S.+Biancoauthor=A.+Fantinatiauthor=S.+Salvadoriauthor=R.+Guerriniauthor=P.+Secchieroauthor=G.+Zauli&title=Design%2C+synthesis%2C+and+biological+characterization+of+novel+mitochondria+targeted+dichloroacetate-loaded+compounds+with+antileukemic+activity&doi=10.1021%2Facs.jmedchem.5b01165"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01165%26sid%3Dliteratum%253Aachs%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DVoltan%26aufirst%3DR.%26aulast%3DMelloni%26aufirst%3DE.%26aulast%3DTisato%26aufirst%3DV.%26aulast%3DCeleghini%26aufirst%3DC.%26aulast%3DBianco%26aufirst%3DS.%26aulast%3DFantinati%26aufirst%3DA.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DSecchiero%26aufirst%3DP.%26aulast%3DZauli%26aufirst%3DG.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520characterization%2520of%2520novel%2520mitochondria%2520targeted%2520dichloroacetate-loaded%2520compounds%2520with%2520antileukemic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D147%26epage%3D156%26doi%3D10.1021%2Facs.jmedchem.5b01165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Zhang, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, K. Y.</span><span> </span><span class="NLM_article-title">Unexpected discovery of dichloroacetate derived adenosine triphosphate competitors targeting pyruvate dehydrogenase kinase to inhibit cancer proliferation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">3562</span><span class="NLM_x">–</span> <span class="NLM_lpage">3568</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01828</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01828" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1eis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3562-3568&author=S.+L.+Zhangauthor=X.+Huauthor=W.+Zhangauthor=K.+Y.+Tam&title=Unexpected+discovery+of+dichloroacetate+derived+adenosine+triphosphate+competitors+targeting+pyruvate+dehydrogenase+kinase+to+inhibit+cancer+proliferation&doi=10.1021%2Facs.jmedchem.5b01828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Unexpected Discovery of Dichloroacetate Derived Adenosine Triphosphate Competitors Targeting Pyruvate Dehydrogenase Kinase To Inhibit Cancer Proliferation</span></div><div class="casAuthors">Zhang, Shao-Lin; Hu, Xiaohui; Zhang, Wen; Tam, Kin Yip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3562-3568</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinases (PDKs) have recently emerged as an attractive target for cancer therapy.  Herein, the authors prepd. a series of compds. derived from dichloroacetate (DCA) which inhibited cancer cells proliferation.  For the first time, the authors have successfully developed DCA derived inhibitors that preferentially bind to the ATP pocket of PDK isoform 1 (PDK1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmY3Q84QJe_bVg90H21EOLACvtfcHk0ljpRY5AVGNw7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1eis7k%253D&md5=fa825a672c4c481c0cc55f59da38b43f</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01828%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%2BL.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DTam%26aufirst%3DK.%2BY.%26atitle%3DUnexpected%2520discovery%2520of%2520dichloroacetate%2520derived%2520adenosine%2520triphosphate%2520competitors%2520targeting%2520pyruvate%2520dehydrogenase%2520kinase%2520to%2520inhibit%2520cancer%2520proliferation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3562%26epage%3D3568%26doi%3D10.1021%2Facs.jmedchem.5b01828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4K" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4K','PDB','5M4K'); return false;">PDB: 5M4K</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4E" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4E','PDB','5M4E'); return false;">PDB: 5M4E</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4H" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4H','PDB','5M4H'); return false;">PDB: 5M4H</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4M4N" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4M4N','PDB','4M4N'); return false;">PDB: 4M4N</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4M" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4M','PDB','5M4M'); return false;">PDB: 5M4M</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4N" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4N','PDB','5M4N'); return false;">PDB: 5M4N</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V25" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V25','PDB','4V25'); return false;">PDB: 4V25</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4P" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4P','PDB','5M4P'); return false;">PDB: 5M4P</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i46"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01478">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_11083"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01478">10.1021/acs.jmedchem.6b01478</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Data relating to screening protocols, X-ray crystallographic studies, protein production, additional compound synthesis, analysis, and characterization (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01478/suppl_file/jm6b01478_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01478/suppl_file/jm6b01478_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01478/suppl_file/jm6b01478_si_001.pdf">jm6b01478_si_001.pdf (692.07 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01478/suppl_file/jm6b01478_si_002.csv">jm6b01478_si_002.csv (2.43 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and structural factors have been deposited with the Protein database. The PDB codes are as follows. Compound <b>10:</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4K">5M4K</a> (PDHK-2), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4E">5M4E</a> (HSP90); <b>21:</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4H">5M4H</a> (HSP90); <b>33a:</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4N">5M4N</a> (PDHK-2); <b>35a:</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4M">5M4M</a> (PDHK-2); <b>38:</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M4P">5M4P</a> (PDHK-2).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01478%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-6" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01478" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990d57689f3c10","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
